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Chapter 1 
General introduction 

General illtroduction 
1.1 Brief history of prenatal diagnosis 
1.1.1 Arnniocentesis 
In the early fifties, prenatal investigation of amniotic fluid started with the evaluation 
of Rhesus sensitization (Bevis, 1950, 1952). It was followed by the discovery that fetal 
gender could be determined by the presence or absence of a sex chromatin body in 
the nuclei of cells in the amniotic fluid (Fuchs and Riis, 1956). 
In 1966, Steele and Breg demonstrated the possibility of culturing and karyotyping 
viabie amniotic fluid ceUs, rnainly of epithelial origin. Further progress was made 
with the refinernent of the technique and timing of arnniocentesis (Thiede et al., 1966; 
Jacobson and Barter, 1967), and the first prenatal diagnosis of Down syndrome 
(Valenti et al., 1968). 
Other important developments, in the same period, were the use of amniocentesis for 
the prenatal detection of biochemical abnormalities (Nadier and Gerbie, 1968), the 
development of ultramicrochemical techniques for rapid prenatal biochemical 
diagnosis (Galjaard et al., 1972, 1977, 1980; Niermeijer et al., 1975), and the finding of 
an association between a raised concentration of alpha-fetoprotein in arnniotic fluid 
and an open neural tube defect of the fetus (Brock and Sutcliffe, 1972). Cytogenetic 
investigations were improved by the discovery of the G-banding technique 
(Seabright, 1971). 
For almost fifteen years alnniocentesis was the only procedure for prenatal 
investigations. At the end of the eighties, more than a quarter of a million 
amniocenteses had been performed and the nurnber to date is probably in the 
rniilions. Nowadays, the safety of second trimester arnniocentesis together with the 
reliability, accuracy and efficiency is weil recognized; it is generally considered as the 
" gold standard". 
Arnniocentesis is usually performed around the 16ih week of pregnancy with a 
cytogenetic result available af ter 10 - 18 days. Second trimester termination of 
pregnancy is not free from medical complications and causes psychological stress 
(Leschot et al., 1982; Thomassen Brepols, 1985). For this reason, developments in 
prenatal diagnosis have led to various new or modified techniques during the past 
decades, arnong others, amniocentesis prior to 15 weeks of gestation (early 
arnniocentesis). It has been established that early arnniocentesis is not a suitable 
alternative to regular arnniocentesis because of a higher risk of pregnancy loss. 
Today, chorionic villus sampling has become the test for first-trimester prenatal 
diagnosis (Cederholm and Axelsson, 1997; Winsor et al., 1999; Johnson et al., 1999). 
1.1.2 Chorionic villi 
Although the fust techniques for 'transcervicaI' chorionic villus sampling (CVS) were 
described in 1958 by Acosta-Sisen, and for 'transabdominal' CVS in 1966 by A!varez 
et al., the fust concept of CVS for feta! diagnosis was published in 1968 by Mohr. 
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He used hysterascopy and was remarkably successful in abtaining villi fram patients 
priar ta elective abartian. Complicatians as damage ta the amniatic sac, matemal 
bleeding, the absence af real-time ultrasaund and the law success rate af charianic 
villus cell culture (Hahnemann, 1974; Kullander & Sandahl, 1973), together with the 
rapid acceptance of amniacentesis delayed any majar research in western cauntries. 
A revival accurred af ter a publishing in China that CVS was successful1y used as a 
method af fetal sex predictian (Anshan Iran and Steel Company, 1975). Russian 
scientists subsequently demonstrated the feasibility of CVS in early prenatal 
diagnasis af inbarn errars of metabalism (Kazy et al., 1982). 
The breakthrough af CVS came with the demanstratian that chorionic villi cauld be 
used far cytagenetic diagnasis withaut the need af cell culture (Simani et al., 1983). 
From that time an, CVS and karyatyping af wlcultured charianic villi became an 
attractive alternative ta amniocentesis. The advantages were obvious; the procedure 
was carried out early in pregnancy, the results were rapidly available, providing a 
diagnosis at 11 - 13 weeks allowing terminatian of pregnancy by suction curettage as 
an outpatient pracedure. The first prenatal diagnasis in The Netherlands in a non-
experimental CVS was perfarmed in June 1983 (Galjaard, 1985; Sachs et al., 1983, 
1985; Jahada et al., 1984). 
After the fust publication of Brambati and Simani in 1983, trials with CVS were 
started in many centres in arder ta gain experience with the sampling and the 
labaratary investigations. Charianic villus sampling became papular and develaped 
rapidly into a widely used prenatal diagnastic pracedure nat aniy far chramasamal 
disarders, but alsa for metabalic disarders ( far early reviews see Galjaard, 1985; 
Kleijer et al., 1986). DNA analysis was faund to be passible for haemaglobinapathies 
(Old et al., 1986) and Duchenne muscular dystraphy (Bakker et al., 1985) (see far early 
reviews Fraccara et al., 1985). 
After almast 10 years af increasing nwnbers af CVS with concomitant decreasing 
numbers af amniacenteses there was a tuming paint due to unsalved problems 
assaciated with CVS. This trend is aisa reflected in the results af our awn centre as 
shown in Figure 1. 
A number af questians can be raised as ta why first-trimester CVS had nat replaced 
second-trimester amniocentesis. 
1) Is there an excess af any sampling related risk for the waman and her fetus in 
comparison ta amniocentesis concerning: 
- Pregnancy loss 
- Vascular disruptive syndromes in the fetus 
- Blaod transfusion between mother and fetus 
2) Are there more laboratory related problems in comparisan to amniatic fluid 
concerning: 
- Laboratory failures 
- Quality af chromosome preparations 
- Discrepancy between prenatal diagnasis and fetal status 
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Figure 1- Nwnber ofamniotic fluid and chorionic vîlli during the years 1976 - 2000 
1.2 Sampling related risks 
1.2.1 Pregnancy loss 
General introduction 
I 
1
1 
'9(j '97 '98 '99 '00 
Yl'ar 
The procedure related risks of pregnancy loss following CVS and amniocentesis have 
been studied extensively world-wide but were difficult to assess due to differences in 
methodology, and the gestational age at the time of the procedure. 
For amniocentesis the risk has been estimated up to 1 % (fetalloss before 28 weeks of 
gestation)(NICHD, 1976; MRC working party, 1978; Golbus et al., 1979; Sachs et al., 
1982,; Canadian collaborative CVS-Amniocentesis clinical trial group, 1989; 
Brandenburg, 1992; Antsaklis, 2000). Transplacental amniocentesis, blood stained 
amniotic fluid, a history of previous spontaneous or induced abortions, and bleeding 
in the current pregnancy tumed out to increase the risk of fetal loss (Tabor et al., 
1986; Brandenburg, 1992; Antsaklis, 2000). 
For CVS, the situation is more difficult to evaluate since the sampling takes place in 
the period of a relatively high rate of spontaneous abortion and two different modes 
of sampling are used (transcervical (TC) and transabdominal (TA) sampling). 
Differences between TC- and TA- CVS associated risks could not be demonstrated in 
two studies (Brambati et al., 1991; Jackson et al., 1992), but in two other studies the 
13 
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risk of TC-CVS was found to be significantly higher than that of TA-CVS, whilst the 
risk of TA-CVS was found to be equal to that of amruocentesis (philip et al., 1991; 
Smidt-Jensen et al., 1992). 
It is generally accepted that the risk of CVS assoeiated pregnancy loss shows an 
inverse correlation with the skill of the operator. The "Ieaming curve" effect for CVS 
takes 50-150 procedures, depending on the operator to aellieve a minimal fetalloss 
rate (Leschot et al., 1989; Rhoads et al., 1989; Jackson et al., 1992; Wijnberger et al., 
2000). According to quality standards issued by the Dutch Society of Obstetrics and 
Gynaecology (NVOG), qualified gynaecologists have to perform a minimum of 30 
supervised procedures before operating on their own patients. The WHO /P AHO 
(1999) has stated that the risk of pregnancy loss is equal aftel' amruocentesis and TA-
CVS in experienced hands. 
1.2.2 Vascular disruptive syndrames 
Aftel' the first report of Firth et al. (1991) on limb reduction aftel' CVS, this matter has 
been studied intensively without clear conclusions. In some studies an assoeiation 
was found between vascular disruptive syndromes and CVS (Mastroiacovo and 
Cavalcanti, 1991; Burton et al., 1992, 1995; Firth et al., 1994, 1997; OIney et al., 1995), 
while in other studies no assoeiation was found (Schloo et al., 1992; Froster and 
Jackson, 1996; WHO/PAHO, 1999). In all studies it was established that in the case of 
limb reduction, the gestational age at sampling ranged :from 8 to 11 weeks. The 
general conclusion has been that CVS should be postponed to late first trimester (11 -
12 weeks)(NICHD, 1993). 
1.2.3 Blood trans fusion between mother and fetus 
Theoretically, the only sampling related risk left is transfusion of blood between 
mother and fetus. Feto-matemal-transfusion (FMT) can occur spontaneously early in 
pregnancy, but is also known to take place in assoeiation with CVS (Los et al., 1989; 
Smidt-Jensen et al., 1993; Jansen et al., 1997). Since large FMT-volumes have been 
established without apparent effect on the pregnancy outcome it has been speculated 
that FMT might be followed by matemo-fetal-transfusions (MFT) as a compensatory 
exchange transfusion (Los et al., 1996). MFT might introduce vaso-active substanees 
into the fetal circulation and cause a vascular accident in the fetus (Quintero et al., 
1992; Los et al., 1999). However, to our knowledge there is only one case of fetal 
demise cleal'ly documented to be caused by FMT (Los et al., 1993) and therefore, 
FMT remains a theoretical risk. 
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1.3. Laboratory related problems 
1.3.1 Laboratory fai/ure 
One of the potential problems is a laboratory failure, consisting of the failure of ceil 
growth, infection, or harvesting failures, resulting in insufficient numbers of 
metaphases, or even no metaphases at all necessary for chromosome analysis. 
Fortunately, the frequency of laboratory failures is very low. For amniotic fluid and 
chorionic villi the laboratory fallure rate is 0.1 % - 0.4% and 0.3% - 2.0%, respectively. 
(Ledbetter et al., 1990, 1992; Lippman et al., 1992; Smidt-Jensen et al., 1993; Lam et al., 
1998; Waters et al., 1999). Our own figures are just at the upper limit for amniotic 
fluid (0.40%) and in the lower region of the reported range for chorionic villi (0.54%) 
(Los et al., in press). 
1.3.2 Quality of chromosome preparations 
Another potential laboratory related problem is poor quality of chromosome 
morphology. The chromosome quality is based on the subjective judgement of the 
technicians and the cytogeneticist. An important parameter characterizing the quality 
of the metaphases is the banding resolution; the ISCN (International ~ystem for 
Hurnan !:ytogenetic Nomenelature) is adhered in order to define the total nurnber of 
bands in the metaphases (lSCN, 1985, 1995; ACC, 1988). 
lt is weil known that the quality of cytogenetic preparations depends on the type of 
cells studied and that the quality varies from preparation to preparation. The 400 
band resolution level should be the aim for prenatal specimens. However, it is not 
always possible to achieve this. 
The nurnber of bands observed in metaphases of short-term cultures of chorionic villi 
ceils (STC-villi)(trophobla.st ceils) is between 200 and 400, which is in fact below the 
usual preferred standard. However, the combined use of STC-villi and long-term 
culture (LTC-villi)(cultured cells of the mesenchymel villus core) can improve the 
quality of chromosome analysis and results in an acceptably high quality compared 
with that of amniotic fluid cells. Figure 2A + 2B show karyotypes of a fairly good 
STC-villi preparation with approximately 300 bands and an average quality 
karyotype of LTC-villi elisplaying about 400 bands from the same sample. The 
nurnber of bands observed in metaphases of cultured amniotic fluid ceUs meet the 
required band level. Figure 3 shows an average quality karyotype from amniotic 
fluid cells also displaying about 400 bands. 
lt may be argued that the nwnber of bands reflects the accuracy with which small 
structural chromosomal abnormalities can be determined. The last few years, the 
accuracy has been enhanced by the use of fluorescence in situ hybridization using 
DNA probes (FISH) (Klinl;er et al., 1992; Lebo et al., 1992; Van Opstal, 1998). 
FISH has proved to be a u.seful tooi for the detection of minor (farnilial) chromosome 
rearrangements, but it cannot yet replace conventional karyotyping. 
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Figure 3 - Karyotype of amniotic fluid cells 
1.3.3 Discrepancy betwe", prenatal diagnosis and fetal status 
Probably the most setious laboratory rel.ted problem is discordance between the 
prenatal cytogenetic diagnosis and the outcome of the pregnancy. 
The finding of chromosomal mosaicism in amniotic fluid cells or chorionic vilIi 
preparations poses a sibrnificant problem in prenatal diagnosis because of the 
difficuity of determining whether the mosaicism reflects the true chromosomal 
constitution of the fetus. Mos.icism is caused by an abnormal cell division resulting 
in the presence of two or more cells with an identical abnormality, among the other 
normal cells. Because of the diagnostic importance a separate section wiJl be devoted 
to this topic. 
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1.4 Chromosomal mosaicism 
1.4.1 Am"io!ic fluid and letus 
In amniotic fluid, two types of mosaicism are known: pseudomosaicism and true 
mosaicism. If the aberrant cells are confined to a single colony or to one culture 
dish/ flask, it is defined as a pseudomosaicism, whereas a true mosaicism involves 
the presenee of aberrant cells/ colonies in two or more independent culture 
dishes/flasks. Pseudomosaicism is believed to originate in vitro, and hence, to be 
without clinical consequences. Based on the number of abnorrnal cells/ colonies 
detected and their distribution within the culture dishes, a classification of 4 types 
has been made (Boué et al., 1979): 
1. Pseudomosaicism type A; one cell or one region in a colony abnormal 
2. Pseudomosaicism type B; all the cells of one single colony abnormal 
3. Pseudomosaicism type C; multiple colonies within the sanle culture dish 
abnormal 
4. True mosaicism; two or more abnormal colonies in at least two independent 
culture dishes 
Pseudomosaicism occurs in 0.6 - 1.1 % of amniocenteses (Bui et al., 1984; Hsu and 
Perlis, 1984; Worton and Stern, 1984), with the majority of cases being type A. 
Since, these 'in-vitro' events have no clinical significanee they are generally not 
reported to clinicians because of the negligible risk for a true mosaicism (Hsu et al., 
1984). 
The frequencies of true mosaicism range from 0.1 - 0.3%, with an average rate of 
cytogenetic confirmation of 70% in fetal tissue (Bui et al., 1984; Hsu and Perlis, 1984; 
Worton and Stern, 1984). 
The method for distinguishing pseudomosaicism from a potentially true mosaicism 
is increasing the number of metaphases in other rushes than the rush in which the 
abnormal cells/ colonies were present. The investigation of an insufficient number of 
cells might erroneously designate a true mosaicism as a pseudomosaicism and lead 
to a false-negative prenatal cytogenetic diagnosis. In 1992, Hsu et al. developed two 
different levels of work-up, with a modification in 1999, for the differentiation 
between pseudomosaicism and true mosaicism (Tabie 1). Extensive and moderate 
additional work-up mean the analysis of 24 and 12 cell colonies, respectively, the 
initial dish with the abnornlal cells/ colonies not included. According to Hook (1977) 
this can rule out a 12% and 23% level of mosaicism at a 95% confidence level, 
respectively. 
The use of these guidelines results in an accurate and reliable diagnosis of 
pseudomosaicism or true mosaicism in cultured amniotic fluid cells. 
18 
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Table 1- Guidelines for work-up for the differentiation between pseudomosaicism and mosaicism 
(Hsu et al., 1992, 1999) 
A. Indications for extensive work-up (24 colonies exdusive the lJaffededlJ dish) 
,., Autosomal trisomy involving ehromosomes 2, 5, 8, 9,12,13,14,15,18,20,21, 22 
(SCo,MCo) 
,., Unbalaneed struetural rearrangement (MCo) 
,., Marker clrromosome (MCo) 
B. Indications for moderate work-up {12 colonies exdusive the JJ affected" dish} 
,., Autosomal trisomy involving a ehromosome 1, 3, 4, 6, 7, 10, 11, 16, 17, 19 (SCa, MCa) 
,., Unbalaneed structural rearrangement (SCo) 
,., Marker chromosome (SCo) 
,., Extra sex chromosome (SCo, MCo) 
• 45,X (SCo, MCo) 
,., Balanced struetural rearrangement (MCo) 
C. No additional work-up (routine analysis of 16-20 colonies from ~2 dishes) 
,., Balanced struetural rearrangement (SCo) 
,., Break at eentromere with 10ss of one arm (SCo) 
,., All single eeIl abnormalities 
SCo - single colonyjsingle dish; MCo - multiple coloniesjsingle dish 
1.4.2 Chorionic villi and jetus 
While acquiring experience with cytogenetic diagnosis in chorionic villi, especially in 
direct- and STC-villi preparations, it became clear that this did not always reflect the 
chromosomal constitution of the fetus (Mikkelsen, 1985; Leschot et al., 1987, 1989, 
1990; Sachs et al., 1990). During the past decade, it became clear that the reliability of 
cytogenetic diagnosis couJd be improved by the combined use of STC- and LTC-villi 
preparations (Ledbetter et al., 1992; ACC, 1994; Hahnemarm and Vejerslev, 1997). 
Although fetus and placenta originate trom the same zygote, their chromosomal 
constitution can be different. This is the prevalent problem with CVS as documented 
by numerous cases of discordant fjndings in fetus and placenta known as confined 
placental mosaicism (CPM) (Kalousek and Dill, 1983). 
Based on the position of the different cell lines and the knowledge of the fetal 
karyotype, three general types of discrepancies can occur (Kalousek, 1990). 
Table 2 shows the classification of CPM which is used by most centres. 
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Table 2 - Classitication of CPM according to Kalousek et al (1990) 
Type I Type II Type m 
--------------=---
Direct- and STC-villi Abnormal/Mosaic Normal AbnonnalJMosaic 
LTC-villi Normal Abnonna1lMosaic Abnormal/Mosaic 
Fetus or Newbom Normal Normal Normal 
Unfortunately, the situation is not always that simpIe. The distribution of different 
celllines among the different tissues is not necessarily equal (Ledbetter et al., 1992). 
In 1994, Pittalis et al. proposed a more detailed classification of all theoretical types of 
karyotypic combinations in the trophoblast (STC-viili), mesenchymal core of the villi 
(LTC-villi), and the fetus proper (TabIe 3). This classification includes all possibilities 
of discreprulcy runong the three compartments STC-villi, LTC-villi and fetus. 
20 
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Table 3 • ClassificatioD of theoretical combinations of mosaicisms according to Kalousck et al. (1992) and 
Pittalis et al. (1994) 
Category STC-villi LTC-villi Fetus 
Homogeneous 
Nonnal NHC 
Abnonnal AHC + + + 
Mosaicism 
Generalized GMAC m m m 
Concordant GMRC + + m 
+ m m 
m m + 
m + + 
+ m + 
m + m 
Discordant GMTD +' +' +' 
GMDD + + 
m m 
+ m 
m + 
GMDC + + 
m m 
+ m 
m + 
Confined 
Placenta CPMI + 
CPMI m 
CPMII + 
CPMII m 
CPMm + + 
CPMm m m 
CPMIII + m 
CPMm m + 
CPMm +' +' 
Fetus CFM + 
m 
STC - short-term culture; LTC -long-term culture; CPM - confined placenta! mosaicism; 
- = nonnal karyotype; + = abnormal karyotype; m "" mosaic karyotype; 1,2,3 = different abnormal karyotypes. 
NHC 
AHC 
GMAC 
GMRC 
GMTD 
GMDD 
GMDC 
CFM 
NormaI homogeneous concordance 
Abnormal homogeneous concordance 
GeneraIized mosaicism absolute concordanee 
Generalized mosaicism rclative concordance 
Generalized mosaicism tota! discordance 
Generalized mosaicism confined direct normality 
Generalized mosaicism confined culture normality 
Confmed feta! mosaicism 
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Knowledge of the early embryonic development is essential to understand the 
background of the theoretical consistencies of mosaicism. 
A model on the first postzygotic cell divisions has been proposed by Crane and 
Cheung (1988) and Bianchi (1993). From !he 8 cell to the 16 cell stage, the 
formation of the morula starts with the separation of the cells into twa 
compartments: (1) an outer ceH layer, !he troplwblast, which gives rise to !he 
trophoblast part (cytotrophoblast and syncytiotrophoblast) of the placenta and 
(2) an inner eell maS5 (ICM) which gives rise to the embryo. 
Subsequently morphological changes occur in the lCM resulting in two layers: (1) 
the epiblast and (2) the hypoblast. This stage of development is known as !he 
blastocyst stage (~64 cells) which contributes to the forming of !he embryo and 
severaI extra-embryonic structures. The epiblast gives rise ta all or nearly all of 
the eells of the embryo and the hypoblast gives rise to the extra embryonic 
mesoderm (EEM). The EEM includes the yolk sac, mesoderm of arnniotic and 
chorionic membranes, umbilical eard, and mesodermal core of chorionic villi. 
The latter component is investigated in the LTC-villi. 
Concurrently, the trophoblast cells start to proliferate rapidly and gradually 
differentiate into !wo layers: (1) an inner cytotrophoblast, which is mitotically 
active (mitoses can be seen and studied in STC-vü1i), and (2) an outer 
syncytiatrop/wblast (Figure 4 and 5). 
1.4.3 Mosaicism for numerical chromosome aberrations 
Mosaicism occurs through errors in either meiosis or mitosis. In case of a meiotic 
error in the gamete, this willlead to the formation of a trisomic zygote. During early 
embryonic development the extra chromosome can be removed; this reduction of 
trisomy to disomy is known as 'trisomic zygote rescue'. Theoretica!ly, there are three 
possibilities for this rescue, leading to either a norma! morula or to a mosaic moruIa 
when it happens in the fust postzygotic ceH division: 1) chromosome demolition, 
which involves the destruction and remova! of one of the three chromosomes 
resulting in two disomic daughter ceHs, 2) non-disjunction, where a failure of the 
duplication product will produce one disomic and one lethal quadrisomic ceH, 3) 
anaphase lagging, where one duplication product stays behind and gets lost during 
mitosis, resulting in one disomic and one trisomic daughter ceH (Figure 6)(Los et al., 
1998a; Van Opstal, 1998). 
If the 'trisomic zygote rescue' is delayed to a second or subsequent ceH division, the 
morula will always be mosaic; the later the rescue takes place the more abnormal 
ceHs are present in the morula. 
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Figure 4 illustratcs the normal early emhryonic development and shows that the eells obtained by 
CYS do not belong to the compartment of the [etus proper as do the amniotic Ouid cells obtained by 
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Figure 5 demonstrates an exarnplc of possible dislribution of norm al and abnormal ce lis in case of 
mosaicism leading 10 theoretical cornbinatiolls according to Pittalis ct al. (1994) 
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Figure 6 - Theoretical possibilities of trisomic zygote rescue 
In case of a rnitotic error, this can also lead to a mosaicism. Depending on the timing 
of rnitotic non-disjunction the morula will be completely abnormal or mosaic. An 
example is given in Figure 6a. Theoretical distributions of normal (disornic) and 
abnormal (trisornic) ceUs after rnitotic non-disjunction are demonstrated in Figure 6a 
when this event happens in the fust four ceU divisions. If the rnitotic error occurs in 
the ftrst ceU division this willlead to a homogeneous abnormal morula while there 
will be a mosaic morula when this event happens during any subsequent ceU 
division. 
1.4.4 Mosaicism for stnJ.ctural chromosome aberrations 
Not only a numerical mosaicism causes a diagnostic dilemma, but also the finding of 
a structural mosaicism. The m.itotic origin of a sh'uctural rearrangement, a deletion, is 
given in Figure 7, and the theoretical distribution of normal and abnormal ceUs 
foUowing a rnitotic event in one of the fust four ceU divisions is given in Figure 7a. 
~\ I  
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Figure 7 - Mitotic origin afa structural rearrangement; a deletion 
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General introduction 
Looking at Figure 6a and 7a it is dear that differentiation between generalized 
mosaicism and CPM would be desirabie. This might be done by a work-up protocol, 
similar to the work-up protocol used for the differentiation between true mosaicism 
and pseudomosaicism in amniotic fluid cells. 
In 1993, we started with the development of a work-up protocol for the 
differentiation between generalized mosaicism and CPM in case of STC-villi analysis 
only (Tabie 4)(Los et al., 1998b). After the introduction of routine analysis of LTC-villi 
additional to STC-villi in 1997, we developed a second work-up protocol for the 
analysis of both STC- and LTC-villi (Tabie 5)(Van den Berg et al., 2000). Both work-
up protocols turned out to be very useful guidelines for the differentiation between 
generalized mosaicism and CPM. 
Table 4 - Tbe number ofmetaphases to be investigated in STC-villi ooly (LTC-vilJi not available) 
Normal karyotype 
Numerieal aberration 
+21 
Triploidy 
47,XXY 
47,XXX 
47,XYY 
+13,+18 
with US abnormality 
without US abnormality 
45,X 
with US abnormality 
without US abnormality 
Aneuploidy *13, 18,21, X and Y 
Mosaic aneuploidy 
Mosaic tetraploidy 
One cell abnormality 
+7,+8,+9,+ 11,+13,+ 14,+ 15, + 18,+2I,+mar 
STC-villi 
no. of eells 
16 
16 
12 
16 
16 
16 
16 
16 
16 
20 
30 
30 
Follow-up amniocentesis 
FISH Karyotype 
+ 
+ 
+ 
+ 
+ 
consideration in each case 
Other consideration in each case 
Structural rearrangemeot 
Familiar balanced 
Familiar unbalanced 
De -novo 100% 
mosaic 
FISH - FISH on uncultured amniotic fluid-cells 
16 
16 
16 
20 
+ 
+ 
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Table 5 - Work-up protocol for the investigation ofSTe-aod LTC -villi, in various circumstances 
STC-villi LTC-villi LTC-villi Cytogenetic AC 
(n) (n) result interpretation 
--- --------
Normal karyotype in STC-and LTC-villi 8 8 NBC 
Numerical aberration in STC-villi 
Trisomy 21 16 ABC 
Trisomy 13, 18 with US abnonnality 16 AHC 
Abn AHC, Grvm.C, CPM III 
without US abnonnality 16 8 Mos GMRC, CPM III + 
Norm GMDC,CPMI ? 
Triploidy 12 ABC 
Abn AHC, GMRC, CPM III 
47,XXY, 47,XXX, 47,XYY 16 8 Mos GMRC,CPMlli + 
Norm GMDC,CPMI ? 
Abn AHC, GMRC, CPM 111 
45,X with US abnonnality 16 8 Mos GMRC, CPM III 
Norm GMDC,CPMI ? 
Abn ARC, GMRC, CPM III 
without US abnonnality 16' 8' Mos GMRC,CPMlli + 
Norm GMDC,CPMI 
Abn AHC, GMRC, CPM DI + 
Aneuploidy '" 13,18,21, X and Y 16 8 Mos GMRC, CPM III + 
Norm GMDC,CPMI 
Abn GMRC, CPM III ? 
Mosaic aneuploidy 20' 10' Mos GMAC, GMRC, CPM 111 + 
Norm GMDC,CPMI 
One eeU abnormality 
(+7,8,9,11,13, 14, IS, 18,21, ESAC) 20 10 NBC 
Tetraploidy special protocol ... 
Structural rearrangement in STC-villi 
Familial balallced 8 8 ABC 
unbalanced 16 AHC 
Abn ARC, GMRC, CPM III 
De-nova balanced 16 8 Mos GMRC, CPM III 
Norm GMDC,CPMI 
Abn ARC, GMRC, CPM 1lI 
unbalanced 16 8 Mos GMRC, CPM III 
Norm GMDC,CPMI 
Abn AHC, GMRC, CPM III 
ESAC familial 16 16 Mos GMRC, CPM III 
Norm GMDC,CPM1 
Abn ARC, GMRC, CPM III 
De-novo 16 8 Mos GMRC, CPM III + 
Norm GMDC,CPMI 
Abn GMRC, CPM 111 
MosaÎc structural rearrangement 20 10 Mos GMAC, GMRC, CPM 1lI 
Norm GMDC,CPMI 
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Table 5 - eontinued 
STC-villi LTC-villi STC-viUi 
(0) (0) result 
Normal karyotype In STC-and L TC-villi 8 8 
Numerical aberration in LTC-villi with normal STC-villi 
One eell abnormality 8 16 
100% 8' 16' Mos 
Norm 
Mosaie 8' 16' Mos 
Norm 
Struetural rearrangement in LTC-villi witb normal STC-villi 
One eell abnormality 8 8 
100% 16 16 Mos 
Norm 
Mosaic 16 16 Mos 
Norm 
Genera! introduction 
Cytogenetic 
ioterpretatioo 
NHC 
GMRC, CPM III 
GMDD,CPM11 
GMAC, GMRC, CPM 111 
GMDD,CPMII 
NHC 
GMRC, CPM III 
GMDD,CPMU 
GMAC, GMRC, CPM UI 
GMDD,CPMU 
AC 
+ 
+ 
? 
+ 
+ 
+ 
'" - additional FISH on.interphase level; A - previously deseribed by Noomen et aL (2000); Van den Berg et al. 
(2000), Abn = abnorma!; AC = amniocentesis; ESAC = Extra Structural Abnormal Chromosome; Mos = mosaie; 
Norm = nonnal; for abbreviations see a[so Tab!e 3. 
Cytogenetieists spend a large amount of time distinguishing pseudomosaieism from 
true mosaicism and confined placental mosaicism from generalized mosaieism, and 
often feel uncomfortable interpreting the findings. 
The guidelines introduced by Hsu et al. in 1992 for diagnosing pseudomosaieism and 
true mosaieism in amniotic Duid cell cultures and our own guidelines for the 
distinguishing of confined placental mosaieism and generalized mosaicism in 
chorionic villi has been considered very effieient and effective. Both guidelines will 
not only give more insight into the frequency of mosaieisms but will also lead to a 
better interpretation of the cytogenetic results. This will lead to a higher predictive 
value of cytogenetic dia gnosis after amniocentesis and chorionic vilIus sampling 
which also means a decrease in the number of follow-up investigations. 
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1.5 Aims of this thesis 
The genera! principles of our prenata! investigations are: 
o To establish areliabie diagnosis which means a sensitivity and specificity at or as 
close as possible to 100%. 
o To establish the diagnosis as early as possible with the safest teclmique available 
and with the maximum yield of relevant information. 
In our laboratory, we have regularly been confronted with diagnostic problerns after 
CVS and to alesser extent after amniocentesis. 
We decided to evaluate our CVS and amniocentesis analyses for reliability, accuracy 
and efficiency in order to arrive at an optimal quality of prenata! cytogenetic service. 
o Since the introduction of CVS we have occasionally (1-2%) been confronted with 
diagnostic problerns after the analysis of STC-villi alone. This, together with 
reported collaborative studies has raised some concerns about the accuracy and 
reliability of CVS after the analysis of STC-villi alone. The evaluation of 3500 CVS 
cases is addressed in Chapter 2. 
o Recommendations about the combined use of both STC- and LTC-villi were made 
to provide a more accurate diagnosis in chorionic villi. We studied the reliability 
of cytogenetic results in both viJJj compartrnents and compared the number of 
follow-up amniocenteses with the figure from the study of STC-villi alone. 
Results of this study are presented in Chapter 3. 
o Multiple gestations present a particular problem in prenatal diagnosis. Most 
reports concern the increased risk of fetal loss for women undergoing 
amniocentesis. However, the genetic and/ or laboratory aspects of amniocentesis 
and CVS were not explored in depth of any large series. We investigated the 
accuracy and reliability of both procedures 10 arrive at better recommendations 
for this group of patients. Our experience with 500 multiple pregnancies is 
presented in Chapter 4. 
o Since fust-trimester CVS has not reached the populaIity of second-trimester 
amniocentesis despite its clinical and psychological advantages questions have 
been raised as to why this is the case. Differences in sampling related risks, or in 
the reliability and accuracy of laboratory results in favour of amniocentesis are 
possible causes. We have evaluated the diagnostic performance of cytogenetic 
investigations after amniocentesis and CVS as a potential cause for this 
remarkable observation. This study is described in Chapter 5. 
o Attention was also given to (recurrent) specific diagnostic cytogenetic problerns. 
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An evaluation of some special cases are presented in Chapter 6, such as the finding 
of trisomy 9 which poses a serious problem in prenatal diagnosis (6.1); the 
meaning and interpretation of mosaic tetraploidy in CVS (6.2); a presumed case of 
GMDC which tumed out to he a general mosaicism after extensive investigations 
(6.3); the finding of the simultaneous presence of isochromosomes 18p and 18q, 
and the determination of the mechanism of formation is presented in 6.4. 
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Summary 
Among 3499 cytogenetically investigated semi-direct chol'ionic villus samples, 219 
(6.3%) abnormal karyotypes were encountered. The karyotypes were considered 
certainly abnol'mal (generalized abnormal with high probabillty) in 109 cases (3.1 %), 
and in 110 cases (3.1 %) uncertainly abnormal (potentially confined to the placenta), 
requiring further investigation. Of these 110 uncertain abnol'malities, the cytogenetic 
result tumed out to be finally abnormal representing generalized abnormality in 36 
cases (32.7%), finally normal representing confined placental mosaicism (CPM) in 69 
cases (62.7%), and remained undetermined in 5 instanees (4.5%). The rate of the 
numbers of cel'tainly abnormal and all (certainly + uncertainly) abnormal results, the 
certainty rate, and that of generalized abnormalities and all abnormalities 
(generalizecl abnormalities + CPM cases), the predictive value, are strongly 
correlated with the cytogenetic risk. Therefore, we advise chorionlc villus sampling 
for cytogenetic investigation only in women with a cytogenetic risk equal to or 
exceecling that of a 40-year-old pregnant women. Because of the high rate of prenatal 
follow-up investigations af ter the finding of uncerlain results in semi-direct villi, 
semi-direct and cultured villi should be karyotyped simultaneously . 
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Introduction 
First-trimester prenatal diagnosis in chorionic villi was successfully introduced in 
our departrnent in 1983 (Sachs et al., 1985; 1988). However, since 1992, the number of 
chorionic villi displays a decrease with • concomitant increase in the nurnber of 
arnniotic fluid samples (Fig. 1). There are two reasons for this decrease. The first 
concerns the yet unsolved problem of inducing fetal vascular disruptive syndromes 
by the sampling procedme (Firth et al., 1994; 1996; NICHD, 1993; Kuliev et al., 1996; 
Olney et al., 1995; Froster & Jackson, 1996, Los et al., 1996). The second re.son is the 
limited representativity of an abnormal karyotype in chorionic villi far the actual 
fetal karyotype due to confined placental mosaidsm (CPM) (Kalousek & Dill, 1983; 
Kalousek & Vekemans 1996; Wolstenholme, 1996). Various studies focused on the 
combined cytogenetic results in cytotraphoblast cells, direct or semi-direct (short 
term culture; STC) villi, and cultured cells of the mesenchym.1 core, cultured (long 
term culture; LTC) villi (Vejerslev & Mikkelsen, 1989; Teshim. et al., 1992; Ledbetter 
et al., 1992; Smidt-Jensen et al., 1993; Wang et al., 1993; Associalion of Clinical 
Cytogenetidsts Working Party on Chorionic Villi in Prenatal Diagnasis, 1994; 
Wolstenholme et al., 1994; Pittalis et al., 1994). Some studies comprised cytogenetics 
in STC-villi only (Caspari et al., 1994; Leschot et al., 1996), others in LTC-villi only 
(Hogge et al., 1986; Fryburg et al., 1993). 
N 
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Figure 1 N The numbers of amniotic fluid and chorionic villus samples received from 1970 until 1996 
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The best results of karyotyping in chorionic villi are realized when STC- and LTC-
villi are investigated simultaneously (Ledbetter et al., 1992; Association of Clinical 
Cytogeneticists Working Party on Chorionic Villi in Prenatal Diagnosis, 1994; Pittalis 
et al., 1994). However, for technical or economie reasons various restrictive polieies 
concerning the use of either STC- or LTC-villi alone have been implemented. Such a 
restrietive poliey of discarding STC-villi and using only LTC-villi has been reported 
by Smidt-Jensen et al. (1993). Another restrictive policy is the routine cytogenetic 
investigation in STC-villi, and in case of an abnormality the additional investigation 
of LTC-villi, which has also been implemented in Dur laborat~ry for some years 
(Breed et al., 1990; Sachs et al., 1990; Leschot et al., 1996). 
We stopped the culturing and potential investigation of LTC-villi in 1993 since less 
than 1 % of the initiated cultures were actually investigated and in the majority of 
cases, LTC-villi turned out to be non-available when needed. We present Dur 
experienees with prenatal cytogenetic diagnosis in STC-villi during a four year 
period. 
Material and. Methods 
During the years 1993-1996, 3726 chorionic villus samples were received; 3027 
samples were from the Dijkzigt Hospital, Rotterdam, The Netherlands, and 450 from 
the Merwede HospitaI, Dordrecht, The Netherlands. The remaining samples came 
from other centres in The Netherlands or from other countries. Chorionic villus 
sampling in the Dijkzigt and Merwede Hospitals was performed transabdominally in 
all cases as decribed earlier Oahoda et al., 1990). For the samples coming from other 
centres, inforrnation on the method of sampling was not provided in most cases. The 
indieation for prenatal diagnosis was cytogenetie in 3303 of the 3726 cases [advaneed 
maternal age (~ 36 years), parental carriership for structural rearrangements or 
marker chromosomes, feta! abnormalities on ultrasound, recurrence risk of 
chromosomal abnormality, previous child with multiple congenital malformations, 
farnily history of chromosomal abnormality, risk for X-linked diseases]. In the other 
423 cases, the reason for prenatal diagnosis was biochemical (recurrence risk for 
various metabolic diseases, risk for X-linked metabolie disease in male feLuses) or 
DNA-investigation (recurrence risk for various autosornal recessive, autosomal 
dominant or X-linked inherited diseases, previous child with microdeletion or 
uniparental disomy syndrome). In 206 of these 423 cases, chromosomal analysis was 
additionally performed. 
STC-villi slides were prepared using fluorodeoxyuridine (FdU) synchronization 
(Gibas et al., 1987). Karyotyping was routinely perfornled with Trypsin-Giernsa 
staining. Sometimes other staining techniques, such as DA-DAPI-staining, Ag-NOR-
staining, C-banding or endonudease-banding were used. Normally 16 cells were 
analysed, in the case of a single cell with trisomy 8, 9, 13, 18 or 21, and in the case of a 
supernumerary marker chromosome this number was extended to 30 cells. When 
two or more cells among the 16 analysed cells showed the same abnormality, at least 
30 cells were investigated whenever possible. A karyotype in STC-villi was 
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considered normal in the case of 46,XX or 46)CY, ± inversion (9)(P12q13), and/ or ± 
one cell exhibiting any abnormality. All other results were considered abnormaI. 
Abnormal karyotypes were considered certainly abnormal when they were assumed 
to represent generalized abnormality with a high probability and allowed for clinical 
decisions without further prenatal investigations. A cytogenelic result was 
considered uncertainly abnormal when it could potentially be confined to the 
placenta, and requlred further investigation (Ledbetter et al., 1992; Association of 
Clinical Cytogeneticists Working Party on Chorionic Villi in Prenatal Diagnosis, 1994; 
Leschot et al., 1996). A cytogenetic result was defined as a mosaicism when two or 
more cells showed a karyotype different from the karyotype(s) in the other cells (cell 
lines). Mosaicism was divided into three levels: low level (~ 10% abnormal cells), 
medium level (11 % - 33.3% abn cells) and high level (~33.3% abn cells). 
Follow-up studies involved dependend on the encountered cytogenetic problem 
fluorescence in situ hybridization (FISH) on STC-villi slides and sometimes 
subsequently on (uncultured) arnniotic fluid cells, parental karyotyping, 
arnniocentesis and/ or ultrasound investigation. FISH on interphase cells of STC-villi 
preparations displaying aneuploidy or polyploidy mosaicism was used for 
differentiation of coincidentallocal mitotie division errors from mosaicism and was 
performed as decribed before (Van Opstal et al., 1995; 1998). 
In the case of confirmation of the mosaicism in STC-villi, FISH was performed with 
the same probe(s) on uncultured anmiotic fluid cells for the differentiation between 
CPM and generalized mosaicism (Van den Berg et al., 1997; Van Opstal et al., 1998). 
Interpretation of signal distributions has been described previously (Van Opstal et 
al., 1998). FISH on metaphases of STC-villi and cultured anmiotic fluid cells was 
carried out for potential identification of marker chromosomes and derivatives (In 't 
Veld et al., 1995a; Joosten et al., 1997). Parental karyotypes were prepared from 
peripheral blood lymphocytes according to standard techniques. Amniotic fluid cells 
were cultured with the in situ method on glass coverslips also according to standard 
techniques. First- and second-trimester ultrasound investigations were performed in 
our departrnent as described previously (Wladirniroff et al., 1995; Cha'ban et al., 
1996). In some cases with (mosaic) unusual trisomy, DNA studies were performed 
for the investigation of the paren tal origin of the supemumerary chromosome 
and/or on uniparental disomy (UPD) (Van den Berg et al., 1997; Van Opstal et al., 
1998). 
In the case of termination of pregnancy (TOP), we always tried to confirm the 
cytogenetic abnormality in fetal fibroblasts. Information on the course and outcome 
of pregnancy was received from the women and/ or the referring midwife or 
physician. Birthweights of babies were appreciated according to the tables of 
Kloosterman (1970). Statistical analysis comprised X' tests and binomial statistics. 
Results 
STC-villi preparations were made of 3509 chorionic villus samples. In 10 cases (0.3 
%), no cytogenetic diagnosis could be made due to laboratory failu,..,. In 3499 cases 
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(99.7%), a cytogenetic result was achieved. Normal karyotypes were found in 3280 
samples (93.7%) and abnormal results in 219 cases (6.3%). Single-cell abnormalities 
were encountered in 566 samples (16.2%). Half of the abnormal karyotypes were 
certainly abnormal (N=109), and the other half uncertainly abnormal (N=110); the 
exact nature and numbers of the certainly and uncertainly abnormal cytogenetic 
results in relation to the indication for prenatal diagnosis are shown in Fig. 2. In one 
case, an unbalanced rearrangement was considered certain on the indication 
ultrasound abnormalities, because it became known af ter sampling that there was a 
familial rearrangement in the woman's family of which the encountered 
rearrangement was one of the possible unbalanced farms. The distribution of 
certainly and uncertainly abnormal cytogenetic results in STC-villi among the 
various indications is presented in Table 1. The frequencies of certainly abnormal 
cytogenetic results in the various indications showed a statistically significant 
difference, in contrast to those of uncertainly abnormal results. The certalnty rates 
(certainly abnormal:all abnormal) differed statistically significantly between the 
various indications. 
Table 1 - Certaiuty rates of aboormal cytogenetic results (certainly ahoormal: all ahoormal) in STC-villi 
amoog the various indicatioDs 
Ahnormal 
Indication N Nonna! N Certainlyl Unccrtainli 
Certainty rate3 
(95% Cl) 
----- ----~----
MA 36·39 22H2 2191 91 (4.0%) 13 (0.6%) 78 (3.4%) 0.143 (0.078 - 0.232) 
MA 2:40 447 424 23 (5.1%) 13 (2.9%) 10 (2.2%) 0.565 (0.345 - 0.768) 
US ABN 165 116 49 (29.7%) 40 (24.2%) 9 (5.5%) 0.816 (0.680 - 0.912) 
CARRIER 110 41 39 (48.8%) 39 (48.8%) 0 (0%) 1.000 (0.910 - 1.000) 
DNAIBIQ 206 201 5 (2.4%) 2 (1.0%) 3 (1.5%) 
OTHER 319 307 12 (3.8%) 2 (0.6%) 10 (3.1%) 
0.235 (0.068 - 0.499) 
TOTAL 3499 3280 219 (6.3%) 109 (3.1%) 110 (3.1%) 0.498 (0.432 - 0.564) 
95% Cl = 95% confidence interval. l Frequencies of certainly aboarmal results (US ABN and CARRIER 
combined) differ significantly (X2 = 727.65, df= 4, p < 0.001). 2 Frequencies ofuncertainly ahoarmal results (US 
ABN and CARRlER combined) do not differ significantly (X2 == 3.85, df== 4, P > 0.05). 3 Certainty rates differ 
significantly (i! "" 110.12, df= 4, P < 0.001). 
Follow-up investigations and pregnancy outcomes in women with uncertainly 
abnormal karyotypes in STC-villi and a final abnormal prenatal cytogenetic 
diagnosis representing generalized abnormality (N=36) are presented in Table 2. 
TOP was requested and carried out in 23 cases; in 12 cases, the pregnancies were 
continued because none or only minor phenotypic consequences were expected from 
the abnorrnal karyotypes. 
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Figure 2 - Certainly (white squares) and uncertainly (black squares) abnormal karyotypes in STC-villi ofwomen with VariOllS indications for prenatal cytogenetic diagnosis 
during the study period 1993-1996. MA:= matemal age; US ABN = ultrasound abnormalities; CARRIER = parental carriership for structural rearrangement or marker 
chromosome; DNAJBIO = cytogenetic investigation secondary to DNA or biochemical investigation; OTHER = previous child with chromosome abnonnality or congenital 
malformations, family history of chromosome abnormality, other reasons for prenatal cytogenetic diagnosis; struct. = structural; rearT. = rearrangement 
Table 2 _ Further investigations in cases of uncertainly abnormal results in STC-villi witb finaUy abnormal cytogenetic results (generalized abnormalities). Abnormal or N at FISH 
means an abnormal or ncnnal signal distribution. No comment at pregnancy outcome means a normal baby witb a birtbweigbt between pS and p9S 
Amniocentesis 
Case PD Karyotype FISH on Parental Ultrasound 
No. indication in STC-villi STC-villi karyotype investigation FISH Karyotype Pregnancy outcome 
. . ---_._----
------------------------------- ------------
MA 36-39 4ï,xx,+i8[18] Abnomlal N Abnonlla! 47,À'X,+i8 TOP 47,À'X,+i8 
2 MA 36-39 47,XY,+18[301 Abnormal N Abnormal 47,XY,+18 TOP 
3 MA 36-39 47,XY,+lS[30] TOP 47,XY,+18 
4 MA 36-39 47,xx, +21 [2S]l46,XX[2] Abnormal Abnormal TOP 47,XX,+21 
5 MA 36-39 47,xx,+21[24]146,XX[6] Abnonnal N Abnormal 47,XX,+21 TOP 47,XX,+21 
6 MA 36-39 47,xx, +21 [2S]!46,XX[2] TOP 47,XX,+21 
7 MA:::' 40 47,XY,+ IS[27]!46,XY[3] Abnonnal N Abnormal TOP 47,XY,+18 
8 US ABN 47,XX,+21 [27]146,XX[3] TOP 47,XX,+21 
9 US ABN 47,XY,+lS[IS]! Abnorrnal Abnormal 47,XY,+l8 TOP 47,XY,+18 
48,XY,+ 18,+20[13]/ 
46,XY[3] 
10 US ABN 47,xx, +21 [27]146,XX[3] Abnonnal TOP 47,XX,+21 
II MA 36-39 45,X[l0] N 45,X[I]!46,XX[54] Cont. 'f', < p2.3 
12 MA 36-39 45,X[22] Abnormal TOP 45,X 
13 MA 36-39 45,X[30] Abnormal Abnorrnal Abnormal 45,X TOP 45,X 
14 OTHER 45,X[16] Abnonnal N N 45,X[5]146,XX[34] Cont. ~ 
15 OTIfER '5,X[l6] Abnormal N,N Abnonnal TOP 45,X 
16 MA 36-39 '5,X[31 ]!46,XY[24] AbnOffilal Abnorrnal 45,X[3]!46,XY[l4] TOP 45,X[5]!46,XY[45] 
17 MA 36-39 46,Xdol(Y)[16]! Identification N,N N Identification 46,XidicY[17]/ TOP 46,Xidic(Y)(qll)[15]1 
46,Xidic[YJ[14]/45,X[4] (46,XidicY/delY)[2]1 45,X[l3]! 
45,X[l] 46,Xd,I(Y)(qll)[2]' 
IS MA 36-39 47,XXY[6]!46,XY[2] Abnormal Abnormal 47,XXY[3]!46,XY[6] Cont. ~ 
19 OTIffiR 4S,X[6]!46,XX[24] Abnormal N Abnormal 45,X[l]!46,XX[15] Cont. ~ 
20 MA 36-39 47,xx,+9[30] Abnonnal Ahnormal Abnorrnal 47,XX,+9[7]!46,XX[30] TOP FISH;47,XX,+9[30%]/ 
46,XX [70%f 
21 US ABN 47,XY,+22[16] Abnonnal 47.XY.+22 TOP 47,XY.+22 
22 US ABN 47,XY,+22[16] Second TOP 47,XY,+22 
Ahnormal 
23 OTIffiR 47,XY,+9[16] Abnormal Abnormal Abnonnal 47,XY,+9[4]!46,XY[26] TOP FISH;47.XY,+9[87%]1 
46,XY[l3%]1 
Table 2 - Continued 
Amniocentesis 
C", PD Kmyotypo FISH on Parental Ultrasound 
No. indication in STCvilli STC-villi karyotype investigation FISH Karyotype Pregnancy outcome 
24 MA 36-39 46,xx,add(Iq)[16J Identification N,N TOP 46,XX,duP(I)(q2?3q3?2) 
25 MA 36-39 46,xx.der(21;21) Abnormal N Abnonnal 46,XX,der(21;21) TOP 46,XX,d,«21;21) 
(qlO;qlO),+21[16J (qlO;qlO),+21 (qlO;qIO),+21 
26 MA 36-39 46,X,d'«Xp)[16J ldentification N,N N ldentification 46,X,inv(X)(p22.3q26) Conl. ~ 
27 MA 36-39 46.xx,inv(3) 46,XY,inv(3) Conl. ~ 
(p21q26.2)[16J 46,XX 
28 MA 36-39 46,xx,~4;I3) 46,XY,t(4;13) Conl. ~ 
(q34;q21.3)[16J 46,XX 
29 MA 36-39 46,lCY,inv(8) 46,xY,inv(8) Cont. d' 
(p21.3p23.3)[16J 46,XX 
30 MA 36-39 45,XY,d,«I3;14) 46,XY Conl. d' 
(q10;qI0)[16J 45,XX,dcr(13;14) 
31 US ABN 46,XX,dcr(21;21) TOP 46,XX,der(21 ;21) 
(q10;qI0),+21[16J (qlO;qlO),+21 
32 MA 36-39 47 ,xx. +mar[28]! Identification (?) NIN TOP 47,XX,+mar[13]1 
46,XX[2J 46,XX[21J 
33 MA 36-39 47;XY,+mar[24]! Identification (?) 46,XY Cant. d' 
46,XY[14J 47,xx.+mar[21]/ 
46,XX[28J 
34 MA;:: 40 47.xY,+mar[30] Identification N,N N 47,xx,+mar Cont. ~ 
(satellites) 
35 MA 36-39 92,XXYY[5J!46,XY[45J N 92,XXYY[2J! Conto d' 
(92,]{J{YY!46,XY)[2J! 
46,XY[29J 
36 MA 36-39 45,xx,-21[21J Identification 46,XY[68J! Abnormal IUD 45,XX,-21 l 
47,XY,+marI21! 
46,XX 
Abbreviations(see also legend of Fig. 2): add = additional (chromosomal material); cont. = continuation ofpregnancy; del = deletion; der = derivate; idic = isodicentric; inv = 
inversion; IUD = Întra-uterine death; mar = marker chromosome; MCA = multiple congenital malforrnations; N = normal; NI = non-informative; PD = prenatal diagnosis; 
RhC = Rheslls factor C; TOP = tennination ofpregnancy; gel. TOP = selective TOP. I Previously described (in 't Veld et aL, 1995a); 2 prcviously described (Van den Berg et 
al., 1997); 3 previously described (Joosten et al., 1997). 
Table 3 - Further investigations in cases of uncertainly abnormal results in STC-villi with finaUy normal cytogenetic results (CPMs). Abnormal or N at nSB means an abnormal or 
normal signal distribution. No comment at pregnancy outcome means a oorroal baby with a birthweight between p5 and p95 
Amniocentesis 
Case PD Karyotype FISH on Parental UltrasoWld 
No. indication in STC~vil1i STC~vi!1i karyotype investigation FISH Karyotype Pregnancy outcome 
---,~_.-
37 MA 36·39 48,ÀI' ,+ 13,+ 20[3J/46,XY[2iJ ".1 N N 46,)1.')' Con!. d', 34 weeks 
solutio placentae' 
38 MA 36·39 47,XY,+13[3]/46,XY[27] NI N NI 46,XY Cant. d',<pS 
39 MA 36~39 47,XX,+ 18[2]/46.XX[28] N N N 46.XX Cant. !i! , <pSI 
40 MA 36~39 47,JO[, + J3[2]/46,XX[28] N 46,XX Cant. ~, 
41 MA 36~39 47,XY, + J3[2]/46,XY[28] N 46,XY Cant ~, 
42 MA 36-39 47,XX,+18[2]/46,XX[28] N N 46,XX Cant. ~, 
43 MA~40 SO,xx, + 7,+ 13,+20,+21 [3]/46,XX[321 N N N 46,XX Cont. ~ 
44 MA36~39 45,X[15]146,J<X[7] Abnonnal N 46,XX Cant. ~ 
45 MA36~39 45,X[3]/46,XX[29] N 46,XX Conl. ~ 
46 MA 36-39 45,X[2]/46,XX[28] N Cont. ~ 
47 MA 36·39 45,X[8]/46,XX[27] Abnormal N 46,XX Cont. ~ 
48 MA 36·39 45,X[2]/46,XY[28] N Con!. ~ 
49 MA 36-39 47,XXX[8]/46,XX[22] Abnormal N 46,XX Cant. 
" 50 MA 36-39 45,X[2]146,XX[27] Abnonnal N 46,XX Cant. ,
51 MA 36·39 45,X[3]146,XX[28] N N 46.XX Cant. ~ 
52 MA 36-39 45,X[2]/46,XX[28] Abnonnal N 46,XX Cant. ~ 
53 MA 36·39 45,X[2]/46,XY[33] N Cant. d' 
54 MA 36-39 45,X[2]/46,XX[28] N Cont. ~ 
55 MA 36-39 45,X[2]146,XX[28] N Cant. ~ 
56 MA 36-39 45,X[5]/46,XX[25] Abnonnal N 46,XX Conl. ~ 
57 MA 36-39 45,X[2]146,XY[23] Abnonnal N 46,XY Conl. ~ 
58 MA 36-39 45,X[2]/46,XY[28] N Cont. ~ 
59 MA~40 45,X[2]/46,XY[28] N Conl. ~ 
60 MA~40 45,X[2]146,XY[28] N Cant. ~ 
61 MA~40 45,X[2]/46,XX[28] N Cant. d' 
Table 3 - Continued 
Amniocentesis 
C", PO Karyotypo FISH on Parental Ultrasound 
No. indication in STC-villi STC-villi karyotype invcstigation FISH Karyotype Pregnancy outcome 
62 us ABN 45,X[2]/46,XX[l8] Abnonnal 46,XX IUD !i!, 27 weeks,omfalocèle, 
IUGR 
63 MA 36-39 47,XX,+7[30] Abnormal N N 46,XX Cont. !i!,p5 
64 MA 36-39 47,J<Y,+I6[32] Abnormal N N 46,XY Cont. <1' 
65 MA 36-39 47,XY,+3[3J] Abnormal N N 46,XY Cont. <1' 
66 MA?:: 40 47,XX,+16[30] Abnormal N N 46,XX Cont. !i!, normal, UPD J6! 
67 MA?:: 40 47,XX,+22[50] Abnormal Abnormal IUD 15 weeks, 46.xx, MCA! 
68 OTIIER 47,XX,+16[30] Abnormal Abnormal Abnormal 46,XX IUD 'l', IUGR, 33 weeks, 
MCA,. <p2.31 
69 MA 36-39 47,XX,+7[8J!46XX[26] Abnormal N N 46,:XX Cont. 
" 
70 MA 36-39 47,XX,+16[2JI46,XX[28J Abnomlal N N 46,XX Cont. 
" 
71 MA 36-39 47,J<Y,+7[21]/46,XY[lI] Abnormal N N 46,XY Cant. d' 
72 MA 36-39 47,XX,+7[3]146,XX{27] Abnormal N N 46,XX Cant. 
" 
73 MA 36-39 47 ,XV ,+7[l2J!46,XY[ 18J Abnormal N N 46,XY Cont. <1" 
74 MA 36-39 47,XX,+22[2]146,XX[28] N N N 46,XX Cont. , 
75 MA 36-39 47,XY,+7[6]/46,XY[24] Abnormal N N 46,XY Cont. <1" 
76 MA 36-39 47,XX,+2[4]/46,XX[15] 46,XX Cont 
" 77 MA 36-39 47;XY,+3[71/46,XY[221 Abnormal N N 46,XY Cont. <1" 
78 MA 36-39 47,XY,+8[3]/46,XY[15] TOP 0", 46,XY, MCA 
79 MA 36-39 47,XX,+11[5]/46,XX[25] Abnonnal N N 46,XX Cont. , 
80 MA?:: 40 47,XY,+7[41/46,XY[101 Abnorma! N N 46,XY Cont. <1' 
81 DNAIBIO 47,XY,+3[61/46,XY[24] Abnormal N N 46,XY Cont. <1" 
82 DNAJBIO 47 ,XX, +7[3J/46,XX(30J Abnonnal N N 46,XX Cont. 9,36 weeks1 
S3 l\l[A 39-39 46,XY,d,«7p)[l3] N,N 46,XY Cont. d' 
84 MA 36-39 46,XY,llq-[l7] N,N 46,XY Cont. 0", M. Hirschsprung 
85 MA 36-39 46,XY,der(10)[16] N,N TOP 46,XY 
86 MA 36-39 46,JCX,d,«16q)[22) N,N 46,XX Cont. !j!, 32 weeks 
Table 3 - Continued 
Amniocentesis 
C"'O PD Kruyotypo FISH on Parental Ultrasound 
No. indication În STC-villi STC-villi karyotype investigation FISH Karyotype Pregnancy outcome 
87 l'M.:: 40 45,X,d,«9p)[2V46,xx,d,«9p)[28) N,N N 46,X:X ConL $,34 wccks, 
nydrops Îetalis t'RhC) 
88 US ABN 46,XY"dd(I6q)[20] Identification N,N Abnormal TOP 46,XY 
(t(11 or 12);16) 
89 MA 36-39 47,XY,+mar[3]/46,XY[30] N,N N 46,XY Conto O',<p5 
90 MA 36-39 47,xx. +mar[17]146,XX[3] Identification (?) N,N Abnormal TOP 46,XX 
91 DNAIBIO 47,xx, +m,,[3]/46,xx[27] N,N 46,xx Cant. ~ 
92 MA 36-39 46,J<Y,8p-[16)/46,XY[2] N,N 46,XY Cont. 0" 
93 MA 36-39 46,XX,do«5p)[6]/46,XX[l3] N,N 46,XX Cont. ~ 
94 MA 36-39 46,XY,do«7)[22V46,XY[14] Identification (?) N,N 46,XY Cont. 0" 
95 MA 36-39 46,xx,do«6)[2S]/46,XX[6] Identification (?) 46,XX Cant. ~ 
96 l'M. 36-39 46,xx,der( 13; 13){ q lO;q 1 0)[ 12]1 Abnormal Slightly abnormal N 46,XX Cont. ~ 
46,XX[18] 
97 OTIlER 46,XX,I( 6; 13)[ 6)146,XX[34] 46,XX Cont. !jl, 34 weeks,p97. 7, 
(10ftwin) bilateral c!cft 
(othernonnal 'f') 
98 OTHER 4 6,XX, +5,der( 5; 13){ q 1 O;q 1 0)[24]1 N,N N 46,XX Con!. ~ 
46,xx, + 13,der(13; 13)[1 ]/46,XX[ 5] 
99 MA 36-39 92,XXYY[l6] Abnormal N N 46,XY Cont. 0" 
100 MA 36-39 92,XXYY[2]/46,XY[lI) Abnormal N N 46,XY Cont. 0", nypospadia,> p97.7 
101 MA 36-39 92,XXYY[43] Abnormal Transient abnormal N 46,XY Cont. O',>p95 
102 MA 36-39 92,XXXX[22V46,XX[l4] Abnormal N N 46,XX Cant. ~ 
103 OTIlER 92,XXYY[20)/46,XY[2) N N 46,X"Y Cant. 0" 
104 OTIlER 92,XXYY[34V46,XY[S3] Abnormal N N 46,XY Cant. 0" 
105 OTHER 92,XXYY[S]/46,XY[2S] N Transient abnormal Conto 0', > p97.7 
Abbreviations: see Fig. 2 and Table 2. 
I Previously described (Van Opstal et al., 1998). 
Table 4 - Further investigatious in cases of uncertainly abnormal results in STC-villi with ÏmaUy undetermined cytogenetic results. Abnormal or N at FISH means 
an abnormal or normal signal distrlbution. No comment at pregnancy outcome me~ns ~ nonna1 baby with l! bh1h weight between pS aod p9S 
Amniocentesis 
C", PD Karyotype FISH on Parental UJtrasound ----" 
No. indication in STC-villi STC-vilIi karyotype investigation FISH Karyotype Pregnancy outcome 
106 MA 36-39 47,XY,+13[4] Ahnorrnal IUD, growth fallure fetal tissue 
107 MA 36-39 (I 45.X [30J Ahnonna! N.N N Abnormal Growth failure Se!. TOP of affected twin 
oftwin) (12 weeks (other nonna! 0")1 
amniotic fluid) 
108 US ABN 45.Xl2JI46,XY[28J Abnonnal TOP, no tissue for confum.ation 
109 MA 36-39 47.XX.+3[13JI46.XX[19J Abnonna! N Cont.~, > p95 
110 MA 36-39 47,XY,+mar[26]/46,XY[12] Identification (?) N.N N Cont. d' 
Abbreviations: see Fig. 2 and Table 2. 
1 Previously deseribcd (in't Veld et al., 1995h). 
Chapter 2 
In one case (number 36) intra-uterine death (IUD) occured. Follow-up investigations 
and pregnan"'J outcomes in women with uncertainly abnormal karyotypes in STC-
viIJi and a final normal (prenataI) cytogenetic diagnosis representing CPM (N=69) are 
presented in Table 3. In 62 cases a live infant was bom and in three cases (numbers 
62, 67 and 68) IUD occurred. TOP was carried out in four cases (numbers 78, 85, 88, 
and 90); in cases 88 and 90 because of ultrasound abnormalities, thought to be caused 
by the chromosomal abnormality, and in cases 78 and 85 before any follow-up 
investigation took place and af ter incorrect follow-up investigation, respectively. 
Follow-up data of women with an undetermined prenatal cytogenetic diagnosis are 
shown in Table 4. TOP was carried Dut in !wo pregnancies; in case 107, it concemed 
selective term.ination of one fetus of a !win pregnancy at 12.5 weeks of gestation after 
confirmatory FISH investigation of an early anmiotic f1u1d sample only. 
Two pregnancies proceeded to term and resulted in the birth of norrnal babies. In 
case 106, IUD was established with ultrasound investigation after the findings of 
trisomy 13: fetal fibroblasts failed to grow following suction curettage 
The final results of follow-up investigations of uncertainIy abnormal karyotypes 
in STC-villi among the various indications, expressed as the confirmation rates 
[abnormal: (abnormal+ normal)] are presented in Table 5. 
Table 5 - Results of follow-up investigations of uDcertainly sboormal cytogenetic results in STC-villi 
among tbc varioH5 indications with calculated confirmation-rates [abnormal:(abnormal + norroal)] or 
[generalizcd abnormalty:(generalized aboormality + CPM)J 
Final results 
._-----~--
Uncertainly Abnonnal 
abnarmal (generalized Nonnal Unknown Confirmation rate 
Indication results abnormality) (CPM) (undetermined) (95% Cl) 
--_._. __ ._--------_._ ..• 
---- "----' ... _. 
MA 36-39 78 24 50 4 0.324 (0.220 - 0.443) 
MA::: 40 10 2 8 0 0.200 (0.025 - 0.556) 
US ABN 9 6 2 0.750 (0.349 - 0.968) 
CARRIER 0 0 0 0 
DNAIBIO 3 0 3 0 0.000 (0.000 - 0.708) 
OTHER 10 4 6 0 0.400 (0.122 - 0.738) 
TOTAL 110 36 69 5 0.343 (0.252 - 0.434) 
95% Cl "" 95% Confidence Interval 
The confirmation rates of the different chromosomal abnormalities in STC-villi are 
shown in Table 6. The 219 abnormal karyotypes were non-mosaic in 147 (67%) and 
mosaic in 72 instances (33%). All 72 mosaic findings were uncertaln; so, 65% of 110 
uncertainly cytogenetic results concemed mosaic findings. Low, medium, and high 
level mosaicism was encountered in 30,17, and 25 instances, respectively. 
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Table 6 - Generalized abnormalities versus CPM cases among tbe varioDS initially uucertainly 
chromosomal abnormalities in STC-villi aud tbe calculated coufirmation-rates Igcncralizcd 
abnormality:(generalized abnormality + CPM)] 
Uncertainly Generalized Chromosome 
abnonnality abnormal abnonnality CPM Undetermined 
+13,+18 
+ 13,+ 18,+21 rnosaicism 
low (s.10%) 
medium (11-33.3%) 
high t: 33.3%) 
45,X 
Sex chromosomal mosaicism 
4 
7 
o 
7 
6 
low (S 10%) 16 
medium (11-33.3%) 5 
high ~ 33.3%) 3 
Unusual trisomy (*" 13,18,21 )(rnosaicism) 
full(IOO%) IQ 
low (s.10%) 4 
medium 8 
high t: 33.3%)(11-33.3%) ., 
Structural rearrangements 
balanced 5 
unbalanced 9 
Marker (rnosaicism) 
full (100%) 
low (s.10%) 2 
medium (11-33.3%) 0 
high ~ 33.3%) 4 
Mosaic structural rearrangements 
low (s.10%) 0 
medium (11-33.3%) 2 
high t: 33.3%) 5 
Other (mosaicism) 
full (100%) 3 
low (s. 10%) J 
medium (11-33.3%) 2 
high t: 33.3%) 3 
All abnonnalities 
full (100%) 38 
low (s. 10%) 30 
medium (1 1-33.3%) 17 
high t: 33.3%) 25 
Total 110 
3 
o 
o 
7 
5 
o 
2' 
2 
4 
o 
o 
o 
5 
3 
1 
o 
o 
2 
o 
o 
o 
I 
I 
o 
o 
22 
1 
2 
11 
36 
o 
7 
o 
o 
o 
15 
3 
1 
6 
4 
8 
2 
o 
6' 
o 
2 
o 
I 
o 
2 
5 
2 
o 
2 
3 
14 
28 
15 
12 
69 
o 
o 
o 
I 
o 
o 
o 
o 
o 
I 
o 
o 
o 
o 
o 
I 
o 
o 
o 
o 
o 
o 
o 
2 
I 
o 
2 
5 
I Also high level mosaicism ofY -chromosomal structural abnonnality (case 17, Table 2). 
2 Also low level sex cbromosomal mosaicism (case 87, Table 3). 
Confinnation rate 
(95% Cl) 
J .000 (0.292 -1.000) 
0.000 (0.000 - D.410) 
J .000 (0.590 - 1.000) 
1.000 (0.478 - 1.000) 
0.000 (0.000 - 0.218) 
0.400 (0.053 - 0.853) 
0.667 (0.094 - 0.992) 
0.400 (0.122 - 0.738) 
0.000 (0.000 - 0.602) 
0.000 (0.000 - 0.369) 
0.000 (0.000 - 0.708) 
1.000 (0.478 - 1.000) 
0.333 (0.075 - 0.701) 
0.000 (0.000 - 0.842) 
0.667 (0.094 - 0.992) 
0.000 (0.000 - 0.842) 
0.000 (0.000 - 0.522) 
0.333 (0.084 - 0.906) 
0.000 (0.000 - 0.842) 
0.000 (0.000 - 0.708) 
0.61 1(0.435 - 0.769)' 
0.034 (0.001 - 0.178)' 
0.1I8 (0.015 - 0.364)' 
0.478 (0.268 - 0.694)' 
0.343 (0.252 - 0.434)' 
3 Confinnation rates ofthe summarized non-mosaic and various mosaic results differ significantly «Xl =: 29.44, 
df= 3, P < 0.001). 
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The majority of mosaic karyotypes turned out to be CPM (55/69 known cases, 80%), 
and the minority generalized mosaicism (14/69 known cases, 20%). Non-mosaic 
uncertainly cytogenetic results were more likely to be generalized mosaicism (22/36 
known cases, 61 %). The confirmation rates increased significantly in the rank order 
of low, medium, high level mosaicism and non-mosaicism (Tabie 6). The frequencies 
of generalized abnormalities among the various indications differed statistically 
significantly whilst those of CPM cases did not (Tabie 7). Hence, the predictive 
values of abnormal karyotypes in STC-villi [generalized abnormalities:(generalized 
abnormalities + CPM-cases)] in the various indications showed a statistically 
significant difference (Tabie 7). 
Table 7 - Generalized abnormalities versus CPM-cases in STC-villi among tbc various indicatioDs aod tbc 
calculatcd predictive values of aboormal cytogenetics [generalized nbnormality: (gcncralized"abnormality 
+ CPM)] for tbc fetal karyotype 
All Generalized Predictive valuel 
Indication N ahnarmal abnonnalityl CPM' Undetermined (95% CI) 
MA 36·39 2282 91 (4.0%) 37 (1.6%) 50 (2.2%) 4 (0.2%) 0.425 (0.320 • 0.536) 
MA~40 447 23 (5.1%) 15 (3.4%) 8 (1.8%) 0(0.0%) 0.652 (0.427 • 0.836) 
US ABN 165 49 (29.7%) 46 (27.9%) 2 (1.2%) I (0.6%) 0.958 (0.858 . 0.995) 
CARRIER 80 39 (48.8%) 39 (48.8%) 0(0.0%) 0(0.0%) 1.000 (0.910 - 1.000) 
DNAIBIO 206 5 (2.4%) 2 (1.0%) 3 (1.5%) 0(0.0%) 
OTHER 319 12 (3.8%) 6 (1.9%) 6 (1.9%) 0(0.0%) 
0.471 (0.230 - 0.722) 
TOTAL 3499 219 (6.3%) 145 (4.1%) 69 (2.0%) 5 (0.1 %) 0.678 (0.615 - 0.740) 
! Frequencies of generaJized abnormalities (US ABN and CARRlER combined) differ significantly <X2 = 
593.16, df~ 4, P < 0.001). 
2 Frequencies of CPM-cases (US ABN and CARRIER combined, DNAIBIO and OTHER combined) do not 
differ significantly (X2 = 2.45, df= 3, P > 0.05). 
l Predictive values differ significantly (X2 = 64.68, df= 4, P < 0.001). 
In a considerable number of patients (78/110, 71%), FISH on STC-villi slides was 
performed. In most instanees (N=66) it concerned interphase FISH for the 
differentiation of coincidentallocal mitotic division errors from mosaicism in cases 
displaying mosaic trisomy, tetraploidy or sex chromosoma] mosaicism. In 12 mosaic 
cases, 11 low level and one medium level mosaicism, FISH indicated a coincidental 
local mitotic division error, and follow-up arnniocentesis was only performed in !wo 
instances. In 54 instances, FISH confirmed mosaicism in STC-villi; subsequent 
amniocentesis was carried out 48 times. In the remaining six cases, TOP was carried 
out (N=4), IUD occurred (N=1) or only follow-up ultrasound investigation could be 
performed (N=1). Amniocentesis was performed in 74 instanees after uncertainly 
abnormal results in chorionic villi, and FISH on uncultured arnniotic fluid cells for 
differentiation of generalized mosaicism from CPM in 55 cases. In 2 of these 55 cases 
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only FISH was performed and in 53 cases, FISH was followed by karyotyping 
cultured amniotic fluid cells. FISH was non-informative in one case (number 38 of 
Table 3) and FISH results and karyotypes showed a discrepancy twiee; in case 14 of 
Table 2, FISH showed a normal signal distribution whereas the karyotype revealed a 
mosaie 45,X/46,XX, and in case 68 of Table 3, FISH with a 16-probe showed an 
increased percentage (26 %) of three signals containing nuclei whereas the karyotype 
was nOlmal. FISH was carried out in 12 cases on the metaphase level for 
identification of derivatives or marker chromosomes with various probes. In case 26 
of Table 2, for instanee, whole chromosome paint wcpX showed der (X) to stain 
completely; wcp Y showed, in accordance with the information of the paint 
manufacturer (Cambio Lid, Cambridge, U.K.), an aspecific signaIon the expected 
place X(pter), but another, expected on X(q13), also on the p-arm of der(X), 
compatible with a pericentric inversion. Karyotyping and extended FISH-
investigations on subsequently cultured arrmiotic fluid cells with the X-centromere 
probe (pBarnX5) and the probes cpq23.1 (Xpter, Ypter), cAL24 (Xp21.2), and c7B2 
(Xq28) confirmed the presence of a pericentrie inversion. 
All 12 live bom infants in the generalized abnormality group (TabIe 2) were 
phenotypiealiy normal. In the CPM group (TabIe 3), three of the 62 (5%) live bom 
children had congenital malformations (Hirschsprung's disease in case 84, bilateral 
deft in case 97, and hypospadia in case 100), and one displayed uniparental disomy 
16 (matemal heterodisomy 16, case 66). The IUD cases (numbers 62, 67, and 68) 
showed multiple congenital malformations (MCA). Together with the two TOP cases 
(numbers 88 and 90) showing ultrasound malformations and another TOP case (no 
78) showing MCA at autopsy, nine CPM cases (13.0%; 95% Cl 6.1 %-23.3%) displayed 
congenital malformations. The birthweights of children in the CPM group were 
located between the p5 and p95 in 54 of the 62 cases (87%). Three of the four children 
with birthweights exceeding the p95 were confined to the group of seven (mosaie) 
tetraploidy- CPM cases (P=0.05, binornial statistics). 
Discussion 
The composition of the group of abnormal cytogenetic results in STC-villi equals that 
of various previous studies (Ledbetter et al., 1992; Wolstenholme et al., 1994; 
Association of Clinical Cytogeneticists Working Party on Chorionic Villi in Prenatal 
Diagnosis, 1994; Pittalis et al., 1994). Our figure for CPM cases (69/3499; 2.0%) is 
perfectly comparabIe to that (101/4498; 2.2%) from Leschot et al. (1996). The 
proportion of generalized mosaieism of 20% among the mosaie results in STC-villi is 
somewhat higher than the reported figure of 10 - 12% (Ledbetter et al., 1992; Pittalis 
et al., 1994; Phllips et al., 1996). The higher prevalenee of generalized mosaicism in 
our series rnight be due to the fact that we had quite a number of high level mosaic 
trisomy 18 and 21 cases, all of which tumed out to be generalized abnormal, 
although high level mosaicism of trisomy 18 is very unpredietable (Van Opstal et al., 
1995). 
Another factor might be that we consider the encowlter of a Itpseudomosaicismlt in 
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arnniotic fluid cells after the finding of mosaicism of the same abnormality in STC-
villi, a generalized mosaicism rather than a combined pseudomosaicism and CPM as 
has been done by others (Ledbetter et al., 1992; Wolstenholme et al., 1994; Leschot et 
al., 1996). We found a statistically significant relation between the level of mosaicism 
in STC-villi and the Iikelihood of representing a generalized mosaicism. A1though it 
is known that the distribution of normal and abnormal cells in mosaic placentae can 
be very irregular (Schuring-Blom et al., 1993; Henderson et al., 1996), the proportion 
of chromosomally abnormal cells in STC-villi seems to reflect the numbers of 
chromosornally abnormal and normal cells in the early cIeavage stages and the 
chance of abnormal cells to be distributed to the fetal compartment as weIl. This issue 
has been profoundly discussed by Wolstenholme (1996), Robinson et al. (1997), and 
Los et al. (1998). 
An increased risk of intra-uterine growth retardation (IUGR), fetal loss and poor 
pregnancy outcome has been reported in association with CPM (Schwinger et al., 
1989; Johnson et al., 1990; Goldberg et al., 1990; Kalousek et al., 1991; Breed et al., 
1991; Wapner et al., 1992; Brandenburg et al., 1996). The prevelance of 13% congenital 
malformations in our CPM group is in agreement with these reports. No increased 
frequency of IUGR was noted in our CPM cases, in agreement with the findings of 
Leschot et al. (1996). However, a statistically significant proportion of the children 
bom after the prenatal diagnosis of mosaic tetraploidy-CPM showed birthweights 
above the p95; extreme birthweights, low as weIl as high, are to be expected in CPM 
cases (Wolstenholme et al., 1994). 
Half of the abnormal karyotypes encountered in STC-viIli turned out to be 
uncertaln, and so, many prenatal follow-up investigations were required, amongst 
others 74 arrmiocenteses representing a second invasive procedure in 2.1 % of the 
women undergoing chorionic viIIus sampling. These investigations were insufficient 
or incomplete in some of the 110 cases with uncerlain results. This has led to two 
TOP procedures with the finding of normal karyotypes in fetal tissues. In two other 
cases normal karyotypes were also found in fetal fibroblasts after TOP, but in these 
cases the reasons for TOP were rather the severe ultrasound malformations. The 
investigation of the karyotype in LTC-villi as weIl might have resulted in 
continuation of the two, in hindsight, erroneously terminated pregnancies. The 
combined use of STC- and LTC-vilIi for the prenatal establishment of the fetal 
karyotype has been strongly advocated (Ledbetter et al., 1992; Pittalis et al., 1994; 
Hahnemann &: Vejerslev, 1997a, b), but has in practice achieved in less than half of 
the cases (Ledbetter et al., 1992; Teshima et al., 1992). In our laboratory, the culturing 
of chorionic villi has never been a great success despite initially reported favourable 
results (Sachs et al., 1990). The limiting factor for successful culturing is the amount 
of viIli obtalned; it decIined from a mean of 20 mg Oahoda et al, 1990) to 15 mg in the 
years thereafter. At least 20 mg villus tissue is recommended for the successful 
performance of STC-villi and LTC-villi preparations (Srnidt-Jensen et al., 1993); 
Leschot et al. (1996) stated that only cultures of chorionic villi were initiated in case 
of an amount of 35 mg villus tissue or more. We never used LTC-villi only as has 
been reported by others (Srnidt-Jensen et al., 1993; Ledbetter et al., 1992; Teshima et 
al., 1992). In our opinion, the (partially avoidabIe) risk of a cytogenetic false-positive 
58 
Cytogenetic investigatio1t in STC~villi 
misdiagnosis by using STC-villi alone (4/3499; 0.1 %) was to be prefened over the 
unavoidable risk of 0.5 - 1.8% of maternal cell contamination potentially leading to 
diagnostic failures in LTC-villi (Ledbetter et al., 1992; Smidt-Jensm et al., 1993; 
Associalion of Clinical Cytogeneticists Working Party on Chorionic Villi in Prenatal 
Diagnosis, 1994; Saura et a!., 1997). Saura et al. (1997) reported that metaphases were 
completely of maternal origin in 0.5% of cultured chorionic villi. Concerning false-
negative results, LTC-villi are more reliable than STC-villi (Ledbetter et al., 1992; 
Pittalis et al., 1994; Hahnemann & Vejerslev, 1997a), especially in cases with a high 
risk for cytogenetic abnormalities (Kennerknecht et al., 1993). Fortunately, we did not 
encounter noticeable false-negative results in our study period. For the quality of the 
karyotype, LTC-villi are preferabIe over STC-villi. Finally, for the discovery of 
potentia! cases of fetal UPD, LTC-villi alone are not suitable, since UPD cases are 
only associated with CPM types I and III (Wolstenholme, 1996; Los et al., 1998). 
FISH on STC-villi preparations and on uncultured arnniotic fluid eells turned out 
to be effective for the differentiation of coincidentallocal mitotic division enors from 
mosaicism in STC-villi, and generalized mosaicism from CPM, respectively. A 
remarkable discrepancy was encountered in case 68 of Table 3, which has a!ready 
been discussed in detail (Van Opstal et al., 1998). 
The certainty rates and predictive values of abnormal cytogenetic results of STC-
villi in the various indications showed that the cytogenetic performance is only 
acceptable when the cytogenetic risk is substantially increased. The best results were 
achieved in women with the highest risks: carriers of structural rearrangements and 
women displaying feta! abnormalities on ultrasound. Therefore, we advise chorionic 
villus sampling to those wamen with singleton pregnancies and a cytogenetic risk 
equal to or greater than that of a 40-year-old pregnant woman, averaging 3.4 % in the 
fust trimester of pregnancy for all abnormalities (Hook, 1990), or 2.7% for just the 
trisomies 13, 18 or 21 (Snijders et al., 1994). In this lirnited group of wamen we prefer 
chorionic villus sampling over amniocentesis. In twin or triplet pregnancies, we 
prefer chorionic villus sampling allowing for a selective TOP as early as possible in 
case of discrepant results (Brambati et al., 1996); our case 107 of Table 3 is an example 
of this policy. We also prefer chorionic villus sampling in the case of prenatal DNA 
or biochemical investigations representing a high genetic risk in most cases and in 
which cytogenetics is only additional. Finally, some "young" women (of advanced 
matemal age) will of course insist on chorionic villus sampling as will same "older" 
wamen insist on arrmiocentesis, and their wishes should be respected. 
In conclusion, prenatal cytogenetic di.gnosis on STC-villi alone required a high 
number of prenatal follow-up investig.tions. Notwithstanding l11is fact, there 
remained a risk for false-positive results. Cytogenetics should preferentially be 
carried out on STC-villi and LTC-villi simultaneously in order to improve the quality 
of the karyotype, to reduce the risk of false-positive results and to eliminate the 
theoretical risk of false-negative diagnoses. For this reason we improved the yield of 
obtained tissue in chorionic villus sampling, reintroduced the cultW'ing of villi and 
introduced the routine analysis of LTC-villi additional to STC-villi in 1997 in oUT 
department. We prefer chorionic villus sampling over amniocentesis on cytogenetic 
indications only when a cytogenetic risk of at least 3% is present. 
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Summary 
We report in detail the cytogenetic results of 1838 consecutive chorionic villus 
samples with the availability of both short-term culture (STC-villi) and long-term 
culture (LTC-villi) preparations in 1561 cases (84.9%). 
A high degree of laboratory success (99.5%) and diagnostic accuracy (99.8%) was 
observed; in four cases of low mosaicism, all four associated with the final birth of a 
normal child, a small risk of uncertainty was accepted. The combined analysis of 
STC- and LTC-villi reduced follow-up amniocenteses by one-third in comparison 
with the analysis of STC-villi alone. We believe that the desired level of quality and 
accuracy of prenatal cytogenetics in chorionic villi can only be achieved when both 
STC- and LTC·villi are available. We conclude that CVS might then be the mode of 
prenatal diagnosis of fust choice in pregnancies with a high (cytogenetic) risk. 
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Introduction 
Since its introduction in our departrnent in 1983, first-trimester chorionic villus 
sampling has become a welcome altemative to mid-trimester amniocentesis, 
especially for women with a high genetic risk (Los et al., 1998; Sachs et al.,1988). 
However, the safety of chorionic villus sampling as weil as the accuracy of 
cytogenetic laboratory findings in chorionic villi (CV) have been subject to intensive 
investigations (Brambati et al.,1990, 1991; Jackson et al., 1992; Smidt-Jensen et al., 
1992; Halmemann and Vejerslev, 1997a; Smith et al., 1999; WHO/PAHO 
Consultation on CVS, 1999). 
The prevalent problem in CV is the occurrenee of chromosomal mosaicism in 1-
3% of CV cases (Kalousek et al., 1992). Both true mosaicism and confined placental 
mosaicism (CPM) are weil documented (Kalousek and Dill 1983; Wang et al., 1994; 
Kalousek and Vekemans, 1996). The three conditions of an abnormal karyotype in 
'semi-direct' preparations (short-term cultured villi; STC-villi), in long-term cultured 
villi (LTC-villi) and in both STC- and LTC-villi combined with a normal karyotype in 
the fetus (or amniotic fluid cells) are defined as CPM type !, I!, and IIl, respectively 
(Kalousek and Barrett, 1994; Kalousek and Vekemans, 1996; Wolstenholme et al., 
1996). True mosaicism can be generalised mosaicism with ilbsolute or relative 
~oncordance (GMAC, or GMRC, respectively). In the case of GMAC, mosaicism is 
encountered in all three compartrnents (STC-villi, LTC-villi and fetus proper) whilst 
in the case of GMRC, mosaicism in at least one compartrnent is accompanied by the 
non-mosaic abnormality in the other compartrnent(s). Additionally, generalized 
mosaicism with a giscrepant (normal) karyotype in STC-villi (GMDD) or LTC-villi 
(GMDC), can be distinguised. Finally, the finding of different abnormal karyotypes 
in all three compartrnenls is known as generalised mosaicism with total giscrepancy 
(GMTD) (pittalis et al., 1994). 
Several studies (Ledbetter et al., 1992; ACC, 1994; Pittalis et al., 1994; Halmemeann 
and Vejerslev, 1997a; Los et al., 1998) have shown that the results of STC-villi are less 
representative for the fetal status than thase of LTC-villi or the combined results of 
both. The analysis of STC-villi only may resuIt in an inappropriate number of follow-
up amniocenteses and even unnecessary termination of pregnancy in some cases 
(Los et al., 1998). Combining the cytagenetic analysis of both STC- and LTC-villi is 
gaining popularity among several laboratories, and experiences with large series 
have become available (Smidt-Jensen et al., 1993, Pittalis et al., 1994; ACC, 1994; 
Smith et al.,1999). To rninirnize diagnostic pitfalls and interpretation dilemmas of 
mosaic findings, the routine analysis of both STC- and LTC-villi was introduced into 
our departrnent in 1997 (Los et al., 1998; Van den Berg et al., 1999). 
During a 3-year period we focussed our attention to the combined cytogenetic 
resulls of STC- and LTC- villi. The aims of this study were: 
1. To establish the improvement of chromosome quality by the investigation of LTC-
villi. 
2. To investigate the reliability of cytogenetic results in both villi compartrnents. 
3. To compare the reduction-rate in the number of follow-up amniocenteses with the 
figure from our previous study with the analysis of STC-villi alone. 
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Materials and Methods 
During a 3-year period a tota! of 2032 chorionic villus samples were received in our 
department. Chorionic villus samples were obtained under continuous ultrasound 
guidance by transabdominal aspiration as described previously Oahoda et al., 1990). 
At least 20 mg of villi are required for chromosomaI analysis of both STC- and LTC-
villi in those cases where the indication for prenatal diagnosis is cytogenetic only. In 
cases where primarily DNA or biochemical investigation is indicated, at least 40 mg 
of villi are required when additional chromosomaI ana\ysis is also requested. 
Cytogenetic investigation was performed in 1838 cases. The indications for 
cytogenetic investigation induded advanced maternal age (MA)(,,36 years), the 
parents being carriers for structural rearrangements or marker chromosomes 
(Carrier), ultrasound abnormalities (US Abn), recurrence risk of chromosomal 
abnormalities, a previous child with multiple congenital abnormalities, or a farnily 
history of chromosomal abnormality, and other reasons (Other) (n = 1663). In the 
remaining 175 cases the reason for prenatal diagnosis was a recurrenee risk for 
Mendelian inherited diseases detectable with DNA analysis or various metabolic 
diseases (DNA/BlO); secondary chromosomaI analyses were performed. 
The aspirated villi samples were carefully washed and estimated under an 
inverted microscope. Villi fragments were isolated from maternal tissue and blood 
dols. For the STC-villi preparation 15 mg were incubated overnight using 
fluorodeoxyuridine (FdU) synchronization (Gibas et al., 1987). The remaining villi 
were simultaneously used for the preparation of LTC-villi, which consisted of a 
trypsin - EDTA and collagenase treatment at 37°C for 60 and 120 minutes, 
respectively (Smidt-Jensen et al., 1989). Cells were cultured in Lab-tek®1I Chamber 
slides™ (Nalge Nunc International, Naperville, IL, USA) and harvested in situ after 
5-7 days. Karyotyping was routinely perforrned by G-banding using thePancreatin-
Trypsin-Giernsa staining technique. Sometimes a DA-DAPI staining was used in 
addition. In one case R-banding was used for inactivation studies of a balanced 
(X;autosome) translocation using methotrexate cell synchronisation and 
bromodeoxyuridine incorporation according to standard protocols. The inactivation 
pattern was studied in LTC-villi, amniotic fluid (AF) cells and fetal blood (FB) 
lymphocytes. 
The numbers of metaphases that were investigated in STC- and LTC-villi under 
various circumstances are presented in Table 1 and Figure 1. In cases where LTC-villi 
were non-available, normally 16 cells were analysed in STC-villi as described 
previously (Los et al., 1998). A karyotype in STC- and/or LTC-villi was considered 
normal in cases of 46,XX or 46,XY ± inversion (9)(P12qI3) and/ or ± any one-cell 
abnormality. Allother resulIs were considered abnormaI. These could either be non-
mosaic in STC· and LTC-villi (all cells in both compartmenls abnormaI) or mosaIc in 
STC- andJor LTC-villi (two or more cells abnormal in one or two compartments). 
Previously, abnormal karyotypes in STC-villi have been divided into certainly 
abnormal (abnormal) and uncertainly abnormal (uncertain) resulls (Los et al., 1998). 
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Table l-Tbe number ofmetaphases investigated in various circumstances in STC-and LTC-villi 
LTC-villi (D) STC-viIIi (D) 
8 
._ .. -.. ~ ...... "_._._-_ .. _~-
Normal karyotype in STC-villi 
Numerical aberratiOD in first 8 STC-villi cells 
+21 
Triploidy 
47,XXY 
47,XXX 
47,XYY 
+13,+18 
with US abnormality 
without US abnonnality 
45,X 
with US abnormality 
without US abnormality 
Aneuploidy *13,18, 21, X and Y 
Mosaic aneuploidy 
One eeU abnonnality 
+7,+8,+9,+11,+ 13,+ 14,+15,+ 18,+21,+mar 
Tetraploidy 
Other 
Structural rearrangement in first 8 STC-villi cells 
Familiar balanced 
Familiar 1mbalanced 
De -novo 100% 
mosaic 
• = Additional FISH investigations on interphase nuctet. 
8 
16 
12 
16 8 
16 
16 8 
16 8 
16' 8' 
16 8 
20' 10' 
20 10 
special protocol (Figure 1) 
consideration in each case 
8 8 
16 
16 8 
20 10 
In the present study, abnonnal karyotypes are divided into six categories: 
1. Abnonnal STC-villi which were assumed to represent generalized abnormalities 
and allowed a clinical deeision without further prenatal investigations. 
2. Uneertain STC-villi in eombination with normal LTC-villi, giving a certainly 
nonnal cytogenetic result ( abnonnalities confined to the STC-villi; CPM type I). 
3. Uneertain STC-villi in combination with abnormal LTC-villi, giving a certainly 
abnormal cytogenetic result (generalized abnonnalities). 
4. Uneertain STC-villi with nonnal or abnonnal LTC-villi, giving an uncertain 
eombination of cytogenetic results requiring follow-up investigation. 
5. Nonnal STC-villi with abnonnal LTC-villi, giving an uncertain combination of 
cytogenetic results requiringfollow-up investigation. 
6. Uncel'tain STC-villi, LTC- villi non-available, follow-up investigations indicated. 
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Figure 1 - Management plan for the finding oftetraploid cells in STC- and LTC-villi, according ta Noomen et 
al. (2001). 4N eelIs = tetraploid eells; 2N eells = diploïd eel1s. 
In several cases additional FISH on interphase nuclei (n=200) of STC- and LTC-villi 
was performed in cases with aneuploidy mosaicism for the differentiation between a 
coincidental local mitotic division error and mosaicism or for a more accurate 
establishment of the distribution of abnormal cells in both villi compartments (Van 
den Berg et al., 1997; Los et al., 1998; Van Opstal et al., 1998). In some cases FISH on 
metaphases of STC- or LTC-villi was carried out for the verification of small 
redprocal translocations and marker chromosomes. In cases of structural 
rearrangements or mosaicism of a marker chromosome, parental karyotypes were 
prepared according to standard techniques. 
Follow-up investigation involved amniocentesis with FISH on (uncultured) 
amniotic fluid cells, regularly followed by chromosome analysis on cultured 
amniotic fluid cells, DNA studies and/ or uitrasound investigation. FISH on 
uncultured anmiotic fluid cells (n=100) was performed for the differentiation 
between CPM and generalized mosaidsm. For these investigations the same probes 
72 
Cytogenetic investigation in STC- alld LTC-villi 
were used in STC-, LTC-villi and arrmiocytes (Van den Berg et al., 1997; Van Opstal 
et al., 1998). Amniotic fluid cells were cultured in Lab-tek®II Charnber slides™ 
according to standard protocols. 
In some cases DNA studies were performed for !he investigation of matemal cell 
contamination, cross contamination, uniparental disomy (UPD) or !he parental origin 
of a supemumerary chromosome (Van den Berg et al., 1997; Van Opstal et al., 1998). 
Follow-up ultrasound investigations were performed in our departrnent as 
described previously (Wladimiroff et al., 1995). In cases of termination of pregnancy 
(TOP), confirmation of the cytogenetic abnormality was performed in as many cases 
as possible. 
Information about !he pregnancy outcome of all CPM cases and translocation 
carriers was received from the women, the referring midwives or physicians. 
Statistical analysis comprised X' tests (of proportions). 
Results 
Cytogenetic investigations were performed in 1838 chorionic villus samples (Tabie 
2). STC-villi and LTC-villi preparations could be made of 1561 samples. in 277 cases 
LTC-villi were non-available. In 1829 cases (99.5%) a cytogenetic result was achieved. 
In nine cases, no cytogenetic diagnosis could be made due to laboratory failure in 
eight cases and insufficient material in one case, respectively. The failure-rate of LTC-
villi was 22/1561 (1.4%). Normal karyotypes in STC- and/or LTC-villi preparations 
were found in 1671 samples (91.4 %). An example of karyotypes in STC- and LTC-villi 
preparations of !he same sample is shown in Figure 2. 
Table 2 -Tota) number of chorionic viUus samples received duriog the 3-year period (1997-1999) 
Total i 1997 1998 1999 
Total cvs.,' . .'~;: Irn':2032 . I 670. 706 656 I 
DNAIBIO investigation only 194! 57 68 69 I 
ÇY!Qgenetic investigation . __ .. 1838 j' 613 638 587 __ . 
STi;l~I~~;e~~!atiOn:.,; .~ ir ~!:~ 93.7%' ·~~~·91.S;% ~~~ "94.9% ;~~ 94.1 % 
STC results (LTC not analysed) 72 4.6 o/c 20 5 % 29 4,8 % 23 4.2 % 
STC results (LTC failure) 22 IA % 14 3.5 % 2 0.6 % 6 0.4 % 
LTC results (STC failurel _: ____ ~ __ ._ .. ~.~-:----_'i 0.3 %1-----_...9_ .... __ . ____ 0 _~ ______ ~ ___ A ... J_.±'~ 
STC:investigation (LTC noIi~ava.ilable)_ \tt~: -,277 I 213 28 36 
STCresults 268 96.8% 20596.2% 28 100% 3597.2% 
STC failure 9 3.2 % 8 3.8 % 0 1" 0.8 % 
Töw-C~ètic'~üiiS-,7--C'-"c7 \fC iiizjï9'Ü-iX ---i05'9iC'iO/;-""63S-ïöóo/; -586-'99~8-% 
a"" «5mg 
73 
Chapter3 
,---~-,,- ---._------~,_ .. _-
... _-----~--
A 1< ' I! Ir J\ U ~d 
2 3 4 5 
~1 J' n )( u i« ~f n J\ ,j/I\ 
6 7 8 9 10 11 12 
U U 1l~ UK '~ tA U 
i3 i4 15 16 17 18 
•• '-":. S.~ , ..... ~ 1<. l 1 
i9 20 2i 22 X Y 
B j )~ U n 11 n 
2 3 4 5 
il ~~ n \1 ~~ I( ~f U 
6 7 8 9 IO 11 12 
M .,à~ ~~ St ~~ Bi 
i3 14 15 16 17 18 
ê~ ~~ "ti ~ " i'" I 8 
i9 20 21 22 X Y 
_.. -' 
Figure 2 - Karyotypes of one CV sample after (A) STC~villi preparation showing about 300 bands and (B) 
LTC-villi preparation showing about 400 bands 
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The frequency of matemal cell contamination (MCC) in LTC-villi was very low. 
MCC has occurred in only three cases among 761 identified male cases (0.4%). The 
MCC in those cases did not lead to diagnostic errors. Abnormal karyotypes, in STC-
villi and/or LTC-villi preparations were seen in 158 cases (8.6%). These 158 cases 
fitted into our six categories of eertain and Wlcertain karyotypic combinations in the 
STC- and LTC-villi preparations. The exact numbers and the distribution among the 
six categories in relation to the nature of the various abnormalities are shown in 
Table3. 
Ninety-one of these abnormal karyotypes were considered certain1y abnormal 
after the analysis of STC-villi preparations only. In the other 67 cases an Wlcertain 
result was achieved in either STC-, LTC-villi or both preparations. Detailed 
information about these 67 cases anlong the various categories, is presented in the 
Tables 4-8. 
Table 4 summarizes the different karyotypes, further investigations, as weil as the 
cytogenetic interpretation and pregnancy outcome in women with Wlcertain 
karyotypes in STC-villi and a normal karyotype in LTC-villi, and finally normal 
cytogenetic results. All cases tumed out to be CPM type I. 
Table 5 surnmarizes the different karyotypes, additional and follow-up 
investigations, the cytogenetic interpretation and pregnancy outcome in women with 
finally abnormal cytogenetic results (11 abnormalities, 9 carriers). TOP was carried 
out in ten pregnancies. The cytogenetic abnormality was confirmed in nine cases, in 
one case fibroblasts failed to grow. One pregnancy (No. 18) continued at the parents' 
request. Follow-up amniocentesis was only performed in two instances; in one 
instance at the explicit request of the parents (No. 19) and revealed the same 
chromosome aberration. TOP was requested and carried out. In the other case (No. 
14) subsequent arnnlocentesis and cordocentesis were carried out simultaneously for 
X-inactivation studies. These studies conducted on LTC-villi, AF and FB cells showed 
the normal X to be inactive and the derivative X chromosome (and the derivative 9) 
to be active in all investigated cells (50 metaphases per sample). 
Table 6 summarizes the karyotypes, additional and follow-up investigations, 
cytogenetic interpretation and pregnancy outcome of Wlcertain STC-villi with 
normal or abnorrnal LTC-villi resulting in a finally Wlcertain cytogenetic result. 
There were six cases of CPM type I, two cases of CPM type III, one carrier and two 
instances of sampling problems leading to mosaic karyotypes. In five cases (Nos 1-5) 
FISH was performed on interphase level for the demonstration or exclusion of a 
mosaicism in either STC- or LTC-villi or for the establishment of a more accurate 
level of mosaicism in STC-villi. In case No.l, subsequent arnnlocentesis was carried 
out for the differentiation of CPM I from GMOC. FISH on Wlcultured amniocytes 
revealed a norrnal signal distribution with a chromosome 13 specific probe and 
therefore the diagnosis of a rare CPM type I of non-mosaic trisomy 13 could be made. 
The pregnancy continued and resulted in the birth of a healthy male infant. 
In case No. 3 the possibility of a real sex chromosomal mosaicisrn was considered 
and subsequent amniocentesis was carried out; FISH on Wlcultw-ed amniocytes 
revealed a normal Xi signal distribution (Van den Berg et al., 2000). 
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Trisomy 13,18 
Trisomy 21 
Triploid}' 
Sex chromosomal aneuploidy 
100% 
mosaic 
Marker cmomosomes 
100% 
mosaic 
StructuraJ rearrangements 
balanced 
unbalanced 
Unusual trisomy 'j; 13,18,21 
Aulosomal mosaic 13,18,21 
Autosomal mosaic :;t. 13,18,21 
Mosaic structural rearrangements 
Parental karyotype 
STC abnormal 
'97 '93 '99 
4 11 4 
13 11 9 
337 
975 
2 
chorionic villus 
Combination STC + LTC certain 
STC uJlcertain STC uncertain 
LTC normal LTC abnormal 
'97 '98 '99 '97 '98 '99 
2 2 
2 
2 2 
2 
2 5 
2 
y~S!i .!,:v.:s:i~a:ir:n ___________ } ___________ ~ _ } __ ~ _________ 5 __ ~ __ _ 
Amniocenteses 
a = One amniocentesis at explicit request of the parents, one for X inactivation study. 
b = One amniocentesis for UFD investigation. 
2a 
Certain karyotypes appear unshaded in the tabie, whereas uncertain karyotypes are indicated by grey shading 
Table 4 - Uncertain STC-villi karyotypes with Donnal LTC-villi karyotypes fmaUy resulting in nonnal cytogenetic results 
STC-villi LTC-vÎlli Parental Amniocentesis CylogenelÎc InterpretalÎon 
Case Indieation Karyotype FISH Karyotype FISH karyotype US Karyotype FISH & Pregnancy outcome 
MA 36-39 45,X[2]/46,XY[18] N 46,XY N CPMI Cont. healthy cf 
2 Olher 45,X[2]/46,XY[21] N 46,XY N CPMI Cont. healthy cf 
3 MA 36-39 92,XXYY[3]/45,X[2]/ N 46,XY CPMI Cant. healthy cf 
46,XY[47] 
4 US Abn 45,X[2]/46,XX[18] A 46,XX[10] b N CPMI TOP 
5 MA 36-39 45,X[J]/46,XX[17] A 46,XX[10] b N CPMI Cant. healthy!j! 
6' ather 47,XY,+mar[21]/46,XY[5] 46,XY[24] CPMI Cont. healthy cf 
7 MA 36-39 47,XY,+mar[2]/46,XY[17] 46,XY[16] CPMI Cant. healthy cf 
8 MA 36-39 47,XX,+7[3]/46,XX[ 17] A 46,XX N CPMI Cant. healthy!? 
9 MA 36-39 47,XX,+7[2]/46,XX[19] N 46,XX N CPMI Cant. healthy!? 
10' MA 36-39 47,XX,+22[4]/46,XX[16] A 46,XX N CPMI Cont. healthy!? 
11 Carrier 50,X:X,+ 3,+5,+ 7 ,+8[5]/ 46,XX CPMI Cant. healthy!? 
46,XX[15] 
12 ather 46,XX,add(21 )(P?)[ 5]/ N 46,XX CPMI Cant. healthy!? 
46,XX[15] 
13 MA 36-39 46,X,t(Y; 15)[27]/46,XY[ 19] 46,XY[25] CPMI Cant. on going 
. ~_._. __ .... _""--~ 
a = One of twin pregnancy, tbc other twin displayed a nonnal karyotype. 
b = Matemal eeU contamination not excluded. 
A = Abnorrnal; add = addÎtÎonal matcrial of unknown origin; Cont. = eontinuatÎon of pregnancy; 1 = Îdentification; mar = marker chromosome; N = norrnal; TOP = 
tennination of pregnancy; US = follow-up ultrasound Învestigation. 
Table 5 - Uncertain STC-viIli karyotypes witb abnormal LTC-viIli karyotypes finaUy resulting in abnormal cytogenetic results 
STC-villi LTC-villi Parental Amniocentesis Cytogenetic Interpretation 
------- -'---
Case Indication Karyotype FISH Karyotype FISH karyotype US Karyotype FISH & Pregnancy outcome 
.. ------_ .. --
--------------_.- -'-" 
MA,40 47,XX,+18 47,XX,+18 A A TOP confinned 
2 MA,40 47,XY,+18 47,XY,+18 A A TOP confmned 
3 MA 36-39 47,XX,+18 47,XX,+18 N A TOP confirmed 
4 US Abn 47,X,del(Y),+ 18[16]1 A 47,X,dc1(Y),+ 18[7]1 NIN A TOP confirmed 
46,X,-Y,+ 18[14] 46,X,-Y,+18[1] 
S MA 36-39 45,X 45,X A A TOP confirmed 
6 MA 36-39 45,X 45,X N A TOP confirmed 
7 MA 36-39 47,XXY 47,XXY A TOP confirmed 
8 MA 36-39 47 ,xx, +mar[28]/46,XX[2] [ (?) 47,XX,+mar[24] NIN A TOP 
9 MA 36-39 47,xx, +mar[16]/46,XX[2] [ (?) 47,xx,+mar[10]/46,XX[8] mar pat Carrier Cont. healthy!j! 
10 MA 36-39 46,XY,t(7;11) 46,XY,t(7;11) t(7;II)mat Carrier Cont. healthy d' 
11' MA 36-39 4S,XY,de,(I3;14) 4S,XY, dec(13;14) NIN Carrier Cont. 22 wks ppt 
12 Other 4S,XX,dec(I3;14) 4S,XX,dec(13;14) t(I3;14)pat Carrier Cont. heaJthy!j! 
13 US Abn 4S,XX,dec(IJ; 14) 4S,XX,dec(13;14) t(I3;14)mat Carrier Cont. healthy!j! 
14 Carrier' 46,X,t(X;9) I (A) 46,X,t(X;9) N 46,X,t(X;9) Carrier Cont. healthy!j! 
IS' MA 36-39 46,XX,t(18;19) 46,XX,t(18;19) I (A) NIN N Carrier ConL healthy!j! 
16 MA,40 46,XY,t(lO;II) [ (A) 46,XY,t(1O;11) NIN Carrier Cant. healthy d' 
17 MA 36-39 46,XX,dec(21) [(N) 46,XX,dec(21) N v(21)pat Carrier Cont. On going 
18 US Abn 46,XX,dec(21) 46,xx, dec(21) t(9;21)pat A Cont. !j! MCA 
19 Carrier" 4S,X,t(19;21)[ 16]1 A 4S,X,t(19;21 )[13]1 A 4S,X,t(19;21)[42] A A TOP confirmed 
46,X,deI"(Y),t(l9;21)[ 4] 46,X,deI"(Y),t( 19;21 )[20] 46,X,deI"(Y), 
t(19;21)[9] 
20 MA 36-39 47, XY, +idie( IS)[ 12]1 [(A) 47,XY, +idie( IS)[12]1 1 (A) NI- A TOP confirmed 
46,XY[6] 46,XY[S] 
a = One of twin pregnancy, the other twin displayed a nonnal karyotype; b = Matemal carriership t(13;14).; c "" Matemal carriership t(l9;21); ? "" not identified; der = 
derivative; idic = isodicentric chromosome; mat = matemal; pat = paternal; MCA = multiple congenital malfonnations. For. abbreviation see also Table 4. 
Table 6 - Uncertain STC-viIli wUb normal or abnormal LTC-villi karyotypes finally resulting in uocertain cytogeoetic results 
STC-vil1î LTC-villi 
Case Indication Karyotype FISH Karyotype 
MA 36-39 47.XY.+13 A 46.XY 
2 MA 36-39 47,xxx A 46.XX' 
3 MA 36-39 4S;X A 46.XY 
4b MA ~40 4S.X[28]/46;XX[22] A 46,X:X ~ 
Sb MA ~40 4S.X[28]146.XX[2] A no metaphases 
6' MA 36-39 46.XX[21]/46.XY[IO] 46.XX[ I 0]/46.XY[20] 
7 US Abn 46.XY.del(2)(p?) I (Al' 46.XY.del(2)(p?) 
8 MA 36-39 46;xY.der(3Xq?) I(N) 46.XY.der(3)(q?) 
9 US Abn 46.XY .der( 16?)[ 5]/46.XY[3] I(N) 46.XY.der(16?)[1 ]I 
46;xY[6] 
10 MA :<:40 47.XY.+mruc[l2]/46.XY[9] I (A) 47.XY.+mruc[I]l46.XY[29] 
11 MA,40 46,KY,der(IS)[20Jl46.XY[lOl I (Al 46,XY 
a = One of twin pregnancy. the other twin displayed a nonna! karyotype. 
b = Twin pregnancy; previously described (Van den Berg et aI.,1999). 
c = Matemal eeU contamination not excluded. 
d = FISH revea1ed a t(1 ;2), del = deletion. 
For abbreviation see also Table 4 and S. 
Parental Amnioeentesis 
FISH karyotype US Karyotype FISH 
N N 
N 46.XX N 
N 46.XY N 
N 46,X:X N 
A 46.XY N 
t(1 ;2)mat 
NIN 46.XY 
N NIN N 
N NIN 46,XY N 
Cytogenetic Interpretation 
& Pregnancy outcome 
CPM I Cont. healthy d' 
CPM I Cont. healthy ~ 
CPM I Cont. healthy d' 
CPM I Cant. healthy!i! 
wrong Cant. healthy d' 
sampled 
cross Cant. healthy!i! 
cant. andd' 
Carrier TOP d'MCA 
CPM III Cont. healthy d' 
CPM III TOP 46.XY 
CPMI Conto healthy d' 
CPMI Cont. hea!thv d' 
Table 7 - Normal STC-villi witb abnormal LTC-villi karyotypes fmally resulting in uncertain cytogenetic results 
STC-villi LTC-villi Parental Arnniocentesis Cytogcnctic Interpretation 
Case Indication Karyotype FISH Karyotype FISH karyotype US Karyotype FISH & Pregnancy outcome 
----_._----".,,---_.~_.~ .. _----
MA 36·39 46,XX N 47,XXX[3J/46,XX[15J 46,XX N CPM II Con!. healthy ~ 
2 MA 240 46,XY N 47,XY,+ i(2IXqIO) A 46,XY N CPM II Cant. on going 
3 MA 240 46,XY 47,XY,+mar[2]/46,XY[28J CPM II? Cont. healthy d' 
4- MA ~40 46,XX 47,XX,+mar[2J/46,XX[25J CPM II? Cont. healthy Ei! 
5 carrier 45,XX,der(13;14) N 46,XX,+8,t{l3;I4) A N N CPM II Con!. hea1thy ~ 
6 MA 36·39 46,XX N 47,XX,+ 18(1 OJ/46,XX[20J A 46,XX N CPM II Con!. healthy ~ 
7 carrier 45,XY,der(13;14) N 46,XY,der(13;14),+18 [4J/ A 45,XY,der(13;I4) N CPM II Cant. healthy d' 
45,XY,der(13; 14)[28J 
8 MA 240 46,XY N 47,xy,+2I[19J/46,XY[4J A N CPM II Cant. healthy d' 
9 MA 36·39 46,XX N 47,lCX,+2[2J/46,XX(14J A N Recommended CPM II? Cant. healthy Ei! 
10 US Abn 46,XY 47,XY,+8[2J/46,XY[18J N N CPM 11 Cant. healthy r:f 
11 DNAIBIO 46,XY N 47,XY,+9[2J/46,XY[ 17J/ A 46,XY N CPMII Cant. 
46,XX[6J MCC 
12 MA 36·39 46,XX N 47 ,XX,+ I O[12J/46,XX[7J A N CPM II Cant. healthy!f 
13 MA 36·39 46,XX N 47,XX,+20[2J/46,XX[14J N CPM II Cant. healthy r:f 
14 MA 240 46,XY A 47,XY,+16[7J/46,XY[9J A N CPM III Cont. healthy d' 
a = One of twin pregnancy, the other twin displayed a nonnal karyotype. 
For abbreviatîon see a1so Table 4 and 5. 
Table 8 - Uncertain STC-villi, LTC-viUi non-available 
STC-villi LTC-villi Parental Amniocentesis Cytogenetic Interpretation 
Casc Indication Karyotype FISH Karyotype FISH karyotype US Karyotype FISH & Pregnancy outcome 
----_ .. 
MA,40 47,XXY 47,XXY A A Cant. healthy d' 
2' MA 36-39 45,X[6]/46,XY[24] N 46,XY N CPM Cant. healthy ei' 
Iorill 
3' MA 36-39 45,X[4]/46,xx[26] A CPM Cant. healthy!j! 
Iorill 46,xx 
4 DNAJBIO 46,X,+mar[IJ]/45,X[5]/ A 46,XX N CPM Cant. healthy 'T! 
46,XX[12] Iorill 
5 MA,40 47,XX,+mar[15]146,XX[28] NIN N 46,XX CPM Cant. healhty!j! 
Iorm 
6 MA 36-39 46,XX,inv(3) inv(3)pat carrier Cant healthy!j! 
7 Other 46,XY,de1(22)(q?) t( 11 ;22)mat 46,XY,t(I1;22) carrier Cant. healthy d' 
8 MA 36-39 47,XY,+ 18[9]/46,XY[22] A N 46,XY N CPM Cant. healthy d' 
lor III 
9 DNAJBIO 47,XX,+20[13]/46,XX[16] CPM I TOP" 46,XX 
a = One oftwin pregnancy, other twin displayed a normal karyotype. 
b = TOP because of abnormal DNA results 
For abbreviation see also Table 4, 5 and 6. 
C1.apter 3 
In cases 4 and 5, a twin pregnancy, both fetuses showed a mosaic 45,X/46,XX in 
STC-villi. Two colour FISH with X and Y probes on LTC-villi revealed one normal 
sample and one with an increased percentage nuclei with of one X signaI. 
Subsequent amniocentesis was carried out for the differentiation of CPM from 
generalized mosaicism. Surprisingly, FISH on uncultured amniocytes revealed one 
normal XX and one normal XY fetus (Van den Berg et al., 1999). 
In case No. 6, also a twin pregnancy, both STC- and LTC-villi karyotypes of one 
twin showed a XX/XY chimerism, while the other twin showed a normal 46,XY 
karyotype. Af ter consuIting the obstetrician, the chimerism was presumed to be 
caused by a sampling problem. Additional DNA analyis was performed and 
confirmed the hypothesis of the cross contamination. A healthy boy and girl were 
subsequently bom. 
In the other three cases (Nos 7, 8, and 9), where the uncertain results were due to 
an insufficient quality of the chromosomes, FISH on the metaphase level was carried 
out for identification and/ or determination of derivatives with various probes. TOP 
was carried out in two cases (Nos 7 and 9) because of ultrasound abnormalities. 
In one case (No. 10) FISH was performed for the identification of the de novo 
marker chromosorne which turned out to be positive with a 13/21 centromeric probe 
and the whole chromosome paint (wcp) 13. Follow-up ultrasound investigation 
showed no abnormality and the pregnancy continued. 
In case No. 11, FISH on STC-villi was applied with a 15psatIII specific probe to 
characterize the extra 15p material, which showed two signals in normal cells and 
only one signal in those cells with the der(15). Subsequent amniocentesis was carried 
out and F1SH on urlcultured amniocytes showed a normal signal distribution. 
Additional UPD investigations revealed a normal biparental chromosome 15 
contribution. 
Table 7 swmnarizes 14 cases with abnormal LTC-villi karyotypes, found af ter 
certain (normal or carrier) STC-villi (13 cases of CPM type II and one of CPM type 
III). Two cases revealed a non-mosaic chromosome aberration (Nos 2 and 5). It 
concerned anisochromosome 21 and a trisomy 8, respectively. In both cases FISH on 
LTC-villi slides turned out to be (non-mosaic) abnormal as weil. To differentiate a 
GMDD from CPM type I!, subsequent amniocentesis in bath cases, in addition to a 
cordocentesis in case 5, was carried out and revealed normal results. The prenatal 
diagnosis of (PM type II could be made. Both pregnancies were continued. 
All other cases revealed mosaicisms. FISH on interphase level was carried out in 
all cases, except in those cases involving a marker chromosome (Nos 3 and 4). 
Subsequent amniocentesis was carried out when FISH on LTC-villi slides was 
abnormaI. All these cases turned out to be CPM type II and the pregnancies 
continued. In case 14, additional FISH on STC- and LTC-villi slides with a 16-probe 
showed an increased percentage (21 %) of three signaIs whereas the STC-villi 
karyotype was normal. Amniocentesis was subsequently carried out and FISH (with 
the same 16-probe) on uncultured AF cells showed a normal signal distribution. The 
diagnosis of (FM III could be made and the pregnancy continued. 
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In case 3 and 4, displaying two cells with a marker cl1romosome CPM type II was 
assumed without follow-up investigation; a small risk of missing a GMDD-diagnosis 
was accepted. In case 9, the parents refrained from amniocentesis because of the 
small risk. 
Table 8 illustrates those cases where LTC-villi were non-available and uncertain 
STC-villi karyotypes were found. In case 3, 4 and 8, FISH on STC-villi slides was 
carried out for the establishment of a more accurate level of mosaicism. This 
subsequent FISH investigation also resulted in the identification of the marker 
chromosome in case 4 which contained the X-centromere region. Subsequent 
amniocentesis was only carried out in cases 4 and 8 and not in case 3 because thls 
involved a twin pregnancy and the small risk of missing a generalized mosaicism 
was taken. In case 7, parental blood investigation revealed a matemal t(11;22) but, 
unfortunately, the STC-villi karyotype remained uncertain and subsequent 
amniocentesis had to be carried out and showed a balanced 46,XY,t(11;22). The 
pregnancy was continued and a healthy male infant was bom. In case 9, TOP was 
carried out because of abnormal DNA results. The trisomic 20 cell line was not 
confinmed in fetal fibroblasts. 
In addition to the abnormalities listed in the Tables 4-8, 114 cases of tetraploidy 
mosaicism were encountered (Tabie 9). In 14 of these cases, follow-up ultrasound 
investigation was performed and in four amniocentesis, all with normal results. All 
these 14 cases were found in 1997 before the tetraploidy protocol was implemented 
(Figure 1) Thereafter, in only one case follow-up investigation took place in fetal 
fibroblasts after TOP because of unfavourable results of prenatal DNA analysis, the 
tetraploidy was not encountered in the fibroblasts. 
During the period of thls study, it was seen that if there were no analyses 
performed in LTC-villi preparations there would have been 53 cases with uncertaln 
cytogenetic results (53/144 abnormal STC-villi; 36.8%). Conversely, the simultaneous 
analysis of STC- and LTC-villi introduced 14 (initially normal) cases with uncertaln 
cytogenetic results. Nevertheless, the total number of uncertain results showed a 
significant reduction from 53/144 (36.8%) to 34/158 (21.5%) (X'=8.60, df=l; p<O.OO1). 
In comparison to our previous study on the analysis of STC-villi preparations alone 
(Los et al., 1998) with 110/219 (50.2%) uncertaln results, the figure of 34/158 (21.5%) 
uncertain results of the present study represents a significant improvement 
(X'=32.02, df=l; p<O.OOI). Thls has not yet resulted in a significant deerease in the 
number of follow-up amniocentes over the period 1997-1999 (28/1829 CV samples) 
compared to that over the period 1993-1996 (74/3499). However, the combination of 
the implementation of the protocol for handling tetraploid cells and the hlgh rate of 
obtalning a cytogenetic resuIt after analysing both STC-and LTC-villi, resulted in a 
significant reduction of the number of follow-up amniocenteses from 74/3499 (2.1 %) 
during the period 1993-1996 to 15/1225 (1.2%) in 1998-1999 (X'=3.89, df=l;p<0.05). 
Af ter follow-up investigations, the 34 uncertaln cases turned out to be CPMs in most 
instanees (30/34) and a generalized abnormality in only four instances. 
The distribution of the final cytogenetic results arnong the various indications is 
presented in Table 9. Frequencies of abnormal results are strongly correlated with the 
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indication for prenatal cytogenetic investigation in contrast to those of CPM cases 
which tumed out to be independent from the a priori cytogenetic risk. 
The frequencies of CPM type I, II, lil, and CPM .type I or lil cases were 1.09% 
(20/1829),0.71 % (13/1829),0.16% (3/1829) and 0.27% (5/1829), respectively. 
The proportion of women with a low cytogenetic risk in the present study is 
significantly lower than that in the previous study (Los et al., 1998) (Tabie 10). 
Table 9 ~ Distribution ofthe final cytogenetic results 2moDg tbc various indicatioDs 
Nonnal Abnonnal CPMb 
-------
Indication N 0.583 4n12n Abn" Carrier II III lor III Other 
-"- ----------- _._------
MA 36-39 954 853 63 11 6 11 5 3 
MA '40 297 259 16 11 3 4 
US Abn 157 90 6 56 2 
Carrier 54 22 4 3 22 2 
DNAIBIO 170 160 7 
Other 197 173 18 2 3 
._--------- ------ ---- .... -.. ---- _. -........ -- ------
AH 1829 1557 114 82 33 20 13 3 5 2 
a = Frequencies of abnonnal results (US Abn and Carrier combined) differ significantly among tbe various 
indications (Xl = 317,01, df= 4; P < 0.001). 
b = Frequencies ofCPM cases (US Abn and Carrier, DNAIBIO and Other combined) are evenly distributed (X2 = 
1.07, df~ 3; p > 0.05) 
20 = Only diploïd eells; 4n12n = Tetraploid and diploïd ceJls. 
Table 10 - DistributioD of CV patients in high- BDd low cytogenetic risk indications 
High risk ~3.5% 
Low risk < 3.5% 
Previous study 
1993 - 1996 ---~
Indications 
MA ,40 
US Abn 
Carrier 
MA 36-39 
BIOlDNA 
Other 
N 
692 
2807 
x' ~ 43.07,df=1 ; P < 0.001 
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1997 - 1999 
N 
507 
1322 
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Discussion 
In a few large studies the relative accuracy of STC- and LTC-villi are compared 
(Ledbetter et al.,1990, 1992; ACC, 1994; Pittalis et al., 1994). The present study 
contributes more information about the accuracy of the analysis of both STC- and 
LTC-villi preparations. 
The overall success rate for obtaining a cytogenetic diagnosis was 99.5% which is a 
good figure in view of the reported percentages (Ledbetter et al.,1992; Teshima et al., 
1992; ACe, 1994). 
The improvement of karyotype quality is evidently shown in Figvre 2. Although 
analysing STC-villi alone did not lead to any overlooked chromosomal aberrations, 
analysing both STC- and LTC-villi clearly optimized the chromosome quality 
resulting in a quality about equal to that of AF cells. 
The very low percentage of MCC in the present study (0.4%) is not only the result 
of careful dissection of the material, the culture method and the choice of appropriate 
medium (Saura et al., 1997; Smidt-Jensen et al., 1989), but is also due to the fact that 
all LTC-villi are harvested in situ, in our laboratory. There were no diagnostic errors 
duetoMCC. 
Since the introduction of the routine analysis of eight cells in LTCvilli additional 
to STC-villi, the number of routinely investigated cells in STC-villi cells has been 
reduced from 16 to 8. As a consequence of this, fewer cases of CPM type I and III 
were expected to be notieed. The observed prevalenee of CPM type I and III was 
1.5% of all 01 samples, which is not significantly different from that of 2.0% obtained 
in our previous study (Los et al., 1998). The total number of cases with CPM type I, II 
and III (2.2%) matches the results of other studies (Leschot et al., 1996; Pittalis et al., 
1994; Wang et al 1994). 
The ultimate number of finally abnormal cytogenetic results in STC- and LTC-villi 
is somewhat higher than in previous studies (Ledbetter et al.,1992; Pittalis et al., 1994; 
Los et al., 1998). This is due ta the fact that we advise chorionlc villus sampling to 
those wamen with a high genetic risk (;'3.5%)(Los et al., 1998). It has been shown 
that this policy, together with the simultaneous analysis of STC- and LTC-villi 
preparations has led to a significant deerease in the proportion of uncertain results in 
comparison to our previous study. Af ter the implementation of all gvidelines for the 
handling of uncertain results, the follow-up amniocentesis rate declined significantly 
by one third, from 2.1 % (1993-1996) to 1.2% (1998-1999). No incolTect diagnoses 
occurred and no false-negative results came to our attention. In four cases a small 
risk of uncertainty was accepted leading to a diagnostic accuracy of just below 100%. 
The observation of a trisomy 8 mosaicism in CV is uncommon (Wang et al., 1994; 
Walstenholme, 1996; Halmemann and Vejerslev, 1997b). It is known that follow-up 
anmiocentesis is not the method of choke to reveal trisomy 8 mosaicism (Klein et al., 
1994; Schneider et al., 1994). Caution should therefore be exercised in the use of 
amniocentesis only. To minimize the risk of a false-negative result, follow-up 
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investigation for the differentiation between CPM type II and GMDD (case 5, Table 
7) was carried out in simultaneously sampled amniotic fluid and fetal blood. 
In patients wit'h an X-autosome translocation, analysis of the X-inactivation pattern 
may help to delineate the clinical phenotype. lt is known that the X-inactivation in 
these cases does not occur at random, but usually folIows the pattern most 
favourable to the subject. In the case of a balanced t(X;aut), the normal X is usually 
inactivated, in contrast, in unbalanced t(X;aut) the translocated X is usually 
inactivated (Mattei et al., 1982; Bettio et al., 1994). About 95% of balanced and 91 % of 
unbalanced t(X;aut) follow this most favourable model of inactivation. It is also 
known that the inactivation pattern of balanced X-autosome translocations may 
differ in lymphocytes and fibroblasts (Zori et al., 1993). We therefore studied X-
inactivation patterns in LTC-villi, amniotic fluid celIs, and fetallymphocytes. 
The importanee of analysing both STC- and LTC-villi in cases with monosomy X is 
welI known (Pittalis et al., 1994; Smith et al., 1999) especially for those cases without 
any ultrasound abnormalities. Only when both STC- and LTC-villi preparations 
show a 45,X karyotype, any degree of reliability can be assumed, where a monosomy 
X in STC-villi only, can be associated with normal and abnormal outcomes. 
However, the likelyhood of an abnormal outcome (generalised mosaicism) in cases of 
a low level 45,X/46,XX mosaicism in STC-villi, is quite low (Ledbetter et al., 1992). 
50, if LTC-villi preparations reveal a normal karyotype, follow-up investigations like 
amniocentesis are not indicated. However, follow-up arnniocentesis or a postnatal 
confirmation in cord blood celIs should be considered in those cases where LTC-villi 
are non-available and FISH on STC-villi shows abnormal signal distributions. In our 
study two cases of 45,X mosaicism, both twIn pregnancies without LTC-villi (cases 2 
and 3, Table 8), were seen. In case 2, amniocentesis was carried out to exclude a fetal 
mosaicism because a prenatally detected 45,X/46,XY mosaicism needs special 
attention. lt is known that there is a risk of fetal abnormalities in such cases (Hsu et 
al., 1989; Chang et al., 1990; Van den Berg et al., 2000). In case 3, it was decided to 
perform a postnatal confirmation rather than taking any risks by instigatinga second 
invasive procedure because the chance of coniirmation is low. 
Experienees with 47,XXX, 47,XXY and 47,XYY are limited (Smith et al., 1999). We 
encountered one non-mosaic case of 47,XXX in STC-villi with a 46,XX karyotype in 
LTC-villi which was also confirmed in AF celIs. Contrary to our previous study (Los 
et al., 1998) it is obvious that sex-chromosomal (non-mosaic) aneuploidies should be 
confirmed by amniocentesis if LTC-villi are not available. 
In conclusion, prenatal cytogenetic diagnosis in STC-and LTC-villi demonstrates a 
very high laboratory success rate together with a quality improvement of the 
karyotype compared to that of STC-villi alone. No incorrect predictions were given 
and no misdiagnoses were made. lt also demonstrates that there is an actual and 
significant reduction for the need of follow-up amniocenteses in comparison with the 
diagnosis in STC-villi alone. Our data confirm the high reliability of cytogenetic 
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results in both villi compartments. Far pregnant wamen with a high cytagenetie risk, 
fust-trimester CV sampling is a very gaod alternative far secand trimester 
amniaeen!esis and might even be the prenatal test af fust ehaice. 
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Summary 
500 women with multiple pregnancies underwent amniocentesis or chorionic villus 
(CV) sampling at our department between January 1988 and July 1997. The aim of 
this retrospective study was to evaluate the laboratory aspects and the consequences 
of discordant results in these pregnancies in relation to the method of sampling. 
Uncertain results in one or bath samples, requiring further investigation were more 
frequent in CV samples (eight times in 163 paired samples, 5%) than in amniotic fluid 
(AF) samples (once in 298 paired samples, 0.3%). Sampling one fetus twice 
(erroneous sampling) was seen oniy once among 163 pregnancies with two CV 
samples in our study. Cross contarnination due to mixed sampling was discovered in 
two of seven pregnancies that underwent DNA diagnosis in CV and might be a 
rather regular occuring phenomenen. In none of the 500 pregnancies mixed sampling 
caused diagnostic dilemmas. A third sampling problem, maternal cell contamination 
caused a diagnostic problem once among the AF samples. Selective fetal reduction 
appeared safer after CV sampling than af ter amniocentesis. Subsequently, CV 
sampling instead of amniocentesis became the method of choice for prenatal 
diagnosis in multiple pregnancies in our department. 
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Introduction 
Multiple gestations present particular counselling, technical and management 
problerns in prenatal diagnosis, especially in case of discordancies (Brambati et 
al.,1991; Christiaens et al.,1994; Brandenburg et al.,1994). Hunter and Cox (1979) were 
the fust to point out the raised genetic risk in twin pregnancies compared with 
singleton pregnancies. This is of particular importance because dizygotic twinning 
increases as a function of advancing maternal age and by the extended use of 
assisted procreation techniques. Genetic prenatal diagnosis is mostly performed 
because of advanced maternal age. 
The genetic andj or laboratory aspects of amniotic fluid (AF) and chorionic villus 
(CV) sampling in multiple pregnancies have not been explored in depth in any large 
series. Most artieles concern the increased risk of fetal loss for women undergoing 
amruocentesis in multiple gestations (Anderson et al.,1991; Pruggmayer et al., 1991, 
1992). To our knowledge there are only a few studies which compare the genetic 
aspects of second-trimester amruocentesis and first-trimester CV sampling for 
multiple gestations (Wapner et al.,1993; Brandenburg et al.,1994). 
Since 1992 we prefer CV sampling over amruocentesis in twin pregnancies because 
of the lower risk of fust trimester selective fetal reduction (SEL RED) in case of 
discordant results. The encounter of a case of confined placenta] mosaicism (CPM) in 
both fetuses of a twin pregnancy due to erroneous sampling, one placenta was 
inadvertently sampled OOce, made us decide to review our experience with genetic 
amniocentesis and CV sampling in multiple pregnancies. Our main objective was to 
investigate the accuracy and reliability of both procedures and what 
recommendations could be made in this group of patients. 
Materials and Methods 
Patients 
Between January 1988 and July 1997, 482 twin and 18 triplet pregnancies were 
observed in a total of 25.850 genetic AF and CV samples in our department. The 
records of all women Witll multiple pregnancies who underwent genetic 
amruocentesis andj or CV sampling over that period were studied and reviewed. 
The indications for prenatal diagnosis in these multiple pregnancies were 
advanced maternal age (;'36 years) (MA), risk for neural tube defects (NTD), 
. parental carriership for chromosomal abnormality (Carrier), ultrasound 
abnormalities (US), recurrenee risk for various metabolic diseases and Mendelian 
inherited diseases detectable with DNA analysis (BlO JONA), previous child with 
(chromosomaI) abnormality (recurrenee risk, RR), other reasons (Other) and follow-
up investigations in amniotic fluid because of Wlcertain abnormalities in a previous 
CV sample (Follow-up). 
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Obstetrical methads 
At the initial visit each patient had an obstetric and genetic assessment. The obstetric 
assessment included a real-time ultrasound examination ta monitor the number of 
fetuses, fetal heart rate, crown-rump length or fetal biparietal diameter and to 
establish the localisation and the nurnber of the placentae. Furthermore, the thickness 
of the septum between the arnniotic sacs and the presence of the lambda sign or T-
sign were evaluated (Kurtz et al.,1992; Wapner et al.,1993). All patients were given 
information about the avaUable diagnostic procedures, the present knowledge of the 
risks involved and the difficulties related to the selectivity in sampling. The patients 
were also infonned about the risks of anomalies in multiple gestations, the possibility 
that the fetuses may be discordant for an abnormality (Hunter and Cox et al., 1979) 
and the risks of selective feticide (Brandenburg et al.,1994). 
All amnÎocenteses were performed by experienced obstetricians under direct 
ultrasound guidance as described previously (Pijpers et al.,1988). Since August 1990 
the identification of the arnniotic sacs has been made by ultrasound only. The use of 
intra-arnniotic dye was abandoned since a relationship between the use of methylene 
blue and the occurrence of jejunal atresia was suspected (Nicolini and Monni,1990; 
Van der Pol et al.,1992; Brandenburg et al., 1997). Approximately 15-20 mi of 
arnniotic t1uid was aspirated from each amniotic cavity. in cases of biochemical or 
DNA investigations 30 mi was aspirated. When amniocentesis was not possible 
because of oligohydrarnnios or anhydrarnnios, fetal blood (FB) sampling was 
performed as previously described (Den Hollander et al.,1994). 
All transabdominal CV sampling procedures were carried out under continuous 
ultrasound guidance by experienced obstetricians (Jahoda et al.,1991). In pregnancies 
where twa distinet placental sites were separated by a thick membrane, each 
placental site was sampled individually. In pregnancies with only one distinet 
placental mass and an identifiabIe thin, wispy membrane an area near each cord 
insertion was sampled. If there was only one placental mass and no membrane could 
be seen and the cord sites were not distinguishable, only one sample was taken. 
SEL RED after discordant results in CV and amniotic t1uid was carried out with 
intracardiac infusion of KC115% (Golbus et al., 1988; Berkowitz et al.,1993). 
Labaratary methads 
The chromosornal analysis of AF cells was performed by the in situ rnethod on glass 
coverslips. CV were incubated overrlight using t1uorodeoxyuridine (FdU) 
synchrorlization (short term culture; STC)(Gibas et al.,1987). Since 1997 long-term 
cultures (LTC) have been initiated sirnultaneously when at least 20 mg was sampled 
(Smidt-Jensen et al.,1989). Metaphase spreads of fetallymphocytes were performed 
according to standard techrliques. 
Trypsin-Giemsa staining was routinely used for karyotyping AF cells, CV cells and 
fetallyrnphocytes and a mirlirnurn of 16 cells/ clones were analysed in each case. 
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Since 1996, interphase fluorescence in situ hybridization (FISH) has routinely been 
performed according to standard protocols (Van Opstal et al.,1993; 1998b) with a 
probe-set for the chromosomes 13, 18, 21, X, Y on uncultured amniocytes of all 
multiple pregnancies in case CV sampling was not possible for gene tic or technical 
reasons, or because of a gestational age beyond the appropriate time for CV 
sampling. FISH was also performed on STC-villi, LTC-villi and AF slides when 
follow-up investigations were needed for the differentiation between 
pseudomosaicism and true mosaicism or between CPM and generalized mosaicism. 
(Van den Berg et al.,1997; Van Opstal 1998a; Los et al.,1998). 
Alpha-fetoprotein (AFP) measurements were done in our department with radial 
immunodiffusion (K1eijer et al.,1978). In cases of equivocal or non-unelerstood raised 
AFP levels, acetyl-cholinesterase (AChE) banding was performed additionally 
(Broek, 1992), and ultrasound investigation carried out. 
Prenatal biochemical anel DNA analysis were done according to techniques as 
described previously (Galjaard and Kleijer,1986; Wanders et al.,1996) and according 
to standard methods. 
Statistics 
The Fisher exact test was used for the statistical analysis of differences between the 
numbers of certainly and uncertainly abnormal cytogenetic results in AF and CV, 
anel for !he evaluation of !he success rate of SEL RED af ter amniocentesis and CV 
sampling. 
Results 
In the group of 500 multiple gestations there were 482 sets of twins and 18 sets of 
triplets. 163 women with a twin pregnancy were successfully sampled twice by CV 
sampling (Tabie 1) and 298 women underwent amniocentesis for both fetuses (Tabie 
2). In 28 twin pregnancies two different samples were received or only one sample 
(Tabie 3). The reason for just one sample was mono-chorionicity in seven cases, 
mono-anmionicity in eight cases and unaccountable in six cases. The reason for two 
different samples (one AF and one CV or FB sample) was because of anhydramnion 
in one of !he two compartments in all seven cases. In eight pregnancies repeat 
sampling was performed because of uncertain laboratory results. 
Four women with a triplet pregnancy were successfully sampleel by CV sampling, 11 
underwent amniocentesis. One of these lalter triplets showed two monozygous 
fetuses in one amniotic sac and a third dizygous fetus in a second amniotic sac, so 
two compartments were sampled. There was one triplet pregnancy where one CV 
and three AF were sampled. Owing to oligohydramnios in one of the compartments it 
was only possible to aspirate enough AF for AFP measurements, which necessitated 
CV sampling for chromosome analysis (Tabie 4). 
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Table 1- IndicatioDs for chorionic villus sampling in twin pregnancies with two samples 
Pregnancies Pregnancies with abnonnal 
Numberof with nonnal results results in one or two samples 
Indication pregnancies in bath samples ----------Nwnber % 
MA 116 107 9 8 
US 9 5 4 44 
RR 12 12 0 0 
Other 10 9 10 
BIOIDNA 13 5 8 62 
Carrier 3 0 3 100 
Total 163 138 25 15 
Table 2 ~ Indications for amniocentesis in twin pregnancies witb {)VO samples 
PregnancÎes Prcgnancies with abnarmal 
Numberof with nonnal results results in one or two samples 
Indication pregnancies in bath samples Number % 
MA 168 160 8 5 
NTD 47 44 3 6 
US 40 21 19 48 
RR 21 21 
Other 6 6 
BIOIDNA 8 6 2 25 
Carrier 2 0 2 100 
Follow-up 6 4 2 40 
(1)' (1)' 
Total 298 262 36 12 
a = follow-up after uncertain result in earlier AF sample 
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Table 3 - Indications for amniocentesis aod choriooic villus sampling in twin pregnancies witb only one 
sample or two different samples 
Number of pregnancies Number ofpregnancies Abnonnal prcgnacies 
with one sample with different samples 
Indication ---_._--------------------_." Nonnal ------ -------
AF CV AF+CV AF+FB pregnancies Number % 
---- ...... - .. _~-----
----
US 10' 2" J 4 14 5 26 
MA 2' J" 5 
NTD I" 
RR I" 
Othcr I" 
Follow-up 100 
Total 14 7 J 4 22 6 21 
AF = amniotic fluid; CV= chorionic villus; FB = feta! blood; a = six are mono-amniotic; b "" all mono-amniotic/ 
monochorionic, c = one is mono-amniotic 
Table 4 - Indications for amniocentesis aod/or chorioDie villus sampling in triplet pregoancies 
Number ofpregnancies with 
samples consisting of 
JAF 
_-,In"d"ic.c'"'"io,,n-,_-,Jc.AF=-_ ,J.C:.V'--__ I-'-CV 2AF 
MA 
US 
Total 
11 
12 
4 
4 
Number of pregnancies with 
----------
Nonnal results in all Abnormal results 
investigated samples in ~ I samples 
IS 
16 
----~-----_ .. _--
o 
2 
2 
Cytogenetic, biochemical aod DNA aoalyses, CV group with two samples. 
(Table 1, 5 aod 6) 
In the 163 !win pregnancies undergoing CV sampling, cytogenetic investigations 
were performed in 161 twin pregnancies; in one pregnancy, only one karyotype 
could be achieved. The two pregnancies without cytogenetic investigations 
concerned cases where biochemical analysis was indicated and the arnount of villi 
was not enough to perform cytogenetic analysis as weil. The success rate of obtaining 
a cytogenetic, biochemical and DNA result of each fetus sampled was 99.7, 100 and 
100%, respectively. 
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Table 5 - Aboormal karyotypes in tbe group witb 2 choriooic villus samples 
Case Indication TwinA TwinB Outcome twin A Outcome twin B 
------------------------
I MA 47,xYY 46,XY Normal r;! Normal r;! 
2" 47,xV,+21 46,XX SEL TOP Norma! ~ 
3" 4S,x 46,XY AF direct FISH: XIXY, SEL RED Normal r;! 
4 92,xxxx[9]/46,xx[22] 46,XX Norma! uItrasound, normal ~ Norma! ultrasound, nonna! ~ 
5 4S,x[6]/46,xy[24] 46,XY AF direct FISH: XY, nonnal r;! AF direct FISH: XY, nonnal r;! 
6 47,xx,+mar[23]/46,xx[16] 46,XX AF: 47,XX,+mar[12]/ 46,XX[7], normal ~ AF: 46,XX, nonnal ~ 
7 48,xY,+7,+13[40]/ 46,XY AF: 46,XY, nonna! r;! AF: 46,XY, norrna! r;! 
47,xy,+7]2]/46,xy[8] 
8 47,xx,+21 46,XX SELRED Norrnal ~ 
9 4S,X[20]/46,XX[7] 4S,X[28]/46,xx[2] AF: 46,X:X, normal ~ AF: 46,XY , norrna! r;! 
10 Other 46,XX,t(6;13)[6]/46,XX[34] 46,XY AF: 46,X:X , 34 weeks, norrna! !? AF: 46,XY, 34 weeks, schizis r;! 
II US 47,XX,+21 46,XX SELRED 33 weeks, nonna! d' 
12 4S,x[2]/46,XX[18] 46,XX AF: 46,XX, 28 weeks, normal ~ AF: 46,XX, AFP i, IUD, 
13 47~t+18 46,XY SELRED omphalocele 
14 47,xY,+21 46,XX SELRED Norrnal r;! 
Norrnal !j! 
15 Caricr 4S,xY,t(14;21)(qIO;qIO)mat 46,XX 36 weeks, normal d' 33 wecks, normal !j! 
16 4S,xY,t(14;21)(ql O;ql O)mat 46,XY 33 weeks, normal r;! 33 wccks, normal r;! 
17 46,xx,t(14; 19)( q24.I;q 13.4)pat 46,XY Norma! ~ Norma! r;! 
AF '" amniotic fluid, FISH'" fluorescence in situ hybridization, a'" previously described by in't Veld et al. (1995); b = previously described by Los et al. (1998) 
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Cytogenetic abnorrnalities 
Certainly discordant, uncertainly discordant and uncertainly concordant abnormal 
results were detected in 17 !win pregnancies (10.5%) (TabIe 5). 
Certainly discordant results were detected in nine pregnancies (numbers 1, 2, 8, 11, 
13, 14, 15, 16, 17); in six of these one fetus exhibited aneuploidy while the other was 
norma!. Based on this information five couples requested SEL RED ,md one couple 
chose to continue the pregnancy because of the minimal phenotypic expression of the 
chromosomal abnormality (number 1). SEL RED in these five pregnancies was 
successful and resulted in the delivery of normal infants. The other three certainly 
discordant results concerned parental translocation carriers. 
Uncertainly discordant results were achieved in seven pregnancies (numbers 3, 4, 
5, 6, 7, 10, 12). In one case (number 3), one fetus exhibited a 45,X karyotype. The 
possibility of a CPM was discussed and an early amniocentesis at 12.5 weeks of 
gestation with rapid investigation on uncultered AF celIs was recommended. Two-
colour FISH with X and Y probes showed a XjXY mosaicism and af ter counselling 
the parents requested SEL RED, which was successful and resulted in the delivery of 
a normal boy. Chromosomal mosaicism was found in the other six pregnancies 
(numbers 4, 5, 6, 7, 10, 12). Additional investigations such as ultrasound and folIow-
up anmiocentesis were performed and the nlosaicism indicated CPM in five of the 
six cases; in case 6, mosaicism of a de nova marker chromosome was confirmed in AF 
celIs. Af ter genetic counselIing and normal ultrasound findlngs the parents chose to 
continue the pregnancy. 
An uncertainly concordant abnormal result was achieved in one pregnancy 
(number 9). In this case both fetuses showed a mosaic 45,Xj 46,XX In STC-villi 
preparations. Two-colour FISH with X and Y probes on LTC-villi showed an 
increased percentage of interphase nuclei with only one X signal In felus B. The other 
fetus (A) turned out to be normal XX. 
The possibility of a real mosaicism in one fetus was discussed and amniocentesis was 
recommended. FISH on uncultered amniocytes revealed normal XX results in fetus A 
and normal XY results in fetus B; 46,XX and 46,XY karytypes were established in 
cultured AF celIs. The parents were informed and after an extra ultrasound 
examination showing one normal female and one normal male fetus, the pregnancy 
continued. A normal girl and normal boy were bom after 37 weeks of gestation. 
Biochemical and DNA analysis 
These were performed in six and seven !win pregnancies, respectively. Concordant 
normal results were encountered in five cases (38%); discordant results in six (46%) 
and concordant abnormal results In !wo cases (15%)(Table 6). 
SEL RED was requested and carried out in five of the six cases of discordancy, 
resulting in the birth of five normal infants. In the case of suspected discordant 
pyruvate carboxylase (PC) activities termination of pregnancy (TOP) was decided on 
elsewhere. Fetal fibroblasts cultures were received from both fetuses; !win B had 
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normal PC activity as predicted, whereas !win A had reduced but not absent activity, 
suggesting heterozygosity ra!her !han an affected fetus. 
In !wo of !he seven prenatal DNA investigations we encountered admixture of CV 
samples, as one DNA sample represented one fetus and the other sample contained 
DNA of both fetuses (cross contamination)(Fig.l). 
Figure 1 - Exarnple of cross contamination 
(admixture of villi of one fetus to that of the 
other) in a twin pregnancy with discordant 
results of cystic fibrosis (CF) rnutation 
(.6.F50B) analysis. The admixture was 
demonstrated with a DNA-marker 
independent Erom the CF; YNZ22.1 
(chromosoome 17). The homozygous fwtus 
displays the matemal allele A3 and the 
patemal allele A1I the heterozygous fetus 
displays the matemal aBele A3J the genuine 
patemaI allele Ai and the admixed paternal 
allele A2" 
YN2 22.1 fTAq I 
Table 6 - Abnormal BlO and DNA results fouod in twin prcgnancies witb two CVS or AF samples 
Indication TwinA TwinB Outcome Twin A Outcome Twin B 
DNA: 
Cystic Fîbrosis 46,XY A 46,XY A TOP TOP 
46,XX A 46,xx N SELRED Nonna! ~ 
46,XX A 46,XY N SELRED Nonna! ~ 
FragiIe X syndrome 46,XX A 46,xx N SELRED Nonna! !j?: 
X-Jinked Retinoschizis 46,XY A 46,XX N SELRED Nonna! !j?: 
BlO: 
Arginino sllccinuria a 46,XX A 46,XY A TOP TOP 
HurIer syndrome 46,XY A 46,XY N SELRED Nonna! cf 
Pyruvate carboxylase 46,XY A 46,XX N TOP, low PCactivity, TOP, nonnal PC 
(PC) deficiency b probably heterozygote activity 
Cystic Fibrosis C 
--,- A -,- A DO follow-up no follow-up 
a = previollsly described by Pijpers et a/.(I990); b = karyotyping in CV samples elsewhere perfonned; c = AF, 
others are CV samples. 
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Cytogenetic, AFP, biochemical and DNA analyses, AF group with two samples 
(TabIe 2, 6, and 7) 
In the 298 twin pregnancies undergoing amniocentesis, cytogenetic investigations 
were performed in 294 twin pregnancies and successful in 292. In two pregnancies no 
karyotype was obtained in one of both samples due to growth failure. 50, the success 
rate of obtaining a cytogenetic result of each fetus was 99.3%. The success rate of 
obtaining AFP, biochemical and DNA results of each fetus sampled was 100%. 
Cytogenetic abnormalities 
Discordant and concordant abnormal results were detected in 15 pregnancies (5%) 
(Tabie 7). Discordant abnormal results were detected in 12 pregnancies. In four of 
these pregnancies one fetus exhibited aneuploidy while the other was normal 
(numbers 3, 4, 5, 6). Based on this information three couples opted for SEL RED 
(numbers 3, 5, 6) and one couple chose to continue the pregnancy because of the mild 
phenotypic expression of the chromosome abnormality (number 4). In three 
pregnancies there was a discordancy for triploidy while the other was normal 
(numbers 19, 28, 31). The pregnancies were too advanced for SEL RED and 
pregnancy outcome is shown in TabIe 7. In five pregnancies (numbers 7, 13, 15, 34, 
35) discordant structural abnormalities were found. In one pregnancy (number 7) 
one fetal karyotype showed an inversion. Chromosome analysis of blood 
lymphocytes of both parents demonstrated the inversion to be familiar. In case 15, it 
eoneerned a mosaicism of a de novo marker chromosome, eneDuntered in a previous 
CV sample (case 6 of Table 5). In the cases 13 and 34 both fetuses showed abnormal 
karyotypes, one a balanced and the other one an unbalanced parental translocation. 
In case 13 the parents opted for SEL RED; unfortunately the pregnancy ended two 
weeks af ter the SEL RED procedure, at 21 weeks of gestation. In the other case the 
pregnancy was too advanced for SEL RED. This pregnancy ended with IUD of the 
affected fetus with the unbalanced karyotype and the delivery of anormal girl with 
the balanced karyotype at 37 weeks of geslation. In the last discordant case (number 
35) there was a discordancy for Cri du Chat syndrome. After counselling the parents 
(both with normal karyotypes) opted for SEL RED at 19 weeks' gestation. 
Unfortunately, the pregnancy ended inunature at 21 weeks' gestation, af ter the 
reduction procedure. 
Concordant abnormal cytogenetic results were detected in three pregnancies 
(numbers 8, 12, and 14). In case 8 both fetuses showed a 46,XXj 46,)CY mosaicism, 
representing an uncertainly abnormal concordant result. The possibility of matemal 
eeU contamination or a cross-contamination was discussed and further diagnostic 
procedures were recommended such as ultrasound examination and repeat 
amniocentesis. Ultrasound examination at the time of the repeat anmiocentesis 
revealed two male fetuses without abnormalities. Chromosome analysis yielded 
norrnal male karyotypes and the pregnancy continued; two normal boys were bom. 
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In the other two cases the concordant abnormal results demonstrated parental 
translocation carriers. 
AFP abnorrnalities 
Abnormal AFP levels in one or both AF samples were detected in 24 pregancies (8%) 
(TabIe 7). Certainly discordant AFP results were detected in six pregnancies 
(numbers 2, 16, 20, 27, 32 and 34); five with both normal karyotypes and one with 
both abnormal karyotypes. US abnormalities were present in all fetuses from the AF 
compartment with high AFP levels. In case 27, both fetuses showed US 
abnormalities. 
Uncertainly discordant AFP levels were present in three cases (numbers 1, 10 and 
11). In one case (number 1) the patient had undergone in vitro fertilization (IVF) and 
the initial number of four feluses was reduced to \wo. The high level of AFP in one 
compartment was assumed to be caused by AFP diffusion out of (one of) the reduced 
compartments. In another case (number 10) the AFP level was equivocal for 16 weeks 
of gestation. Additional US investigation showed a normal fetus and a gestational 
age of only 15 weeks and the AFP level turned out to be normal after correction. The 
high level of ArP in case 11 was explained by fetal blood contarnination. 
Concordant abnormal results were detected in 15 pregnancies. Abnormal AFP 
levels in both compartments with normal karyotypes were detected in 12 
pregnancies (TabIe 7). Seven of these pregnancies (numbers 9, 22, 23, 24, 25, 26 and 
29) showed ultrasound abnormalities of both fetuses which explained the elevated 
levels. In the other five cases (numbers 17, 18, 21, 30 and 33) only one fetus showed 
US abnormalities and the eIevated AFP level of the AF compartment of the other 
normal fetus was assurned to be caused by APP diffusion through the arnniotic 
membranes. Besides the concordant abnormal AFP results there was a discordancy 
for triploidy in three pregnancies (numbers 19, 28 and 31). 
Biochemical and DNA analysis 
These were performed in eight and \wo \win pregnancies, respectively. Concordant 
normal biochemical results were encountered in seven cases (87%) and concordant 
abnormal biochemical results in one case (13%). This latter case escaped from our 
folluw-up. Prenatal DNA analyses were not performed in AF samples on a priori 
known DNA indications; in \wo cases, analysis was performed in addition to 
cytogenetics and AFP measurements for the establishment of zygosity. 
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Table 7: Abnormal results (cytogentics andJor AFP measurement) fouod io twin pregnancies with two amniotic samples 
TwinA TwinB 
c= Indication GA Karyotype AFP Karyotype AFP Ouleome twin A Ouleome twin B 
I MA 16 46,XY A ,.,xv N 35 weeks, nonna] r!' 35 wecks, nonna] r!' 
2 I' ,.,xv A '.,xv N IUD, anencephaly 35 weeks, normal r!' 
3 I' 47,XY,+2l N '.,xv N 19 weeks, SEL TOP 34 weeks, normal r!' , I' ",xxx N ".xx N Nonna! ~ Nonna] ~ 5' I' 47,xx,+2l N 46,XY N 19 weeks, SEL TOP 38 weeks, nonna! <I 
6 17 47,xv,+21 N ".xx N SEL TOP 37 wecks, nonnal ~ 7 16' 46,X'Y,inv(3)(p 13p25) N ",xv N NOnna! <I Nonna] d' 
8 16 46XX[12j/46,xY[7j N 46XX[3]/46,XY[9] N Seeond AF: 46,XY, 28 wcxks, nonna! <I Second AF: 46XY, 28 weeks, nonna! c' 
" 
NTD 18' 46,xY A ",xv A TOP, <I myelocèle TOP, <I myelocèle 
10 16 46,XY A 46,XY N 37 wecks, nonna! <I 37 weeks, normal <I 
11 16 Elsewherc A Elsewhere N Norma! ~ Normal ~ 
'" 
DNAfBlO 14' 46,xy,inv(IIXq2Iq23) N 46)CY,inv(11Xq21q23) N Normal <I Normal r!' 
13 Carrier 17 46,XY,der{9)t(9;12) N 46,xx,t(9;12) N 19 weeks, SEL RED 21 weeks, immalure delivery, 11, 
(p22;plI.2)mal (p22;pI1.2)mal na abnonna!ities 
14 17 47,XY,+i(l5p)mat N 47,XY,+i(15p)mal N Nonnal <I Nonna! r!' 
15 Follow-up 17 47 ,XX, +mar[! 2]/46,XX[7] N ".xx N 35 weeks, nonna! ~ 35 wecks, nonna! 11 
16 14 46,XX N 46.xx A 28 weeks, norrnal \! IUD, ompha!oce1e 
17 US 23 46,XY A 46,xY A IUD,MCA Ncrmal r!' 
18 23 46,XX A 46,XY A 34 weeks, anencepha!y 34 weeks, nonna! r!' 
19 21' 69,xxx A ",xv A 32 weeks, IUD 36 wecks, normal <I 
20 27' ",xv A 46,XY N 32 wecks, omphalocclc, ppt 32 weeks, normal <I 
21 26 46.xx A ".xx A 26 wccks, IUD, mediaslÎnalleratoma 26 weeks, nonnal ~ 
22 22 ",xv A ",xv A 24 weeks, TOP, anencephaly 24 weeks, TOP, eongenital heart defect 
23 24 46,XY A ",xv A 33 weeks, ppt, body sta1k anomaly 33 weeks, <I, mierocephaly, epilcptie 
24 20' ".xx A 46.xx A 22 wecks, TOP, NTD 22 weclcs, TOP,eongenital heart defect 
25 22' 46,XX A 46,XX A 31 weeks, IUD, MCA 31 weeks, IUD, twin 10 !win transfusion 
syndrome 
26 21 46,XY A 46,xv A 25 wecks, ppt, hydrops 25 wecks, ppt, hydrothorax 
27 19 46,XX A ".xx N 19 weeks, IUD, twin 10 Iv.in transfusion 19 weeks, IUD, acardiacus 
syndrome 
28 ,,' 69,XXY A 46,XX A 32 weeks, ppt 32 weeks, nonnal \! 
29 31' 46,XY A ",xv A 32 wecks <I, duodenal atresia 32 weeks r!', esophageal-atresia 
30 26' 46,XX A 46,XX A 36 wecks, ppt, omphalocele 36 weeks, nonnal r!' 
); 21~ 6Y,xxx A 46,xY A ppt Norma! <I 
32 28' 46,xY A FISH XX N 33 wecks, r!'. teratoma 33 wecks, normal \! 
33 25' 46,XV A 46,XY A 37 wecks, <I, dilatated ureier 37 weeks, norrnal <I 
34' 26 46XY,+13,dcri 13; !4) A 45,XX,derii3;14) N IUD,MCA 37 wccks, nonna! \! 
(q\O;q\O) (ql0;qlO) 
35 16 46,xx,del(5)(p 14-pier) N 46,XY N 19weeks, SELRED 21 weeks, immature delivery, r!', no 
abnonnalilics 
GA - gestational age in weeks; a - previously described by Pijpers et al, (1989); b - previously described by Omtzigt et al, (1992); c - normal biochemical results; 
d = previously described by Veld et al, (1997) 
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Cytogenetic and AFP analyses, group with only one or two different samples 
(Tabie 3) 
In this group of twin pregnancies the success rate of obtaining a cytogenetic resuIt of 
each fetus sampled was 100%. AFP measurements were successfully performed in all 
AF samples. 
Cytogenetic abnol1nalities 
These were detected in two pregnancies (7%). One concordant abnormal cytogenetic 
result was deteeted in the case where one AF and one FB sample was performed. 
Both fetuses showed a 47,XX, + 18 karyotype. Af ter genetic counselling the couple 
opted for termination of pregnancy. A discordant abnormal cytogenetic result, 
previously detected in CV, was confirmed (case 3, Table 5). 
AFP abnomUllities 
Abnormal AFP levels were detected in four pregnancies (14%). One mono-amniotic 
pregnancy concemed a normal fetus and a fetus acardiacus which explalned the 
abnormal AFP l.evel. The pregnancy ended with IUD of the affected fetus and the 
birth of one normal child. The other three pregnancies concemed discordancy in AF 
volume (severe oligohydramnios in one and gross polyhydramnios in the other AF 
compartment). The abnormal AF volumes and AFP levels were assumed to be 
caused by twin to twin transfusion. In two pregnancies IUD occurred of both fetuses 
at 24 weeks' gestation. The third pregnancy ended with IUD of one fetus and the birth 
of one normal child. 
Cytogenetic anel AFP analyses, group of triplet pregnancies (Tabie 4) 
In 18 triplet pregnancies in which AF and/ or CV sampling was performed the 
success rate of obtaining a cytogenetic result of each fetus sampled was 100%. AFP 
measurements were successful performed in all AF samples. 
Cytogenetic abnonnalities 
Only one discordant abnormal result was detected in this group of patients (5.6%). It 
concemed a pregnancy in which one CV and three AF samples were performed. The 
fetus with oligohydramnios exhibited a trisomy 21 whlIe the other two fetuses were 
normal. After genetic counselling the couple decided to continue the pregnancy. At 
33 weeks of gestation the pregnancy ended with the delivery of three infants; the one 
with trisomy 21 died 10 minutes post parturn. 
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AFP abnormalities 
One concordant abnormal result was delecled in a triplet pregnancy which showed 
two monozygous feluses (A and B) in one cornpartment and a t1tird felus (C) in 
another cornpartment. The abnormal AFP levels could be explained by the presence 
of two feluses in one AF compartmenl, one felus (B) with obstructive uropathy and 
hydronephrosis in felus C. At 32 weeks of gestation the pregnancy ended with IUD 
of felus B and the delivery of two normal boys. The hydronephrosis seen in felus C 
was not recovered after birth, so it concemed a transient hydronephrosis. 
The rate of certain : uncertain abnorrnal cytogenetic results was significantly higher 
in AF samples than in CV samples (p=0.018). 
In 16 pregnancies a SEL RED was carried out; five at 18-19 week,' gestation af ter 
discordant results in AF; three successful and two resulting in loss of both feluses 
(40%). Selective reduction in the other 11 pregnancies was successfully carried out at 
12-14 weeks' gestation and these pregnancies ended with the birth of single healthy 
children. 
SEL RED seemed safer after early prenatal diagnosis in CV than af ter second-
trimester prenatal diagnosis in AF cells, but this difference was not significant 
(p=0.08). 
Discussion 
Prenatal diagnosis in multiple pregnancies is more complex than in singleton 
pregnancies due to sorne specmc circumslances and potential siluations: 
(1) increased risk of fetal loss (Andersan et al.,1991); (2) certainly and uncertainly 
discordant resulIs; (3) certainly and uncertainly concordant results; (4) SEL RED in 
cases of certainly discordant resulIs in CV or AF; (5) complex counselling. 
Discordant results with the option of SEL RED of the affected felus are to be 
expected in a high frequency in the prenataI diagnosis of Mendelian inherited 
diseases (DNA and biochemical investigatians) (37.5% in autosamal recessive 
diseases and 50% in autosomal dominant diseases), and in a lawer frequency in 
prenatal cytogenetics (Fig. 2). Furthermare, Fig. 2 shows the thearetical figures for 
uncertainly discordant or concordant results requiring further investigation. 
Uncertainly discordant results were abserved in 7/160 twin pregnancies (4.4%) 
cytogenetically investigated in CV samples and expected in 2.8%; twa cases turned 
out to be generalized mosaicism (1.3%) whlle CPM was found in five cases (3.1%). 
Certainly discordant results were encountered in 9/160 twin pregnancies (5.6%), 
which equals the expected figure of 5.9%. 
In AF samples, na uncertainly discordant cytogenetic results were abserved 
(expected frequency 0.4%). However, in the AF group as weIl as in the CV group, 
one pregnancy showed uncertainly concordant karyotypes which is theareticaIly rare 
(expected frequency in CV samples 0.02% and in AF samples 0.0004%). 
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--~ .. _~ 
A Felus A B Felus A 
, , , 
I N lOM lCPMIABN I 
------t--------t-------i-------t------i 
N 1 91 i 0.19 i 1.2 i 3.0 I 
------1---_._--.1.-----_...1_------1--------1 
I I I I I 
Fetus B CM : 0.19 : 0.0004 : 0.0025 : 0,0062 : 
I I I I I 
_____ ....1- ___ . ___ + ______ -1 _______ 1-______ -1 
I I I I I 
CPM: J.:! : 0.0025 : 0.017 : 0.04 : 
I I I I I 
_____ -+- ___ . ___ -f. ______ -j _______ I-______ -1 
I I I I I 
ABN: 3.0 : 0,0062: 0.D4 : 0.096 : 
_____ -L _______ 1 ______ J _______ L ______ J 
Chorion ic Villi 
, , , 
I Normal : Unccrtain : Abnormal : 
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Figure 2 - (A) Probabilities (in%) of concordant and discordant cytogenetic results in CV samples in 
both fetuses of a clizygote hvin pregnancy; the frequencies of normal (N; 95.4%), abnormal (ABN; 
3.1%), generalized mosaicism (CM; 0.2%) and confined placental mosaicism (CPM; 1.3%) are taken 
from Pittalis et al. (1994). (B) Chance (in%) of discordancies in AF samples of dizygote twins. 
Abnormality rate is 2.3% (Ferguson-Smith and Yates, 1984). Rate of llilcertain results requiring further 
investigation is 0.2% (our own figures, 10 times in 5265 cytogenetic investigations) 
In such a case one should be suspicious of a sampling problem as the cause of the 
unprobable results (Brambati et al., 1991). However, another cause might be 
monozygozity of the fetuses. 
Significantly more cytogenetically uncertain results emerged in CV samples than in 
AF samples, eight (5%) versus one (0.3%). Finally, no diagnostic errors were made. 
Concardantly raised AF-AFP levels were encauntered in 15 twin pregnancies. In 8 
of these 15 twins (53%) only one fetus was abnormal; the AFP level in the AF 
cOlnpartment of the normal ferus is assumed to be elevated by diffusion through the 
membranes out of the abnormal compartment (Franke and Estel, 1978; Stiller et 
al.,1988). Discordant AFP levels were seen in nine pregnancies (3%), with an 
abnormal fetus in the AF compartment with the abnormal AFP level in five cases. In 
one pregnancy with two abnormal fetuses, the normal AFP level represented a false 
negative finding. In three pregnancies with two norrnal fetuses, the raised levels 
could be explained by circumstantial factors other than fetal malformations. 
However, sometimes, raised AF-AFP levels are found in twin pregnancies without 
explanation (Brock et al., 1975). 
Discordant ,md concordant results in the prenatal DNA and biochemical 
investigations were within the expected ranges. The numbers are to small for 
speculations about possible uncertain results. However in one case of prenatal PC 
activity measurement in CV, a diagnostic error occurred due to very low PC activity 
in the villi which hampered the discrimination between an affected and a 
heterozygous fetus. 
Discordant or concordant results can be uncertain by two potential events; 
laboratory findings as CPM or pseudomosaicism and by sampling problems. 
Erroneous sampling, mixed sampling resuIting in cross contamination and matemal 
cell cantamination are three sampling problems which can be expected. lt is known 
that in multiple pregnancies there are no guarantees that each fetus is sampled 
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individually. We did not encounter diagnostic problerns in cytogenetics due to 
erroneous sampling or cross-contamination in AF samples. 
However, ane case with a concordant 46,XXj 46,XY mosaicism, presumed to be 
caused by mixed sampling turned out to be caused by maternal eell eontamination 
of bath AF samples. 
CV sampling in multiple pregnancies entails a greater risk of mixed samples than 
with AF sampling, approximately in 4-6% of the patients (Brambati et a1.,1984, 1991; 
Pergament et al., 1992; Wapner et al., 1993). In our CV samples we had na diagnostic 
problerns coneerning cytogenetics due to mixed samples. However, in two of the 
seven pregnancies in which DNA analysis was carried out cross-contamination was 
established without eausing diagnostic problems. This indieates that cross-
contamination might be a frequently oecurring and theoretieally a diagnasis 
disturbing phenomenon. Tt is especially dangerous in prenatal biochemical analysis, 
where cross-contamination of villi of the affected fetus with those of the normal fetus 
might lead to false negative biochemical findings. Sa, in prenatal biochemical 
diagnasis in multiple pregnancies, additional DNA analysis is strongly 
recomrnended in order to detect potential cross contamination. In our series we have 
had noticeable erroneous sampling in only one of the 163 cases (0.6 %), which is not 
signifieantly different from the reported figure of 2 out of 128 (1.6%) multiple 
pregnancies by Pergament et al. (1992). 
Discordancy can be managed in three possible ways; (1) termination of the whole 
pregnancy; (2) SEL RED of the affected fetus; (3) a non interference poliey of the 
affected fetus by continuation of pregnancy. We have seen all these three possibilities 
in our series of 500 multiple pregnancies. Although the difference between SEL RED 
after CV sampling and amniocentesis is not statistically significant, we believe that 
prenatal diagnasis at an early stage (11-12 weeks) enables a safer SEL RED in the 
case of discordant results than at 16 weeks. The risk of complications af ter SEL RED 
is less when it is carried out around 12 weeks' gestation rather than at 16 weeks or 
later (Golbus et al., 1988; Evans et al., 1991). 
Comparing amniocentesis and CV sampling for the prenatal diagnosis in multiple 
pregnancies three major conclusions may be drawn; (1) there is a greater risk of 
uncertain results in CV sampling necessitating a second invasive procedure; 2) there 
is greater risk of mixed sampling leading to cross contamination in CV sampling; (3) 
there is a better performance of SEL RED after CV sampling. 
The simultaneous cytogenetic investigation of bath STC and LTC villi preparations 
will not only reduce the chance of uncertain results and follow-up investigation in 
AF but also imprave karyotyping quality (as in singleton pregnancies)(Los et 
al.,1998). The identification of potential cross contamination by additional DNA 
analysis wil! eliminate the chance of misdiagnasis leading to false-negative 
biochemical results. 
Together with the benefit of an earIier and safer SEL RED af ter discordant results 
in CV, we consider CV sampling the method of choice for prenatal diagnasis in twin 
pregnancies. 
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Summary 
First trimester chorionic villus sampling has not reached the popularity of 2nd trimester 
anmiocentesis in prenatal cytogenetic diagnosis, in contrast to initial expectations. We 
investigated whether a difference in the diagnostic performances of cytogenetic 
investigation in amniotic fluid (AF) cells and chorionic vUli in favour of AF-cells rnight 
justify this. Diah'TIostic performance was measured as laboratory failure rate, karyotype 
qua!ity (G-band score, rate of follow-up samples, rate of wrong diagnoses) and 
karyotype representativity (rate of follow-up samples, rate of wrong diagnoses). 
From 1993 - 1999, 11 883 AF-samples were investigated (AF-ceIIs). In chorionic villi, 
short term culture preparations solely were karyotyped from 1993 -1996 (n=3499) (STC-
villi), short and long-term culture preparations simultaneously, provided a sufficient 
amount of tissue being available, from 1997 onwards (n=1829) «STC + LTC)-villi). 
Laboratory failure rates were the same af ter amniocentesis (0.40%) and chorionic villus 
sampling (0.50%). G-band scores (mean ± SD) were equal in AF-cells (373 ± 38.1) and 
LTC-villi (364 ± 32.6) but significantly lower in STC-villi (311 ± 34.6) (p = 0.001). Follow-
up sampling rates because of quality reasons were the same in AF-cells (0.14%), STC-
villi (0.13 %) and (STC + LTC)-villi (0.11 %). Two wrong diagnoses tumed up among AF-
cells. Follow-up sampling rates because of representativity reasons differed significantly 
between AF-cells (0.10%), (STC + LTC)-villi (1.31 %) and STC-villi (1.99%)(p < 0.001). 
However, the ratios of all follow-up samples and uncertain or abnorma! cytogenetic 
results in STC and (STC + LTC)-villi at cytogenetic risks ;,3% (0.132 and 0.160, 
respectively) were equal to that in AF-cells at risks < 3% (0.155). Two wrong diagnoses 
were made in STC-villi. 
Diagnostic performance improved in the rank order of STC-villi, (STC + LTC)-villi and 
AF-cells. At cytogenetic risks;' 3 %, (STC + LTC)-villi showed a diagnostic performance 
equa! to that in AF-cells. This rnight justify a selective use of chorionic villus sampling. 
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Introduction 
For prenatal laboratory investigations, pregnant women can choose between 
amniocentesis at 16 to 18 weeks' gestation or chorionic villus sampling at 10.5 to 13 
weeks' gestation. After a successful period of first trimester cytogenetic, biochemical and 
ONA-investigations inchorionic vilIi, its use for cytogenetics has become restricted and 
even declined from the early ninety's onwards (Lilford, 1991; Los et al., 1998a). 
TheoreticalIy, three factors could be responsibie for this phenomenon. Two of these are 
associated with the sampling procedure; thepossibly higher abortion risk after chorionic 
villus sampling than after arnniocentesis (Rhoads et al., 1989; MRC Working Party on 
the Evaluation of Chorionic Villus Sampling, 1991; Smidt-Jensen et al., 1992; Lippman 
et al., 1992) and the potential induction of vascular disruptive syndromes by chorionic 
viIlus sampling (Firth, 1997; Froster & Jackson, 1996; Los et al., 1996; WHO/PAHO 
Consultation on CVS, 1999). The third factor is the lower accuracy and reliability of 
cytogenetic laboratory results in chorionic villi than in amniotic fluid (AF) ceUs; this 
concerns especially short term culture (STC) viIli (trophoblastcelIs) and 10 alesser extent 
also long term culture (LTC) viIIi (cultured cells of the mesenchymal vilIus core) 
(KaIousek and OilI, 1983; Wolstenholme, 1996; Ledbetter et al., 1992; Piltalis et al., 1994; 
Halmemann and Vejerslev, 1997). 
We evaluated this Iimited accuracy and reliability in detail by establishing the 
diagnostic performances of cytogenetic investigation in AF-cells, in STC-viIli and in 
simultaneously investigated (STC + LTC) -villi during the years 1993 - 1999 in our 
cytogenetic laboratory. The diagnostic performance was assumed to consist of three 
components; laboratory failure rate (proportion of appropriate samples without 
laboratory results), karyotype quality (banding quality, proportion of foUow-up 
sampling needed to reach sufficient quality and number of wrong diagnoses) and 
karyotype representativity (proportion of follow-up sampling needed to reach certainty 
that the established karyotype represented that of the fetus and the number of wrong 
diagnoses). 
MateriaIs and Methods 
Samples 
Ouring the years 1993 - 1999, we received 11 935 AF-samples and 5368 chorionic vilIus 
samples in our departrnent for prenatal cytogenetic investigation. Th" samples came 
from the University Hospital Oijkzigt (Rotterdam, The Netherlands), .from the Albert 
Schweitzer Hospital (Dordrecht, The Netherlands) and some samples from other 
hospitaIs in The Netherlands or from abroad. Chorionic vilIus sampling, amniocentesis 
and cordocentesis were performed under continuous ultrasound guJdance according to 
standard procedures (Holzgreve et al., 1999). Prenatal cytogenetic investigation was 
requested on the following indications; advanced maternal age (;>:36 years; MA 36-39 
or MA ;>:40), fetal abnormalities on ultrasound (US-abn), parenta! carriership of 
structural chromosomal rearrangements or ESACs (extra struc!ural abnorma! 
II? 
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chromosomes) (Carrier), (recurrence) risk of chromosomal abnormality, previous child 
with multiple congenital abnormalities, family history of chromosomaI abnormality, risk 
for X-linked diseases without further DNA or biochemical investigation (Other), 
prenatal biochemical and DNA investigations with additionaliy requested cytogenetic 
analysis (DNA/BlO), (recurrence) risk for neural tube defects (NTD) and follow-up 
investigation after uncertain results in a previous chorionic villus sample (Follow-up 
CV) or AF-sample (Follow-up AF). 
Laboratory investigations 
AF-cells were c:ultured by the in situ method, initiallyon glass coverslips (until early 
1997) and afterwards in Labtek ® II chamber slides ™ (Nalge Nunc Int., Naperville, IL, 
USA). STC-villi slides were prepared by fluorodeoxyuridine synchronization (Gibas et 
al., 1987). LTC-villi were cultured after trypsin-EDTA and collagenase treatment of the 
villus material (Smidt-Jensen et al., 1989). The same Labtek ® II chamber slides TM were 
used and the metaphases were harvested in situ. Karyotyping of AF-cells, STC-villi and 
L TC-villi was routinely performed by G-banding usingthe Pancreatine-Trypsin-Giernsa 
technique. Sometimes additional staining techniques were applicated; DA/DAPI-, Ag-
NOR staining, endonucIease banding, C-banding or R-banding. The quality of routine 
banding (G-banding) of metaphases according to the International System for Human 
Cytogenetic NomencIature (ISCN)(1995) was assessed with the EQAS chromosome G-
band score (United Kingdom External Quality Assessment Scheme, 1988). 
In AF-cell cultures, 16 cells from 16 colonies from at least two independent culture 
dishes were analysed routinely, according to the guidelines of The Association of 
CytogeneticTechnologists (ACT) TaskForce (Knutsenet al., 1989). Aninvestigation was 
considered as a laboratory failure when less than six colonies could be analysed or the 
quality of chromosome banding was insufficient. Mosaicism and pseudomosaicism 
(PSM) were interpreted as previously described (Boué et al., 1979). In the case of 
suspected PSM, more colonies were analysed according to internationally accepted 
criteria (Hsu et al., 1992). An investigation was repeated in a follow-up sample because 
of quality reasons when these criteria could not be met. An investigation was repeated 
because of representativity reasons when the representation of the fetal karyotype was 
considered uncertain; as example might figure the finding of 46,XX, add(21)(Pll) 
[8]/46,XX [40] in AF-cells (not a PSM case according to the definition), which was, 
however, not recovered in fetal blood (FB)(46,XX [SOl). 
From chorionic villi, only STC-villi preparations were made from 1993 -1996 (STC-
villi). From 1997 onwards, STC and LTC-villi preparations were made sirnultaneously 
when 20 mg or more villus tissue was available for cytogenetic investigation ((STC + 
LTC)-villi). In STC-villi, the routine analysis comprised the investigation of 16 cells. 
When STC ane! LTC-villi preparations were both available, eight cells in each were 
investigated. Also for chorionic villi, the guidelines of the ACT Task Force for 
chromosome analysis were followed (Knutsen et al., 1989). An investigation was 
considered as a laboratory failure when less than six cells could be analysed or 
chromosome morphology tumed out to be insufficient. An investigation was repeated 
118 
Diagnostic perfonnanee in AF-eells a1ld c1wrionie villi 
because of quality reasons when doubt remaJned on the structure of one or more 
chromosomes despite further acceptable morphology. Cytogenetic results could be 
normal, generalized homogeneous abnormal, generalized mosaic abnornlat or represent 
confined placental mosaicism (CPM) (Wolstenholme, 1996; Ledbetter et al., 1992; Pittalis 
et al., 1994). CPM was defined as CPM I, II and III, respectively, w hen a (mosaic) 
abnormal karyotype in STC-villi, LTC-villi, or both was accompanied by a normal 
karyotype in the fetus or arnniotic fluid (Wolstenholme, 1996). In the case of CPM 
without the analysis of LTC-villi, it was designated CPM I or lIl. Our management of 
uncertaincytogenetic results has been described in detail for STC-villi and (STC + LTC)-
villi (Los et al., 1998a; Van den Berg et al., 2000). All follow-up investigations for the 
discrlmination of generalised abnormalities from CPM-<:ases were carried out because 
of representativity reasons. 
Cytogenetic investigation regularly included the use of fluorescence in situ 
hybridization (FISH); the methods, applications and results have been previously 
reported (Los et al., 1998a; Van den Berg et al., 1999, 2000; Van Opstal et al., 1993, 1998). 
Sometimes additional or follow-up investigations were needed before a definite 
prenataI cytogenetic result and its interpretation could be reported. Additional 
investigations involved parental karyotyping in the case of a slructuraJ rearrangement 
or (mosaicism of) an ESAC and ultrasound (US) investigation for the establishment of 
potential phenotypic effects in the case of uncertain laboratory results or uncertaJnty 
about clinical effects of otherwise certain laboratory results. Follow-up investigations 
comprised second or third prenatal invasive procedures for repeat cytogenetic analysis. 
In multiple pregnancies, a repeat sample of each fetus was taken. 
Statistical analysis 
Statistical analysis comprised X' tests (of proportions), the establishment of 95% 
confidence intervals (95% CIs) of ratios and analysis of variances (ANOV A). 
Results 
Cytogenetic results were reported in 11 883 of 11 935 AF-samples (99.6%) and in 5328 
of 5368 chorionic villus samples (99.3% ). No cytogenetic results could be reported in the 
remaining samples due to laboratory failure or to inappropriate quality or quantity of 
the sample (Tabie 1). The laboratory failure rates of cytogenetic investigation inAF-cells, 
STC-villi and (STC + LTC)-villi were equal (0.40%, 0.48% and 0.54%, respectively). 
An example of the chromosome quality in our preparations of STC-villi, LTC-villi 
and AF-cells is shown in a case in which all three compartrnents were prenatally 
karyotyped because of a mosaic abnormality in STC-villi (Figure 1). The chromosome 
G-band score (mean ± SD) was 311 ± 34.6 in STC-villi, 364 ± 32.6 in LTC-villi and 373 ± 
38.1 in AF-cells (ANOV A, F = 9.08, dfl = 2, df, = 27; P = 0.001), representing a 
significantly lower banding quality in STC-villi. 
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Table 1- Numbers ofreceived samples, reported aod failed cytogenetic investigations during tbc years 1993 ~ 
1999; reaSODS Cor fnilure aod calculation of laboratory fallure rate 
Condition Amniotic Fluid 
(1993 - 1999) -~--~---_ ... ~~~~~--'-~-
Received samples 
Cytogenetic results reported 
Laboratory failure of appropriate sample 
- growth. harvest fhilure 
- infection 
- karyotype quality failure 
~ ------------_ ..... -_. -------._.------------
Sampling failure 
- insufficient quantity of sample 
- insufticient quality of sample 
Transport failure 
- leakage, infection 
11935 
11883 
29 
3 
16 
3 
I 
_~_:~:::~~~_~a::!~~_t~~:f?!_~~~c:r.! __________ _ 
Total failure 
Laboratory failure rate 
52 
(29+3+16) 
(j1935~4) 
0.40% 
STC-villi 
(1993 - 1996) 
3522 
3499 
13 
4 
3 
3 
23 
(13+.4)_ 
(3522 - 6) 
0.48% 
(STC + LTC)-villi 
(1997 - 1999) 
1846 
1829 
9 
4 
I 
17 
(9 +.IL 
(1846 -7) 
0.54% 
NS 
Furthermore, chromosomes in AF-cells and LTC-villi showed a sirnilar morphology 
with a more or less sharp banding pattem, whilst those in STC-villi displayed generally 
a certain fuzzyness. 
The number of normal and abnormal karyotypes, carriers, CPM cases, PSM cases, 
and "other" cytogenetic results among the various indications are shown in the Tables 
2 - 4 for AF-cells, STC-villi and (STC + LTC)-villi, respectively. 
The "other" cytogenetic results include mosaic or discrepant findings due to matemal 
cell contamination (MCC), cross contamination (admixing of the sample of fetus I to that 
of fetus 11 andj or vice versa, in a twin pregnancy), wrong sampling (sampling one fetus 
twice and the other not at all in a twin pregnancy) and chimaeric findings. 
The numbers of additional and follow-up investigations, necessary to reach the final 
cytogenetic results and subsequent clinical interpretations, are shown in the Tables 2 -
4. The frequencies of parental karyotyping in the case of unexpected structural 
chromosome abnormalities or ESACs did not differ significantly between AF-cells, STC-
villi and (STC + LTC)-villi. In contrast to this, the difference between the frequencies of 
US-investigations was highly significant (X' = 94.72, df = 2; P < 0.001). The reasons for 
follow-up sampling are given in Table 5. The rates of follow-up sampling because of 
quality reasons were equal in AF-cells, STC-villi and (STC + LTC)-villi. 
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Figu:,c 1 " Karyotypes cfthe same pregnancy in {A} STC-vil!i displaying 318 bands (average quality), (B) LTC-vi!li displaying 325 bands (minus one SD ofmc<ln qU<1lity 
and (C) AF-cells displaying 377 bands (average quality), according to the International System for Human Cytogenetic Nomenclature (lSCN).27 
Table 2 - Amoiotic Fluid 1993-1999 (AF-ceUs) 
Additional investigation Follow-up investigation 
.. _.- .. _---- ----- .. _._. 
Parental 2r.d sample 3rt! sample 
-----.-------~-
Indication N Nonna! Abnonnal Carrier PSM Other ; karyotype US AF FB AF FB 
._-_.,-_ .. _,_ .. _-,------_. 
MA 36-39 6285 6024 74 34 144 9' 43 19 13 1 '
MA,40 1011 949 33 5 24 5 5 5 
US-abn 1097 925 140 8 23 I' 26 7 i 
Carrier 65 32 2 29 2 
DNAIBIO 153 148 2 3 2 
N1D 1061 1020 9 4 27 1 ' 4 41 4 i 
Other 2081 2002 30 10 36 3' 14 5 i 2 
----"---
Total (N,) 11753 11 100 288 92 259 14 94 41 25 
-----------
1 _____ 
Follow-up CV 105 80 18 5 2 14 i 2' 
i 
Follow-up AF 25' 17 7 4 ! 3' 
All (N,) 11 883 11 197 313 98 261 14 95 59 ! 25 5 
1 - MCC (7 cases), 1 culture dish 46,XX, the other 3 dishes 46,XY (1 case); discrepancy between AF and US conceming fetal gender of one fetus oftwin pregnancy (I case) 
2 = FB; nonnal 
3 = Mee-cases 
4 = FB; carrier (2 cases) 
5 = follow-up sample because of discrepancy of feta! gender at ultrasound (0") and AF karyotype (46,XX), due to mixing up of samples (I ease) 
6 = FB; abnorrnal (2cases), nonnal (lease) 
Diag1lOstic petfonnalJce ilJ AF-cells mld c1Jorionic villi 
Table 3 - Chorionic villi 1993-1996; analysis ofSTC-villi ooly (STC-villi) 
Additional Follow-up 
investigation investigation 
-----
CPM Parental 
Indieation N Nonnal Abnonnal Carrier Iorm karyotype -~~I AF FB - .... -- ------~-~ --------MA 36-39 2282 2191 33 7 51 21 54 
MA,40 447 424 14 8 2 7 ' 6 
US-abn 165 116 46 3 3 4 
Carrier 80 41 9 30 - i 
DNAIBIO 206 201 2 3 2 3 
Other 319 307 6 6 2 9 9 
All 3499 3280 110 38 71 27 63L 76 
The rates of follow-up sampling because of representativityreasons and, hence, the total 
follow-up sampling rates showed highly significant differences in the rank order AF-
cells, (STC + LTC)-villi and STC-villi (Tabie SJ. 
The ratios and their 95% CIs of the numbers of all follow-up samples (for quality, 
representativity and other reasons) and the nurnbers of abnormal or uncertain results 
at cytogenetic risks < 3%, ;,3% and at all cytogenetic risks are shown in Figure 2A. At 
all risks, there is a significant difference between these ratios in the rank order AF-cells, 
(STC + LTC)-villi and STC-villi (Figure 2B). However, the ratios in STC and (STC + 
LTC)-villi at cytogenetic risks <0 3% did not differ from that in AF-cells at cytogenetic 
risks < 3% (Figure 2B). 
During the study period, a wrong prenatal cytogenetic diagnosis was made !wice in 
STC-villi; both false-positive cases are examples of the lirnited representativity of the 
karyotype in chorionic villi for that in the fetus (Tabie 6). In AF-cells, a wrong diagnosis 
was made also in !wo instances; the fust case is an example of the lirnitation of 
karyotype quality in AF-cells compared to blood lymphocytes and the second case of 
the lirnitations of FISH investigation (Table 6). 
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A 
Sample Cytogcnetic risk < 3% 
(MA 36-39. DNA/BIO. 
NTD,other) 
CylogcncLic risk 2': 3% All cytogenctic risks 
B 
(MA 2': 40, US-abn, canicr) 
Amniolic Iluid 9451 + 16 
9580 ~IIIIII-
0.155 (0.093 - 0.217) 
STC-villi 
0.102 (O.S99 - 0.792) 
(STC + LTC)-vil!i 
1321 
0.571 (0.372 - 0.755) 
~ = nOlTl'al. ,mier. I'S~I. CP.\!. oo,«(N, =con:lin, N1: afl« follow,up) 
N ... ~"bno"uIIN,="!tl;n.N,,,.ft<rfollow."p) 
'~-l = un"c,';n. follow'up \.lJnplin& 
OIOJ O.lIlO 0.200 0300 
0.034 (0.012 _ 0.072) 
"' tT::~;;!3 
(1.132 (0.065 _0.229) 
0.160(0.088 - 0.259) 
o.,mo 0$0.) 
""' 
91446'" 11753 i <~t;l~jl:: ;': 
0.085 (0.056 - 0.122) 
3329 + 60 
3499 rllllllllï 
0.447 (0.372 - 0.522) 
1720+27 
1829 rlllll.-j 
0.266 (0.183 - 0.349) 
c=J Lowri.k 
_ fljghri,k 
l11'Bffi\iJ All ri,'" 
O.iOO ü.MlO 
Figure 2 _ (A) Numbcrs of nomlaJ. ahnonnal, and unccnain Cylogcnclics I'csuhs in Af-samples, STC-viJli, anti (STC + LTC)- vil!i at low 
«3%), high (::: 3%) 'olnd uil cylogenetic risks. Funhennorc, thc number of repeal im'esligations (only seeond samples) with finally nonnal 
or abnomlUl resulls are ~hown. lbc mlios of follow-up samples and abnormal ur uncertain resulls with their 95% CI's are indicated. (B) 
An overview of the various 95% crs of the thrce types of samples al the dilTcrellt cYlogenctic risks. 
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Table 4 -Chorionic villi 1997 -1999; analysis of STC-villi only in 290 cases (16%) aod of (STC + LTC)- villi in 1539 cases (84%) 
Additional investigatio~_j Follow-up investigation 
Normal CPM Parental 
Indication N 2N 4N/2N Abn Carrier II m lor III Other karyotype US AF FB 
MA 36-39 954 852 63 11 6 II 5 3 2' 9 16 13 
MA,40 297 258 16 11 3 4 2' 4 8 9 
US abn 157 90 6 56 2 5 
Carrier 54 22 4 3 22 2 3 4 (2') 
DNAIBIO 170 160 7 I' - ! 2 
Other 197 173 IS 2 3 - i, 2 3 
All 1829 1555 114 82 33 20 13 3 5 
4 [--20----3-1-----;--- 29 (2) 
2N = diploidy, 4N/2N - tetraploidy/diploidy mosaicism; 1 - cross contamination in one fetus oftwin pregnancy (one case); MCC (one case); 2 - wrong sampling; one fetus twice 
and the other not at all (one case); MCC (one case); 3 = amniocentesis and fetal blood sampling performed simultaneously; AF-results assumed not to be 100% representative. 
Therefore, FB is considered as a follow-up (third) sample ofthc seeond AF-sample and placed between brackets here (two samples); 4 = also MCC 
Table 6 -Wrong prenatal cytogenetic diagnoses in tbe period 1993 -1999 among 11883 AF-samples aod 5328 chorionie villus samples 
Prenatal sample 
STC - villi 
(N = 3499) 
(STC + LTC)- villi 
(N = 1~29) 
AF-eells 
(N=11883) 
Indication 
MA 36-39 
MA 36-39 
Other 
NID 
Prenatal karyotype 
46,XY, der(lO) de-novo 
47,XY,+8[3]146,XY[15J 
46,XX 
45,X[lIJ/46,X,+ mar [8J FISH; 
ESAC,*X or Y ehromosomal material 
Pregnancy - outeome 
TOP 
TOP against our advise 
Normal birth, developmental delay, various 
congcnital malformations 
Continuation ofpregnaney, despite counselling 
a potentially severe abnormal phenotype 
Postnatal karyotype or clinical findings 
46,XY in fetal fibroblasts 
46,XY in fetal fibroblasts 
46,XX, del(18)(q22_2qter) 
de-novo in lymphocytes 
mild Turner phenotype 
FISH'; ESAC = Xp material 
der = derivative chromosome, TOP = termination of pregnaney; 1 = FISH investigation on the original amniotie fluid cell metaphases 
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Table 5 - Reasons fot follow-up cytogenetic iDvestigation in second (and third) samples and the rates offollow-
up sampling for quality and for representativity reason 
Reason for follow-up sampling 
200 sample 
- quality reasons 
- representativity reasons 
- both quality and representativity 
- other reasons 
3rd sample 
- representativity reasons 
- other reasons 
Amniotic Fluid 
(1993 - 1999) 
N, = 11 753 
N, = 11 883 
AF 
15 
5 
3 
2' 
FB 
4 
l' 
-------- ----
All 
Follow-up sampling rate 
- for quality reasons 
- for representativity reasons 
Total follow-up s.unpling rate 
25 6 
15+ (]x 0.5) 
11753 (N,) 
0.14% 
6+(3xO.5) ___ 4 __ 
11 753 (N,) + 11 883 (N,) 
0.10% 
_._.1§___ + 5 
11 753 (N,) 11 883 (N,) 
0.26% 
STC-villi 
(1993 - 1996) 
N = 3499 
AF 
4 
69 
1 
2' 
76 
FB 
4+(lxO.5) 
3499 
0.13% 
69+(1 xO.5) 
3499 
(STC + LTC)-vi1li 
(1997 -1999) 
N = 1829 
AF 
2 
24 
3' 
29 
FB 
(1)' 
(1) 
------
(2) 
2 
1829 
0.11% 
NS 
24 
1829 
1.99% 1.31% 
76 
3499 
X' = 176.25, df= 2; P < 0.001 
...1L 
1829 
2.17% 1.59% 
X' = 146.51, df= 2; P < 0.001 
I - discrepancy of feta! sex between AF results and ultrasound in one fetus of a twin pregnancy (due to wrong 
sampling), second sample of both fetuses 
2 = second sample!; of fetuses with nonnal karyotypes in two twin pregnancies 
3 = wrong sampling (one fetus twice (twice abnormal), tbe other not sampled at all) leading to two second samples, 
one for quality reasons and one for other reasons; second sample of fetus with nonnal karyotype in twin 
pregnancy (1 case); X-inactivation studies in case ofa (X;autosome) translocation (1 case) 
4 = X-inactivation studies in case ofa (X;autosome) translocation (lease) 
5 = third samples are considered to be follow-up samples ofthe second ratherthan ofthe first samples and, therefore, 
the numbers placed between brackets at the first samples 
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Discussion 
For over 20 years, prenatal diagnosis in AF-cells has been regarded as reliable and 
accurate (Golbus et al., 1979). Some time after the introduction of chorionic villus 
sampling, amniocentesis and laboratory investigations in AF-cells became the "gold 
standard" of invasive prenatal genetic diagnosis (Strane et al., 1997). The reliability and 
accuracy of cytogenetic laboratory results of chorionic villi have been subject to many 
investigations. However, a restricted accuracy and reliability of cytogenetic results in 
chorionic villi compared to AF-ceUs did not influence women in choosing amniocentesis 
or chorionic villus sampling, in contrast to professionals in the field of prenatal 
diagnosis (Heckerling et al., 1994; Kuppermann et al., 1999). 
In the literature, laboratory failure rates after amniocentesis have been reported 
between 0.1 % and 0.4% (Lippman et al., 1992; Smidt-Jensen et al., 1993; Waters and 
Waters, 1999). These figures range from 0.3% to 2.0% af ter chorionic villus sampling 
(Lippman et al., 1992; Ledbetter et al., 1992; Smidt-Jensen et al., 1993; Waters and Waters, 
1999). Our figure for AF-cells (0.40%) is just at the reported upper-limit and those for 
chorionic villi (0.48% for STC-villi, 0.54% for (STC + LTC)-villi) are in the lower region 
of the reported range. However, our definition of laboratory failure rate might be rather 
more tight than the published failure rates. The laboratory failure rates in AF-ceUs and 
chorionic villi as parameter of the diagnostic performance of cytogenetic investigation 
did not differ significantly from each otl1er in our laboratory. 
Prenatal cytogenetic diagnosis requires a resolution of 400 bands per haploid set and 
a minimum of150 bands in direct chorionic villi preparations (United Kingdom External 
Quality AssessmentScheme, 1988). AlthoughSTC-villi preparations show a much better 
chromosome banding than direct villi slides, the G-band score in STC-villi was 
significantly less than in LTC-villi or AF-ceUs. TheoreticaUy, this inferior karyotype 
quality is expected to result in a higher rate of follow-up investigations and in more 
wrong (missed orerroneously assigned) diagnoses. However, this was notsubstantiated 
by the figures on these parameters, that turned out to be equal in STC-villi, (STC + 
LTC)-villi and AF-cells. The only two wrong diagnoses were actuaUy made in AF-cells. 
The literature on wrong prenatal cytogenetic diagnoses due to limitations in karyotype 
quality is scarce; for chorionic villi, figures have been reported between 3/7415 (0.04 %) 
(ACC Working Party on Chorionic Villi in Prenatal Diagnosis, 1994), 1/11436 (0.009%) 
(Ledbetter et al., 1992) and 4/62 865 (0.006%) (Hahnemann & Vejerslev, 1997); for AF-
cells only some sporadic cases have been documented (Golbus et al., 1979; Winsor et al., 
1999). Karyotype quality as parameter of the diagnostic performance of cytogenetic 
investigation turned out to be equal in AF-cells and (STC + LTC)-villi, but to be less in 
STC-villi, albeit without noticable consequences in our study. 
The allocation of normal and abnormal cells from the 8 to 16-0eU stage to the 
embryonic compartulents of the fetus proper, extra embryonic mesoderm (EEM) and 
trophoblast in the case of arising of mosaicism in the early embryo may lead to unequal 
distributions in these compartulents (WolstenllOlme, 1996; Pittalis et al., 1994; Los et al., 
1998b). The investigation of the compartulent of interest, that of the fetus proper, in AF-
cells and of the other compartments, those of the trophoblast and EEM, in STC- and 
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LTC-villi, respectively, implicates a fundamental biological difference betweenAF-cells 
and chorionic villi in favour of AF-cells concerning karyotype representativity. The 
significant differences in the frequencies of additional US-investigations and in the 
follow-up sampling rates because of representativity reasons in AF-cells, STC-villi and 
(STC + LTC)-villi are in agreement with this. In the literature, no figures for the follow-
up sampling rates just because of representativity reasons could be found, only rates of 
follow-up sampling for all cytogenetic (quality and representativity) reasons. Figures 
have been reported between 0.3% and 0.4% for AF"cells (Smidt-Jensen et al., 1993; 
Winsor et al., 1999), between 2.0% and 2.2% for chorionic villi with the analysis of STC-
preparations only (Los et al., 1998a; Leschot et al., 1996), between 0.8% and 1.8% with 
the analysis of LTC-preparations only (Sundberg et al.,1999; Sikkema-Raddatz et al., 
2000) and between 0.9% and 1.6% with the simultaneous analysis of STC- and LTC-
preparations when a sulfident amount of villus material was available (Lippman et al., 
1992; Ledbetter et al., 1992; Smidt-Jensen et al., 1993). Our figures of total follow-up 
sampling rates in AF-cells (0.26%), (STC + LTC)-villi (1.59%) and STC-villi (2.17%) were 
within these ranges. Two wrong (false-positive) diagnoses due to limitations of 
karyotype representativity were made in STC-villi. Karyotype representativity as 
parameter of the diagnostic performance of cytogenetic investigation declined 
significantly in therank order AF-cells, (STC + LTC)-villi and STC-villi. However, when 
the numbers of follow-up samples were considered in relation to the numbers of 
abnormal or lfficertaln results, rather than the numbers of all investigations, the 
calculated ratios turned out to be equal for chorionic villi at cytogenetic risks <: 3% and 
AF-cells at cytogenetic risks < 3%. 
The diagnostic performances of cytogenetic investigation in the studied prenatal 
samples increasewitll cOllSiderable intervals in the rankorder ofSTC-villi, (STC + LTC)-
villi and AF-celIs, which justify a restricted use of chorionic villus sampling. 
However, at cytogenetic risks ;,3%, the diagnostic performance of cytogenetic 
investigation in (STC + LTC)-villi, equals the "gold standard" of prenatal diagnosis in 
AF-cells, which might justify a selective rather than a restricted use of chorionic villus 
sampling. 
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Summary 
A cytogenetic survey and follow-up studies were performed in eight cases of full, 
mosaic, and pseudomosaic trisomy 9 prenatally diagnosed among 36.213 prenatal 
samples in our department between August 1970 and July 1996. Besides conventional 
chromosome analysis, interphase fluorescent in situ hybridization (FISH) was 
employed. FISH turned out to be a rapid and accurate method for verification of 
trisomy cell lines and could provide additional information to the prenatal 
cytogenetic results. FISH also enables the study of uncultured specimens of arnniotic 
fluid, not accessible for traditional cytogenetic analysis. In three cases, retrospective 
DNA analysis showed the supemurnerary chromosome 9 to be of matemal origin. 
The disomic cell lines in both mosaic trisomy 9 cases showed matemal uniparental 
disomy. 
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Introduction 
Prenatal diagnosis of trisomy 9, in a mosaic or a non-mosaic state, is an uncommon 
chromosome abnorrnality, fust described by Francke et al. (1975) and Pfeiffer et al. 
(1984). The prenatal detection of trisomy 9 mosaicism in amniotic fluid (AF) cells has 
posed a serious problem for genetic counselling and appropriate monitoring of the 
pregnancy, since in some cases the abnormality could not be confinned, probably 
due to limitation of the trisomic cell line to the fetal membranes Q'fsu and Perlis, 
1984; Pfeiffer et al., 1984). Trisomy 9 (mosaicism) observed in chorionic villi (CV) also 
poses a serious dilemma because it is an unusual trisomy (Ledbetter et al.,1992) and 
may reflect generalized mosaicism as weil as mosaicism confined 10 the placenta 
(CPM) (Kalousek and Dill, 1983; Kalousek et al., 1987, 1991; Appelman et al., 1991). 
Differentiation between pseudomosaicism and true mosaicism or CPM and 
generalized mosaicism is often difficult, due to time constraints and a limited 
amount of available metaphases. Fluorescence in situ hybridization (FISH) allows the 
rapid detection of numerical chromosome aberrations in a large number of cultured 
as weil as uncultured cells. 
In this study, eight cases of pseudomosaic, mosaic or non-mosaic trisomy 9 are 
presented; six cases were detected in AF and two cases diagnosed in CV. We have 
applied FISH with the chromosome 9-specific probe pHUR98 (Moyzis et al., 1987) to 
study (1) AF cultures previously classified as either pseudo- or true mosaic, in order 
to determine whether FISH could provide additional information for the 
differentiation of pseudomosaicism from true mosaicism, and (2) CV preparations 
and uncultured AF specimens, in order to differentiate CPM from generalized 
mosaicism. DNA analysis was perforrned on AF cells, placental tissue, and parental 
lymphocytes to establish the parent of origin of the supernumerary chromosome 9 
and to identify the missing copy in the disomic cellline of the mosaic cases. 
Materials and Methods 
Patients 
Between August 1970 and July 1996, a total of 36.213 prenatal cytogenetic 
investigations were carried out in our department. For this study, we selected all 
cases with a numerical chromosome 9 abnormality. This resulted in six cases among 
the amniotic fluid samples and two cases among the chorionic villus samples with 
either a full trisomy 9, a mosaic trisomy 9, a pseudomosaic, or a confined placental 
mosaicism (CPM) for trisomy 9. 
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Cytogenetic investigations 
Transabdominal chorionic villus sampling (TACVS), amniocentesis, and 
cordocentesis were performed under ultrasound guidance. CV were incubated 
overnight using fluorodeoxyuridine (FdU) synchronization (Gibas et al.,1987). 
AF cells were cultured by the in situ method on glass coverslips. Metaphase spreads 
of fetal Iymphocytes and skin fibroblasts were prepared according to standard 
techniques. Trypsin-Giemsa staining was routinely used for karyotyping and a 
minimum of 16 cells/ colonies were analysed in each case. In cases of chromosome 
mosaicism, pseudomosaicisrn, or when CPM was suspected, more eells were 
analysed and follow-up investigations were suggested. Mosaicism and 
pseudomosaicism were interpreted according to definitions of Boué et al. (1979) and 
Hsu and Perlis (1984). 
Fluorescenee in situ hybridization (FISH) 
Interphase FISH was performed on semi-direct CV preparations, cultured 
amniocytes, fetal Iymphocytes, and fetal skin fibroblasts according to standard 
protoeals, as weil as on slides of uncultured amniocytes (Van Opstal et al.,1993) and 
fetallymphocytes. The latter were prepared by incubating the cells in 0.075M KO at 
37· C for 20 min. Subsequently the cells were fixed by three changes of methanol-
acetic acid (3:1) and dropped onto slides (Garnham and Sutherland,1987). 
The chromosome 9-specific probe pHUR98 (Moyzis et al.,1987) was used for 
detection of the chromosome 9 copy number in interphase nuclei. In one case the 
chromosome 7-specific probe pct7t1 ryvaye et al.,1987) was also used, for detection of 
the chromosome 7 copy number. 
Probes were labelled by nick translation using either biotin-ll-dUTP (BRL), 
biotin-16-dUTP or digoxigenin(DIG)-ll-dUTP (Boehringer Mannheim). 
The probes pHUR98 and pct7t1 (40 ng in 10 \ll of 60 percent formamide/2xSSC) 
and target DNA were denaturated simultaneously for 3 min at 80·C. Hybridization 
was performed overnight at 37· C. Slides were washed three times in 50 per cent 
formamide/2xSSC at 42·C for 5 min, followed by three changes of 2xSSC, twice at 
42·C and once at 60·C. 
Probe detection of biotinylated probes was achieved via alternating application of 
fluoresceinated avidin and biotinylated anti-avidin antibody (Vector Laboratories). 
D1G-Iabelled probes were detected with one layer of anti-DIG-fluorescein 
isothlocyanate (FITC)(Boehringer Mannheim). Finally, the slides were mounted in an 
antifade solution containing propidium iodide and DAPI as a counterstain. 
Slides were exarnined under a Leica Aristoplan epifiuorescence equipped 
microscope and images were captured with the Genetiscan ProbeMaster system 
(Perceptive Scientific International Ltd) including a Xybion cooled CCD 24-bit colour 
camera. 
For each sample, a minimum of 100 intact non-overlapping and non-clumped 
interphase nuclei were counted. Nuclei without signaIs were not included in the 
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data. For the interpretation of the FISH results the 95 % confidence interval of the 
upper reference limit for the proportion of cells with three signals was established in 
diploid tissue control samples, according to Lomax et al. (1994). 
DNA analysis 
In three cases, molecular studies were performed on DNA isolated from uncultured 
and cultured anmiocytes (passage 2 or more), cultured placental tissue, and parental 
lymphocytes according to standard techniques. Studies on the parent of origin of the 
additional chromosome 9 were performed using polymerase chain reaction (PCR) 
amplification of polymorphic lIÛcrosatellite markers. The chromo-some 9-specific 
loci D9S147E (9pter and 9qter), D9S158 (9q34.3), D9S171 (9p21), D9S175 (9q13-q21), 
D9S118 (9q31), and D9S156 (9p23) were studied (Reed et al.,1994). 
The detection was performed with fluorescently labelled primers by selIÛ-
automated methods using an AB! prism 377 DNA sequencer as described previously 
by Reed et al. (1994). ConcIusions about parental origin required at least two 
inforrnative markers. 
Results 
Between 1970 and lIÛd-1996, 25.073 diagnostic AF samples and from September 1983 
to July 1996, 11.140 diagnostic CV samples were received in our laboratory for 
chromosome analysis. A total of eight cases with a numerical chromosome 9 
abnormality were found among the AF and CV groups. The prenatal cytogenetic 
and FISH studies are summarized in Table 1. Ultrasound investigations, pregnancy-
outcome and confirmatory studies are shown in Table 2. 
Amniotic f1uid group 
A total of six cases with a numerical chromosome 9 abnormality were found among 
this group. A full trisomy 9 was seen twiee (cases 1 and 2). Both pregnancies were 
terminated at the parents' request. Confirmation of the trisomy 9 in fetal tissue was 
only possible in case 2, due to growth failure of fetal fibroblasts in case 1. Both 
fetuses showed the trisomy 9 phenotype as described by Chitayat et al. (1995). 
A mosaic trisomy 9 occurred only once (case 3). The parents were informed of the 
cytogenetic results and further diagnostic procedures in order to reach definite 
certainty were recommended: ultrasound investigation, repeat anmi.ocentesis, CVS 
and fetal blood sampling. Ultrasound examination of the fetus revealed some minor 
abnormalities. FISH on uncultered anmiocytes of the repeat anmiotic fluid, selIÛ-
direct CV preparations, and uncultured fetal Iymphocytes revealed the presence of a 
trisomy 9 cell line in all investigated compartments and the parents chose to 
terminate the pregnancy. Trisomy 9 mosaicism was confirmed ir amniotic and 
chorionic membrane and by the phenotypic appearance of the fetus. 
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Table 1 - Cytogenetic and FISH results in the eight prenatal cases with a numerical chromosome 9 abnormality 
Case First 
No. sample 
I 
2 
3 
4 
5 
6 
7 
8 
AF 
AF 
AF 
AF 
AF 
AF 
cv 
cv 
Karyotype 
[ No. of A F coloniesl 
CV cells] 
47,XX,+9 [16] 
47,XX,+9 [21] 
47,XY,+9[4]/46,XY[26] 
47,XX,+9[I]*/46,XX[18] 
47,XY,+9[1]/46,XY[5] 
47,XY,+9[1]/46,XY[I7] 
47,XX,+9[30] 
48,XY,+ 7, +9[2]/46,XY[17] 
Sample 
AF culture 
AF2 direct 
CV direct 
FB direct 
FB culture 
AF direct 
AF culture~ 
AF cultureb 
AF culturea 
AF2 direct 
AF2 culture 
FB direct 
FB culture 
AF culture 
CV direct 
AF2 direct 
AF2 culture 
CV direct 
AF culture 
Follow-up laboratory investigations 
% of nuclei with 1-3 signals 
o 
6 
o 
4 
5 
5 
4 
4 
11 
12 
5 
9 
o 
o 
2 
60 
71 
8 
84 
95 
90 
59 
92 
85 
80 
94 
88 
4 
62 
3 
40 
24 
92 
12 
o 
5 
27 
4 
4 
9 
3 
3 
96 
38 
N 
400 
170 
200 
202 
152 
200 
189 
400 
100 
207 
202 
436 
200 
250 
Karyotype 
[Nn. of AF coloniesl 
CV,FB eells] 
47,XY,+9[8] 
46,XY[30] 
46,XY[17] 
46,XY(100] 
47,XX,+9[7]/46,XX[30] 
46,XY[16] 
Prenatal diagnosis 
Trisomy 9 
Trisomy 9 
Mosaic trisomy 9 
Pseudomosaic trisomy 9 
Type A 
Pseudomosaic trisomy 9 
Typee 
Pseudomosaic trisomy 9 
TypeB 
Mosaic trisomy 9 
CPM 
AF =amniotic fluid; AF2 = repeat amniotic fluid; CV = chorionic villi; FB = feta! blood; CPM = confined placenta! mosaicism; - = not tested or non-informative results; 
• = colony includes abnonnal and normal cells; a = dish without trisomy 9 colonies; b = dish with trisomy 9 colonies. 
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Table 2 - Results ofultrasound investigation and pregnancy-outcome in the 8 cases of (mosaic) trisomy 9 
Case 
no. 
2 
3 
7 
4 
6 
5 
8 
Prenatal 
Diagnosis 
Full trisomy 
Full trisomy 
Mosaicism 
Mosaicism 
Pseudomosaicism 
type A 
Pseudomosaicism 
typeB 
Pscudomosaicism 
typeC 
CPM 
Ultrasound 
investigation 
20 weeks, IUGR, 
skeletal malfonnations 
19 weeks, minor 
abnonnalities (plexus chor. 
cysts, micrognathia) 
16 wecks, IUGR 
29 weeks, IUGR 
Nonnal 
Nonnal 
Pregnancy-outcome 
TOP: 19 weeks, !i! fetus with 
severe facial rnalfonnations 
TOP: 20 weeks, !i! fetus with 
facial dysmorphisms and 
skeletal malfonnations 
TOP: 20 weeks, rJ fetus with 
facial dysmorphisms, 
no autopsy 
TOP: 16 weeks, !i! fetus, 
growth retarded 
Livebom!i!, 37 weeks, SGA, 
transient respirator)' and 
fee ding difficulties 
Livebom nonnal rJ 
Livebom nonnal cl' 
Livebom nonnal rJ 
Confinnatory 
cytogenetic 
investigation 
Failure of fibroblast 
culture 
47,XX,+9 
(fetal skin fibroblasts) 
FISH: 70%+9 
(amniotic membrane), 
88% +9 (chorionic 
membrane) 
failurc offibrob!ast 
culture 
FISH: 100% +9 in 
placenta! tissue, failure 
of fibroblast culture 
46,XX[IOOI 
(blood Iymphocytes) 
TOP - termination of pregnancy; ruGR - intrauterine growth retardation; CPM - confined placental mosaicism; 
SGA = smal! for gestational agc. 
A pseudomosaic trisomy 9 occurred in three cases (Nos 4, 5 and 6). In case 4, 
amniocentesis was performed at 29 weeks' gestation because of intrauterine growth 
retardation (IUGR). The karyotype showed a pseudomosaic state, type A. 
Because uncultured amniocytes from all patients with ultrasound abnormalities 
are stored in Dur laborat~ry, we could perfonn FISH on interphase nuclei of 
uncultured amniocytes which showed the absence of trisomy 9 cells. The infant was 
delivered at 37 weeks and had some minor and transient respiratOJy and feeding 
problems. 
In case 5, only a few colonies could be examined and these were in a 
pseudomosaic state. FISH on interphase nuclei of the remaining (trypsinized) 
cultured amniocytes present on the bottom of all dishes showecl a significant 
population of trisomy 9 cells (27%) in the dish with the trisomy 9 colony. The 
possibility of a real mosaicism was discussed and further diagnostic procedures were 
recommended, such as ultrasound examination, cordocentesis and repeat 
amniocentesis. Ultrasound examination at the time of the repeat amniocentesis and 
cordocentesis revealed no abnormalities. FISH on interphase nuclei of uncultured 
amniocytes and uncultured fetallymphocytes turned out to be nonna!. 
Chromosome analysis of both cultured tissues yielded normal karyotypes and the 
pregnancy continued; a nonnal boy was bom at term. 
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In case 6, FISH on interphase nuclei of the remaining cells was performed and 
revealed no trisomy 9 ceUs, 50 further diagnostic procedures were not necessary. 
Chorionic Villus group 
Two cases with a numerical chromosome 9 abnormality were found among this 
group. In one case (No. 7), we found a tul! trisomy 9 and in another case (No. 8), a 
mosaic trisomy 9. The possibility of false-positive results was discussed and further 
diagnostic procedures were carried out. Depending on those results, amniocentesis 
and structural ultrasound examination of the fetus were recommended. 
In case 7, FISH on uncultured anmiocytes showed an increased percentage of 
interphase nuclei with three signals, indicating the presence of a mosaic trisomy 9. 
This was confirmed by karyotyping. The pregnancy was terminated at the parents' 
request. Unfortunately, confirmation of the trisomy 9 was possible only on placental 
tissue and anmiotic and chorionic membrane . 
In case 8 , FISH on semi-direct preparations turned out to be uninformative and 
FISH on uncultured anmiocytes was not yet available. Cluomosomes from cultured 
anmiocytes revealed normal results and the pregnancy was continued. 
DNA a"alysis 
Retrospective DNA analysis was performed (af ter prolonged culturing of AF ceUs) in 
case 2 showing a tuu trisomy 9 in AF and in the cases 3 and 7 showing a mosaic 
trisorny 9 in AF. The results are summarized in Table 3. 
Table 3 - Alleles oftbe informative chromosome 9 markers in tbe three families Învestigated 
Case Uncultured Cultured 
No. Marker Localization Father Mother Placenta AF eells AF eells 
-------_ .. 
2 D9S118 9q31 2,4 1,3 1,2,3 
D9S156 9p23 3 1,2 1,2,3 
3 D9S158 9q34.3 3 1,2 1 
D9S175 9q13·q21 1,4 2,3 2,3 
7 D9S158 9q34.3 1,4 2,3 1,2,3 2,3 2,3 
D9S171 9p21 3 1,2 1,2,3 1,2,3 1,2 
D9S175 9q13-q21 2 1,3 1,2,3 1,3 
- - not investigated; AF - amniotic fluid 
In the full trisomy 9 case, the supernumerary 9 turned out to be of matemal origin, 
since two matemal alleles and one paternal allele were identified in cultured AF cells 
with two markers (Fig. lA). In both cases with mosaicism, the cultured AF cells 
apparently lost the trisomic cell line and revealed matemal uniparental disomy 
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(UPD) and the absence of a patemal allele for chromosome 9 with two and tbree of 
the tested markers, respectively (Figs lB and IC). 
Heterodisomy was seen in case 7 and partial isodisomy jheterodisomy in case 3. 
However, in case 7, cultured placental tissue and uncultured AF celis showed a 
normal and a weak patemal alleie, respectively, in contrast to the presence of only 
matemal alleles in cultured amniotic fluid eeUs. 
Discussion 
Trisomy 9 (mosaidsm) is an uncornmon but weU-known finding in prenatal 
B 
I'ailler f~lllcf 
, , MlHh~r 
Mother Mmllor 
Un<:ullurc,II\F ~L.........-
3 2 I CU!IU"'dA~ 
3 2 I CullllrcdAf __ ~ 
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-----, ,-~-----, 
Figure 1- PCR analysis ofmicrosatellite markers. (A) Case 2. For D9S 118, the cultured AF cells have both matemal 
alleles (1, 3) and one patemaI allele (2). (B) Case 3. For D9S175, the cultured AF cells show only tbc matemaI 
alleles (2, 3). (C) Case 7. For D9S171, the placenta has both matemal alleles (1, 2) and one patemal aIlele (3). The 
Wlcultured AF cells have both matemal aUeles (1,2) and a weakpatemal allele (3). Tbe culturedAF cells no longer 
show a patemal aIlele, but only both matemaI alleles (1,2). 
diagnosis (Zadeh et al.,1987; Schwartz et al.,1989; Chitayat et al.,1995). Sometimes it 
poses a serious problem for genetic eounselling, since we must distinguish between 
mosaicism, pseudomosaicism, CPM and true trisomy 9 (Hsu and Pedis, 1984; Pfeiffer 
et al., 1984; Appelman et al., 1991; Saura et al., 1995). 
Prenatal detection of trisomy 9 mosaieism in amniotic fluid can be complicated by 
the absence of the trisomic ceUline in different tissues and the subsequent lack of 
fetal anomalies in some cases (Hsu and Pedis, 1984; Merino et al., 1993; Pfeiffer et 
al.,1984). These authors suggested that the trisomic cells may be Iimited to fetal 
membranes. In our study, subsequent cytogenetic investigations in a compartrnent 
other than that in which the abnormality was encountered originally and an 
ultrasound scan were carried out to raise the significance of our prediction of the 
chromosomaI state of the fetus. 
Espedally in the case of subsequent investigations, rapid detection of chromosome 
(9) abnormalities is partieularly Important. In this study, we demonstrated that a 
large number of interphase nuclei ean be sereened quiekly for the presenee of a 
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trisOInic cell line in a subsequent tissue sample (uncultured amniocytes or fetal 
blood) within 2 days sinee metaphases are not necessary for FISH analysis, which 
eliminates the time waiting for tissue culture. Furthermore, relatively low levels of 
mosaic chromosome abnormalities could be detected. It was also shown that the 
application of FISH with a chromosome 9-specific probe has a predictive value and 
can aid in the counselling. 
Trisomy 9 observed in CV may reflect generalized mosaicism or may indicate 
mosaicism confined only to the placenta. CPM has been observed at different stages 
of embryomc development and is assoeiated with variabIe pregnancy outcomes, 
including spontaneous abortions, IUGR and normaI birth (Appelman et al., 1991; 
Ledbetter et al., 1992; Saura et al., 1995). Another factor is that pregnancies with CPM 
are at an increased risk of fetal UPO. The ineidence of fetal UPO depends on the 
chromosome concernedi most CPM 7 cases are probably due to somatic duplication 
and not to trisomic zygote rescue with a concomitant low risk of fetal UPO (Kalousek 
et al., 1996). However, most CPM 16 cases are due to trisomic zygote rescue and 
carry a 33% risk of fetal UPO (Kalousek et al., 1993). No imprinting effects of UPO 9 
are known up to now (Ledbetter and Engel, 1995). 
In this study, all three cases investigated showed the presence of two matemal 
alleles in the trisomic and in the disomic cellline compatible with a meiotic origin of 
the supemumerary chromosome 9 and subsequent partial trisOInic zygote rescue. 
The absence of the patemal allele in cultured AF could be due to loss of the trisomic 
cell line in prolonged culturing of AF cells. Oespite the rarity of chromosome 9 
aneuploidy, one postnatal and one prenatal case of matemal UPO 9 have been 
reported before (Willat et al., 1992; Wilkinson et al., 1996). 50, there seems to be a 
tendency for clrromosome 9 aneuploidy to result in matemal UPO 9. 
This study indicates that caution should be taken in handling prenatal cases with 
(mosaic) trisomy 9; essential steps are presented to provide maxirnal Information to 
facilitate laboratory interpretations and clinical decisions. 
We suggest that generalized mosaicism, pseudomosaieism or CPM eonceming 
chromosome 9 may be differentiated from each other and result in appropriate 
clinical management only when the prenatal analysis is extended to include: (1) FISH 
studies condueted on a large number of interphase cells in dishes with and without 
trisomy 9 colomes, (2) FISH studies on direct cell preparations from another 
compartment, (3) karyotyping from another tissue and/ or compartment, (4) 
ultrasound investigation. 
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Abstract 
Objective: Investigation of the normal frequency of tetraploid metaphases in 
semidirect (STC) and cultured (LTC) chorionic villi. 
Methods: Fifty metaphases in STC- and in LTC-villi slides of 100 women of advanced 
maternal age were screened for tetraploidy. 
Results: Up to three tetraploid metaphases were encountered in 27% of the STC-villi 
preparations; !he scores fitted a Poisson distribution. In all L TC-villi preparations 
tetraploid cells were seen; the scores fitted a log-Gaussian distribution. 
Conc/usions: On the basis of these distributions, we propose a protocol for the 
management of tetraploid metaphases in chorionic villi, strongly reducing !he 
nurnber of prenatal follow-up investigations. 
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Inlroduction 
Tetraploidy in full or mosaic state is a very rare cytogenetic abnormality In livebom 
infants [1]. In in-vitro cultured embryos it is a frequently observed phenomenon [2-4] 
and among spontaneous abomons it comprises up to 10% of the chromosomal 
abnormalities [5, 6]. Because of its rarity after the abortion period, only a few 
prenatally detected cases have been reported [7-10]. 
Some tetraploid cells or colonies are regularly encountered in cultured amniotic 
fIuid cells and regarded as culture artifacts [11, 12]. Furthermore, the prevalenee of 
tetra-ploidy and tetraploid y / di ploid y mosaicism in cultured amniotic fIuid cells has 
been weIl documented [12, 13]. However, a number of collaboralive studies on 
chromosome mosaicism and pseudomosaicism in anmiotic fluid eeUs did not 
mention diagnostic problems involving tetraploidy [14-17]. For chorionic vilIi, such 
experienees or basic data are not available. Therefore, we investigated retrospeclively 
the proportion of tetraploid metaphases in trophoblast cells and cultured cells of the 
mesenchymal core of 100 chorionic villi samples, in order to estabJish the normal 
range for tetraploidy in chorionic villi. The purpose of this study was to provide 
guidelines for the differentiation of true mosaicism from placental confined 
mosaicism and culture artifacts. 
Material and Methods 
The slides of semidirect (short-term culture, STC) and cultured (long-term culture, 
LTC) chorionic villi of 100 pregnant women were screened for diploid and tetraploid 
metaphases. The indication for prenatal investigation was advanced matemal age 
(;;,36 years) in all women. Chorionic villus sampling was performed 
transabdominally. Gestational age ranged from 11.0 to 13.5 weeks. At least 20 mg of 
villi were obtained in all cases. 
STC- and LTC-villi slides were prepared according to standard techniques [18, 19]. 
The LTC slides were harvested in situ after 5-7 days of culturing. STC- and LTC-villi 
slides were investigated after Pancreatin-Trypsin-Giemsa staining. Routine 
cytogenetic investigation involved the karyotyping of 8 cells in STC- as weIl as in 
LTC-villi preparations. For the tetraploid investigation up to 50 metaphases in both 
STC- and LTC-villi slides were screened for tetraploid and diploid metaphases 
without discarding cells displaying low quality chromosomes or potentiaIly 
incomplete metaphases. 
The distributions of tetraploid cell scores in STC and LTC villi were investigated 
with X2 statistics and the Kolmogorov-Smirnov (K-S) test. Further statistics 
comprised caIculations or the use of tables for binomiaI, Gaussian, and Poisson-
distributions. 
The outcome of all pregnancies was ascertained. 
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Results 
Routine cytogenetic investigation revealed normal karyotypes in STC and LTC villi 
in 99 cases. In one instanee, a non-rnosaic trisomy 21 was encountered. The aim of 
scoring 50 metaphases was not a1ways achieved: in STC villi, a mean of 47.5 ceIls 
(range 25-50) and in LTC villi, a mean of 48.1 cells (range 25-50) were investigated. 
The tetraploid cell scores are presented in figure 1. In STC-villi slides, up to three 
tetraploid metaphases were encountered in 27 cases (27%). The scores of tetraploid 
metaphases fitted a Poisson distribution (X'=101.26, df=99; 0.05<p<0.95) with a mean 
cell score of 0.31 and a varianee of 0.317. The 95% (and a1so the 99%) area ranges 
from 0 to 3 ceUs (0- 6%). In LTC-villi slides, all 100 cases (100%) showed tetraploid 
metaphases. The ceU scores in LTC villi fitted a log,caussian distribution (K-S test; 
0.05<p<0.95) with a median ceIl score of 9 cells and a95% area between 2 and 28 cells 
(4-58 %). 
Ninety-six children were bom without congenital maIformations. One child 
displayed bilateral pes equInovarus, and another child a unilateral accessory auride. 
The pregnancy with trisomy 21 was terminated by means of suction curettage. The 
trisomy 21 was confirmed; no tetraploid cells were noted in fetal fibroblasts. In 
another pregnancy, fetal death occurred af ter the chorionic villus sampling. 
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Discussion 
Tetraploidy is known as a rare cytogenetic abnonnality with an associated abnormal 
phenotype (constitutiona! tetraploidy), and as a frequently occurring phenomenon in 
cell culture (artificia! tetraploidy). Moreover, tetraploid cells may be seen in STC villi 
under nonnal conditions representing confined placental mosaicism[20-28J. In our 
study, the tetraploidy cell scores in STC and LTC villi fitted a Poisson and log-
Gaussian distribution, respectively. This remarkable difference in distributions finds 
its orgin in the cell culture. 
Constitutiona! tetraploidy arises in the fust four post-zygotic eell divisions by 
cytokinesis failure, endo-reduplication, or nuclear fusion in binucleated blastomeres 
[2, 3J. Gnce formed, tetraploid cells can undergo correction to normal diploid 
blastomeres again [4J. After the 8-cell stage, embryonic cells are distributed arnong 
the compartrnents of the trophoblast and the inner cell mass (lCM). From the latter 
compartrnent, the future extraembryonic mesoderm, which is investigated in LTC 
viIIi, and the fetus proper wiII arise [29J. Tetraploid cells are almost exclusively 
allocated to the trophoblast compartrnent in the hurnan embryo [2, 30J. in the case of 
constitutiona! tetraploidy in a vita! pregnancy, the lowest level of tetraploidy 
mosaicism in STC and LTC viIIi is theoretically 33.3% assuming that a skewed 
distribution of tetraploid cells towards the lCM compartrnent is not compatible with 
embryo development [31J. Furthennore, we assume that a 50% reduction occurs in 
the number of daughter cells of blastomeres involved in tetraploid formation 
compared to nonna! diploid blastomeres. A cell score of 9 tetraploid cells per 47.5 
investigated cells (19%) in STC viIIi represents the lower limit of the 95% area of a 
33.3% mosaicism and finds itself far outside the 99% nonna! area of 0-3 cells. When a 
cell score of at least 9 cells in STC villi is accompanied by a tetraploidy cell score in 
the LTC viIIi of at least 11 per 48.1 analyzed cells (23%), constitutional tetraploidy in 
the fetus proper has to be excluded or demonstrated. 
Table 1 • Management of the finding of tetraploid (4N) cells in chorionic villi 
Condition 
Observing ~2 4N-cells in search 
for 8 analyzable eeHs in STC-vilJi 
Action 
Screening 50 mctaphases in STC-villi for 4N-ceJls 
2a .:::8 4N-ceUs/50cells in STC-vilJi Routine investigation of 8 analysable eclls in LTC-villi 
2b 
3a 
3b 
~9 4N-cells/50 eeHs in STC-villi 
:<!:9 4N-cellsJ50 eeHs in STC-villi 
s: 10 4N-cells/50 eeHs in LTC-villi 
~9 4N-cellsiSO eells in STC-villi 
~ 11 4N-cellsl50 eells in LTC~villi 
Screening 50 metaphases in LTC-villi for 4N-cells 
Normal cytogenetic results in chorionic viUi 
Amnioeentesis; FISH on uncultured . .o\F~eelis 
AF- amniotic fluid; FISH fluorescent in situ hybridization 
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This minimum LTC-villi cell score of 11 cells is composed of 9 cells (19%) 
representing again the lower 2.5% limit of a theoretica! 33.3% mosaicism of 
constitutiona! tetraploidy and 2 cells (4%) representing the lower 2.5% limit of the 
95% area of artificial tetraploidy. 
With these figures we developed a three-stage protocol for the management of 
tetraploid metaphases in chorionic villi (tabie 1). For follow-up investigation in a 
repeat sample we would advise arnniocentesis with fluorescent in situ hybridization 
on uncultured arnniotic fluid cells; only in this way can the problem of culture-
induced tetraploidy be overcome. 
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Abstract 
We report on the prenatal detection and further genetie studies in a ease of trisomy 
18 eaused by isoehromosome 18p [i(18p)] and 18q [i(18q)] forrnation. The diagnosis 
was made by standard cytogenetie teehniques in arnniotie fluid eeUs and eonfirmed 
by fluoreseence in situ hybridization. The formation of the isoehromosomes eannot 
be explained by a single model; eentromere misdivision and meiosis II 
nondisjunction without recombination or mitotie misdivision are the most likely 
mechanisms of forrnation as indicated by DNA analysis. 
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Introduction 
Several cases of prenatally detected isochromosome 18 have been reported: (mosaic) 
i(18q) [Chen et al., 1998; Froster-Iskenius et al.,1984; Levy-Mozziconacci et al.,1996; 
Qumsiyen et al.,1995; Speed,1986; Sutton and Ridler,1986; Wurster-Hill et al.,1991] 
and (mosaic) i(18p) [Damaude et al.,1996; Göcke et al.,1986; Pinto et al.,1998; Yu et 
al.,1993]. 
Two cases of trisomy-18 syndrome due to double isochromosome formation have 
been reported [Larson et al.,1972; Müller et al.,1972]. To our knowiedge, only one 
prenatally detected case with isochromosomes for both p and q arms [i(18q) + i psu 
dic(18p)] has been published [Romain et al.,1992]. We describe an almost identical 
case: the prenatal detection of a 47,XX,-18, + i(18p) + i(18q) karyotype in amniotic 
fluid cells investigated with conventional cytogenetic techniques, followed by 
fluorescence in situ hybridization (FISH) for the deftnite identification of the 
isochromosomes. 
DNA analyses to determine the mechanism of formation of the isochromosomes 
18p and 18q and the parental origin were carried out. 
Clinical Report 
A 35-year-old pregnant woman (G3, Pl, Abl) was referred for prenatal diagnosis 
because of a positive result of 2nd trimester matemal serum screening for Down 
syndrome and neural tube defects [Beekhuis et al.,1992]. At 15.5 weeks of gestation, 
the matemal serum alpha fetoprotein (MSAFP) and hurnan chorionic gonadotropin 
(MShCG) levels were at 0.88 and 2.10 multiples of the median (MOM), respectively, 
resulting in a risk for fetal Down syndrome of 1:200. The family history of the 
woman and her 35-year-old husband was unremarkable. Amniocentesis was 
performed at 16.5 weeks of gestation. There were no fetal abnormalities noted by 
ultrasound investigation at the time of screening and later at amniocentesis. Alter the 
finding of one normal chromosome 18 accompanied by two isochromosomes [i(18p) 
and i(18q)], likely causing trisomy-18 syndrome, a repeat detailed fetal ultrasound at 
17.5 weeks again showed no abnormalities. The parents opted for termination of 
pregnancy. 
Labour was induced and a stillbom female fetus of 215 g was delivered (mean for 
17.5 weeks is 200 g)[Chambers et al., 1993]. On physical examination, some extemal 
abnormalities were noted like hypoplastic maxilla, micrognathia, and a prominent 
nose giving a bird-like appearance (Fig. 1). The placenta was incomplete and the 
remnants had been removed by curettage; so, no data on placental weight are 
avallable. 
The parents consented to confirmatory studies on a skin biopsy and placental 
biopsy, but not to an autopsy of the fetus. 
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Figure 1 . Frontal view ofthe [etos at 17.5 weeks, showing the prominent oase and the hypoplasia ófthe maxiJIa 
and the micrognathia giving a bird-like appearance 
Genetic Studies 
Amniotic fluid cells were cultured using standard procedures. Chromosomes were 
analyzed by Trypsin-Giemsa banding. The karyotype was 47,X:X,-18, + i(18p) + i(18q) 
in all 16 investigated clones (Fig. 2a). In fetal fibroblasts and chorionic villi (both 
short-term and long-term culture) this karyotype was confirmed in all investigated 
cells. Karyotypes of the parents were normal46,XY and 46,X:X, respectively. 
FISH was performed on unstained slides of cultured amniocytes with a whole 
chromosome 18 paint (WCP 18)(Cambio Ltd., Cambridge, UK), a chromosome 18 
centromeric probe (18cen), U.84 [Devilee et al., 1986J and the telomerie probes 
18pter, 52Mll and 18qter, 2050a6 [National Institutes of Health and Institute of 
Molecular Collaboration, 1996J. Hybridization with WCP 18 was done according to 
the procedure recommended by the manufacturer. A three-color FISH with a 
combination of biotin- and digoxigenin-Iabeled 18cen probe (yellow), biotin-labeled 
18qter probe (red) and digoxigenin-labeled 18pter probe (green) was done according 
to standard protocols. Slides were examined under a Leiea aristoplan fluorescence 
microscope and images were captured by the Genetiscan Power Gene System 
(Perceptive Scientific Instruments Ltd., Chester, u.K.). Hybridization with WCP 18 
resulted in a fluorescent staining of the normal chromosome 18 and both 
isochromosomes (Fig. 2b). Positive hybridization signals were seen with U.84 and 
52Mll and with U.84 and 2050a6, confirming the isochromosomes to be i(18p) and 
i(18q) (Fig.2c), respectively. Additionally to the 16 karyotyped clones, interphase 
nuclei were screened for the signal distribution with U.84 in 17 clones without 
analyzable metaphases; in all clones three spots were counted, proving the presence 
of the abnormal chromosomal constitution in 33 clones. 
DNA was extracted from cultured amniotic fluid cells and blood cells of both 
parents using standard methodology. A total of 21 microsatellite loci were analyzed 
using the polymerase chain reaction (PCR) to determine the mechanism of formation 
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and the parenta! origin of the isochromosomes. peR analysis demonslrated only one 
materna! and one paterna! aIle!e of all investigated markers (Tab!e I). The absence of 
detectab!e recombination precluded the certain establislunent of the parent of origin. 
However, the intensity of bands suggested that the isochromosomes were of 
materna! origin. 
I' i(18pl i{l8q) 
~------.-.. _----- -
Figure 2 ~ Partial karyotype of cultured amniotic fluid cells; (A) Trypsin Giemsa stainillg. FISH signals on 
normal chromosome 18, i(18p) and i(18q) with (B) whole chromosome paint t8 and (C) 18 centromere probe 
Ll.84 (yellow), 18pter probe 52MI! (green), 18qter 2050a6 (red). 
Table I • DNA analysis to detennine the mechanism of formatioo aod the paren tal origiu of the 
isochromosomes i(18p)aod i(18q). Tbe loci are ordered according to their chromosomallocation 
Locus !-ocation Father Mother Fetus 
DI8S59 pl1.32-pter 2,3 1,3 1,3 
D18S476 plU2 1,2 3,3 2,3 
D18S1154 plU2 3,4 1,2 2,4 
DI8S452 plUI 2,3 1,2 2,3 
D18S52 pi 1.22 1,2 1,3 1,3 
D18S1153 pi 1.22 1,2 2,2 t,2 
D18S53 p11.21·p11.22 2,3 1,4 2,4 
DI8S71 pi 1.21 1,2 1,2 1,2 
DI8S40 pi 1.21 3,4 1,2 1,3 
D18S57 q12.2 1,4 2,3 3,4 
D18S1157 q12.3 3,4 1,2 2,4 
DI8S42 q21 1,2 2,3 2,3 
D18S64 q2U2 2,2 1,1 1,2 
DI8S68 q22.1 1,2 3,4 2,4 
D18S483 q22.1 1,1 2,2 1,2 
D18S61 q223 2,2 1,2 2,2 
D18S488 q223 2,4 1,3 3,4 
D18S43 q22·q23 2,3 1,2 1,2 
DI8S1161 q23 2,4 1,3 1.4 
MBP q22-qter 2,3 1,1 1,3 
DI8S70 q23 1,2 3,4 2,3 
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A 
Poslzygotic ccntromere misdivision 
+ 
non-disjunction 
B 
Meiosis II centromere misdivision 
+ 
non-disjunction 
Rccombination 
Meiosis I / Cv 
Meiosis II I \ 
eDeD 
reD @ 
Fertilization 
Postzygotic division ! \ 
GVQE) 
Figure 3 - Schematic representation of possible mechanisms of isochromosome 18p and 18q formation; (A) 
Recombination before Meiosis I followed by postzygotic centromere misdivision and nondisjunction resulting in 
isochromosomes with complete isodisomy; (B) Recombination before Meiosis I followed by centromere 
misdivision and nondisjunction in Meiosis II resulting in isochromosomes with partial heterodisomy. 
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Discussion 
The isochromosomes 18p and 18q in this prenatal case were present in addition to 
one normal chromosome 18 in all cells, resuIting in trisomy 18. Although the 
phenotype may be quite variabie, many typical signs such as growth retardation, 
low-set ears, clenched fists with overlapping fingers, and rocker boltom feet were 
absent in the present case. Mosaicism as explanation was ruled out by the finding of 
trisomy 18 in all 33 present clones. 
The indicatian far prenatal diagnasis was a screen-pasitive result far fetal Dawn 
syndrome because of a rather elevated MShCG level. In genera!, trisomy 18 is 
associated with very low MShCG levels [Aitken et al., 1996; Lambert-Messerlian et 
al., 1998]. The high concentration of MShCG in this case is difficult to explain and 
possibly related to the rare chromosomal composition of the trisomy 18, the unusual 
fetal phenotype and the absence of growth retardation. 
Several mechanisms of isochromosome formation have been poshllated. The two 
mast- common mechanisms are misclivision of the centramere, resulting in mana-
centric produets [Darlington 1939, 1940] and the U-type reunion between sister 
chromatids, resuIting in dicentric or mono-centric produets [de la Chapelle, 1982]. 
Although isochromosomes are defined as cytogenetically identical copies of the same 
chromosome arm, recombination could be expected to result in heterozygosity for 
markers especially in the telomeric region, in case of a meiotic origin [Bugge et al., 
1996; Eggermann et al., 1997; Kotzot et al., 1996]. In our case recombination was not 
detected. Molecular genetic analysis utilizing polymorphic markers which map to 
both the short and the long arm of chromosome 18 failed to demonstrate the 
presence of three distinct alleles in the fetus at any locus analyzed. Although a 
meiosis 11 centromere misdivision followed by anondisjunctional error without 
previous meiosis I recombination cannot be ruled out, the most likely hypothesis 
regarding the formation of these isochromosomes, appears to be a postzygotic 
centromere misdivision followed by a nondisjunctional error (Fig.3) since no 
recombination was observed at any of these loci. 
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Abstract 
We report on a prenatally detected case of discordant non-rnosaic karyotypes 
following chorionic villus sampling. A 45,X karyotype was found in cytotrophoblast 
cells and a 46,XY karyotype in rnesenchyrnal core cells. A subsequent arnniocentesis 
showed a true 45,X/46,XY rnosaicisrn. Confirrnatory studies, including fluorescence 
in situ hybridization (FlSH) in various fetal and placenta! tissues as weil as in the 
original villi preparations changed the presumed condition of genera!ized rnosaicisrn 
with culture confined norma!ity to that of generalized mosaicisrn with absolute 
concordanee. 
This case underscores the importance of the investigation of both short-term and 
cultured villi preparations, the irnplementation of prenatal FISH studies, and the 
need for thorough follow-up investigation in cases of discrepant results. 
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Introduction 
Several reports have been published on cases in which the karyotypes of short-term 
cultured (STC-villi) and long-term cultured villi (LTC-villi) did not correspond to 
each other or to that of the fetus [Ledbetter et al., 1992; Kalousek et al., 1994; Leschot 
et al., 1996; Habnemann and Vejerslev, 1997a, 1997b]. However, the prenatal 
cytogenetic observation of an abnormal karyotype in STC-villi, a normal karyotype 
in LTC-villi, and an abnormal karyotype again in the fetal compartment is extremely 
rare [pittalis et al., 1994; Kennerknecht et al., 1998]. This constitution is known as 
generalized mosaicism with discordant culture (confined culture 
normality)(GMDC)[Pittalis et al., 1994]. Theoretically, GMDC can occur as a result of 
the distribution of normal and abnormal cells among the compartments of the 
trophoblast, extra embryonic mesoderm (EEM) and fetus [Los et al., 1998]. 
We present a case of 45,Xj 46,JCY mosaicism, initially thought to represent an 
example of GMDC. Routine cytogenetic analysis showed a 45,X katyotype in STC-
villi and a 46,XY karyotype in LTC- villi. Subsequent amniocentesis disclosed a 
45,Xj 46,XY mosaicism which was confirmed in various fetal and placental tissues. 
Extensive chromosome and fluorescence in situ hybridization (FISH) investigations 
were carried out not only to gain insight into this cytogenetic inconsistency but also 
to find an explanation for this observation based on the emblyogenic models 
presenting combinations of different karyotypes in the various fetal compartments 
[Crane and Cheung, 1988; Bianchi et al., 1993; Wolstenholme, 1996; Los et al., 1998]. 
Case report 
A 35-year-old woman, gravida 4, para 3, underwent transabdominal chorionic villus 
sampling at 12 weeks of gestation because of maternal arIXiety. Medical and farnily 
histories were unremarkable. 
Cytogenetic analysis of cytotrophoblast cells (STC-villl) and of mesenchymal core 
cells (LTC-villi) were performed according to standard techniques [Gibas et al., 1987; 
Srnidt-Jensen et al., 1989]. 
STC-villi showed a 45,X karyotype in all 31 investigated cells. The kruyotype of LTC-
villi was 46,XY in all 24 investigated eells. An arnniocentesis was offered and 
undertaken at 16 weeks of gestation 10 resolve this discrepancy. Ultrasound 
examination at the time of amniocentesis demonstrated a male fetus without 
structural abnormalities. 
FISH on uncultured arnniocytes was carried out as described [Van Opstal el al., 1993] 
with a combination of a centromere probe for chromosome X (pBarnX5)[Willard et 
al., 1983] and a Y heterochromatine probe (RPN1305X)[Lau, 1985]. FISH on 
uncultured arnniocytes demonstrated a XjXY mosaicism which was subsequently 
confirmed in cultured arnniocytes. The diagnosis of true mosaicism for sex 
chromosomal aneuploidy was made. The woman was counseled that there was a 
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smal! risk of abnormal extemal genitalia but a significant higher risk of abnormal 
intemal genitalia (ovatestes); she requested termination of pregnaney. 
The ineidenee of GMDC is extremely rare [pittalis et al., 1994]. Subsequent FISH 
investigations on STC- and LTC-villi were earried out to gain insight into this 
mosaicism. interphase FISH showed a low X/XY mosaicism in LTC-villi and the 
prenatal diagnosis, therefore, ehanged from the presumed condition of GMDC to 
that of generalized mosaicism with relative concordanee (GMRC). GMRC is 
eharaeterized by a homogeneous abnormal karyotype in at least one of the three 
investigated eompartrnents of STC-villi, LTC-villi and amnioeytes, and a mosaic 
karyotype in the other eompartrnent(s)[Pittalis et al., 1994]. A summary of 
chromosome and FISH results is given in Table l. 
Table I - Summary ofprenatal chromosome and FISH analysis 
Tissue Karyotype [N] 
-_._ .. _ .. __ ._~_.-
STC-villi 45,X[31] 
LTC-villi 46,XY[24] 
Uncultured amniocytes 
Cultured amniocytes 45,X[3]/46,XY[20] 
N=number of metaphases and interphase nuclei 
Percent of X and XY 
signals in metaphases 
N X XY 
31 100 
24 100 
50 100 88 
Table II - Summary of confirmatory chromosome and FISH analysis 
Percent of X and XY 
signals in metaphases 
Tissue Karyotype[N] N X XY 
Skin 45,X[I]/46,l{Y[49] 50 8 92 
Left gonad 45,X[4]/46,XY[46] 50 14 86 
Rightgonad 45,x[2]/46,XY[47] 50 18 82 
Left kidney 45,X[5]/46,XY[45] 50 8 92 
Leftlung 45,X[2]/46,XY[48] 50 8 92 
Cultured amnion 46,XY[50] 50 4 96 
Cultured chorion 46,XY[25] 10 100 
STC-villi 1 
STC-villi 2 
STC-yiJIi 3 
STC-villi 4 
LTC-villî 1 10 100 
LTC-villi 2 50 12 88 
LTC-villi 3 17 100 
LTC-vilH 4 10 100 
Percent of X and XY 
signals in interphases 
N X XY 
200 100 
200 20 80 
200 16 84 
200 23 77 
Percent of X and XY 
signals in interphases 
N X XY 
200 22 78 
190 10 90 
200 25 75 
200 24 76 
200 5' 95 
200 3 97 
200 I 99 
100 97 3 
50 34 76 
100 77 33 
100 17 83 
200 100 
200 10 90 
200 II 89 
200 2 98 
N - number of metaphases and interphase nuclei; a-I ~5% with only X signal is within the normal range. 
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Postmortem examination showed a male felus with retrognathia, a broad nasal 
bridge and a broad philtrurn, but no other abnormalities. Normal male genitalia were 
present without any sign of female differentiation. Biopsies of chorionic villi (four 
sites), arnniotic- and chorionic membranes, and fetal biopsies (skin, lung, kidney, left 
and right gonad) were sarnpled for both cytogenetic and FISH analysis. Table II 
surnrnarizes the confirmatory chromosome and FISH analysis. All fetal biopsies 
showed X/XY mosaicism on both metaphase and interphase level. Amniotic- and 
chorionic membranes showed a XY cellline. FISH on STC-villi showed a surprisingly 
high level of XY signals, whereas the LTC-villi displayed a low level of X signals 
only, in two of the four sites. 50 finally, the presurned condition of GMRC turned to 
that of generalized mosaicism with absolute concordanee (GMAC), mosaic abnormal 
karyotypes in all three investigated compartments [Pittalis et al., 1994]. 
Discussion 
An abnormal cell division in early embryonic development may cause chromosomal 
mosaicism that can result in discrepancies between chorionic villi and the fetus 
proper. 
The present case demonstrated a non-mosaic abnormal karyotype in STC-villi and 
a normal karyotype in LTC-villi that could fit into a confined placental mosaicism 
(CPM) type I in which the abnormal cellline is confined to the cytotrophoblast or 
into a GMDC in which the normal cell line is confined to the compartment of 
cultured villi. The incidence of the latter is probably very low, making CPM type I 
more likely [pittalis et al., 1994]. There are several studies that make mention of the 
restricted reliability of cytogenetic diagnosis of mosaic and even non-mosaic 
monosomy X in CVS [Pittalis et al.,1994; Hahneman and Vejerslev, 1997b; Srnith et 
al., 1999]. A definite prenatal diagnosis should be obtained through subsequent 
amniocentesis. 
However, in the present case, FISH on uncultured arnniotic fluid cells showed a 
X/XY mosaicism that was confirrned by the chromosome analysis of the cultured 
cells. These findings fitted into one of the two models suggested, GMDC, an 
extremely rare finding. FISH provided the opportunity to investigate a larger 
nurnber of cells than using conventional cytogenetic methods. Extensive FISH 
investigations on all biopsies described in Table II as well as on the prenatal STC-
and LTC-villi (Tabie I) showed a (low) mosaicism in all compartments which 
demonstrated the GMDC to be in fact the cytogenetic constitution of GMAC. 
The observation of placental site variation of abnormal cells is not uncornrnon and 
indicates that the findings in STC- and LTC-villi are not always representative for 
the fetus [Miny et al., 1991; Schuring-Blom et al., 1993; Henderson et al., 1996]. 
To understand the cytogenetic discrepancies between STC-villi, LTC-villi and 
arnniocytes, it is necessary to implement the knowledge of e.rly embryonic 
development and the origins of these different tissues [Wolstenholme, 1996]. An 
accurate exarnination of all three compartments i.e. the cytotrophoblast, mesodermal 
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care, and fetus was needed to come to a dearer explanation for the chromosomal 
constitution of the present case (Tabie I and II), 
According to the embryogenie model given by Crane and Cheung [1988] 
explaining cytogenetic discrepancies in different compartments we propase that the 
karyotype of the zygote in this particular case was 46,XY, Ta explain the combination 
of karyotypes and the levels of abnormal ceHs in different tissues we propase two 
theoretical modes of origin, The fust mode comprises one event: anaphase lagging in 
the fust deavage resulting in one 45,X and one 46,XY ceH (Fig, lA), In the second 
mode two independent anaphase laggings are proposed, one in the fust and one in 
the second deavage leading to three 45,X ceHs and one 46,XY ceH (Fig, lB), A1though 
the second mode is more complicated and obviously rare it seems the most likely 
mechanism in view of the rarity of GMDC reports in the literature, We propase most 
of the 45,X ceHs to be aHocated to the cytotrophoblast and most of the 46,XY ceHs to 
the inner ceH mass (lCM) due to a selective disadvantage of 45,X cells predominating 
in the lCM and subsequently in the fetus, 
Tms present case not only demonstrates the need for extensive follow-up 
investigation af ter the finding of non-mosaic discordant results in STC- and LTC-villi 
but also demonstrates the crucial role of FISH analysis to get more insight into 
discrepancies in the various fetal compartments, 
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Figure 1 - Mode of origin explaining cytogenetic inconsistencies. A: Anaphase lagging (AL) in Ist eeU 
cleavage and theoretical distribution of abnormal and normal eells. B: Anaphase lagging in lst and 2nd eell 
cleavage and theoretical distribution of abnonnal and normal cells. lCM = Inner Cell Mass; EEM = Extra 
Embryonic Mesoderm. 
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General discussiotJ and future prospects 
7.1 General discussion 
Prenatal cytogenetic diagnosis is performed on amniotie fluid (AF) eeUs or ehorionie villi 
and oeeasionally on fetal Iymphoeytes obtained by cordoeentesis. The main 
disadvantages of cytogenetic investigation on cultured AF-cells are the advaneed 
gestational age (> 15 weeks) at sampling and the long reporting time of laboratory 
results (2-3 weeks). The procedure related risks of pregnaney loss, intra-uterine fetal 
death, and induction of congenital abnormalities have proven to be low (MRC Working 
Party, 1978; Tabor et al.,1986). 
Af ter the introduction of ehorionie villus sampling in 1983 (Simoni et al., 1983) it was 
believed that this new teehnique with its favourable early, fust-trimester sampling, and 
short reporting time of laboratory results would eventually replaee arruuoeentesis. 
However, due to a supposed higher abortion risk in eomparison to amnioeentesis 
(Rhoads et al., 1989; Sntidt-Jensen et al., 1992), and the ongoing argument of the 
induction ofvascular disruptive syndromes (Froster and Jackson, 1996; Los et al., 1996; 
Firth, 1997) this has not been the case. 
Furthermore, doubt has arisen about the aeeuraey and reliability of eytogenetic 
laboratory results of ehorionie villi (Hahnemann and Vejerslev, 1997a). Hence, 
amnioeentesis andsubsequent cytogenetic investigation of cultured AF-eeUs has 
remained the main mode of prenatal cytogenetic diagnosis, and has beeome the "gold 
standard" (Strane et al., 1997). Beeause of the obvious clinical advantages of first 
trimester diagnosis, a thorough evaluation of the diagnostic performance of cytogenetic 
investigation in chorionic villi Was made in this thesis and compared ta that of AF-cells, 
in order to come to fair and evidence- based reeommendations for the use of 
amnioeentesis and chorionie villus sampling. 
7.1.1 Cytogenetic investigation in STC-villi 
The first aim of the experimental wark comprised in this thesis was to exantine the 
reliability of prenatal diagnosis in chorionic villi with the investigation of STC-villi 
alone. The most important questions to be answered were: 
- What is the predictive value of the cytogenetic result in STC-villi. 
- Can reeommendations be made for the prenatal diagnosis using chorionic villi. 
Predictive value 
The predictive value of abnormal cytogenetic results of STC-villi turned out to depend 
on the indication and the type of chromosome aberration found. 
The best results were achieved in women with the highest cytogenetic risks: matemal 
age ;,40 years, carriership of struclural rearrangements, and fetal abnormalities 
established by ultrasound. 
Apart from normal results, the predietive value was found to be high in case of trisomy 
21, triploidy, expected structural rearrangements and in case of ultrasound-
abnormalities in trisomy 13, 18 and 45,X. Furthermore, it was shown that the predictive 
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value for any category of numerical chromosomal aberration is limited if the aberration 
is mosaÎC. 
The confirmation rate of mosaic cases is dependent on the level of mosaicism; a high 
level of mosaicism has a higher predictive value than a low level of mosaicism. 
Recommendations 
We advise chorionic villus sampling to those women with singleton pregnancies who 
have a cytogenetic risk of at least 3%, especially when only STC-villi preparations are 
investigated. Fmthermore, we advice chorionic villus sampling to those women with 
multiple gestations. 
Cytogenetics onchorionic villi should be carried out onSTC- and LTC-villi preparations 
simultaneously in order to reduce the nurnber of uncertain results requiring follow-up 
investigations.ln various retrospective studies, karyotyping ofSTC- as weil as LTC-villi 
preparations has a!ready been recommended (ACC, 1994; Pittalis eta!., 1994; Halmeman 
and Vejerslev, 1997a). Fmthermore, theanalysis ofLTC-villishouldnotonlyreducethe 
risk of false-positive results and eliminate the theoretical risk of false-negative results 
but also improve the quality of the fetal karyotype. 
7.1.2 Cytogenetic investigation in STC- and LTC-vi/li 
Af ter the recommendation that cytogenetics should be carried out on STC-villi and LTC-
villi simultaneously, the subsequent aim of the work described in this thesis was the 
prospective evaluation of the combined cytogenetic results of STC- and LTC- villi. 
During the evaluation of the combined use of STC- and LTC-villi we focussed on the 
following questlons: 
- Is there an improvement of the chromosome quality in comparison to the analysis of 
STC -villi alone. 
- Are the simultaneous investigation ofSTC- and LTC-villi more representative for the 
fetus proper than the analysis of STC-villi alone. 
- Is the predicted reduction in the rate of follow-up investigations realised. 
- Can practicallaboratory guidelines be put fOlward. 
Quality of chromosome preparations 
The improvement of karyotype quality is eVidently shown in chapter 1, 3 and 5. 
A1though analysing STC-villi alone did not lead to any overlooked chromosomal 
aberration in the past, it is om goal with the analysis both STC- and LTC-villi to 
optimize lhe clu'omosome quality resulting in a quality equal to that of amniotic fluid 
cells and, at the same time, to meet the required 400 band level for prenatal cytogenetic 
diagnosis. 
Reliability of Cljtogenetic results 
Large series and various collaborative studies have shown that the combined use of 
STC- and LTC-villi minimizes diagnostic errors and, therefore, chorionic villi are 
acceptable for early prenatal diagnosis (Breed et al., 1990; Halmeman and Vejerslev, 
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1997a, 1997b; Ledbetter et al., 1992; ACC, 1994; Van den Berg et al., 2000a).lt is known 
that the discrepancies between the chromosomal constitution of the fetus and chorionic 
villi are the consequence of the arising of mosaicism in the early embryo and the 
subsequent distribution ofnormal and abnormal cells among thevarious compartments 
(Wolstenholme et al., 1996; Los et al., 1998). However, the combined use of STC- and 
LTC-villi allows the recognition of all possible cytogenetic combinations in chorionic 
villi and the fetus proper. This results in a higher predictive value of the cytogenetic 
result of STC- and LTC-villi in comparison to the predictive value of STC-villi alone. 
This is demonstrated in the proportion of certain abnormal results which has greatly 
improved from50% with the analysis ofSTC-villi alone to approximately 75% with the 
combined analysis of STC- and LTC-villi. 
Follcrw-up investigatians 
It is to be expected that the combined analysis of both villi compartments results in an 
actual and significant reduction for the need of follow-up investigations in comparison 
with the diagnosis of the STC-villi compartment alone. Follow-up investigations were 
required among 2.1 % of the women investigated in chapter 2, which corresponds to 
another study (Leschot et al., 1996). After the introduction of the routine analysis ofboth 
STC- and LTC-villi and the implementation of all guidelines for the handling of 
illlcertain results, follow-up investigation requiring a second invasive procedure 
declined significantly by more than one-third from 2.1 % (1993-1996) to 1.6 % (1997-1999), 
and finally to 1.2% in 2000. 
practicallaharatary guidelines 
In cases with normal karyotypes, 16 cells are analysed routinely, where in all other cases 
a work-up protocol is needed. In view of the literature and our own results, work-up 
protocols were and still are developed in our laboratory for all kind of situations of 
analysing STC-villi alone or both villi compartments. The work-up protocols, 
demonstrated in chapter 1, turned out to be very useful and efficient for the 
differentiation between generalized mosaicism and CPM. 
7.1.3 Prenatal diagnasis in multiple gestatians 
A further aim was the evaluation of a particular group of patients; the women with 
multiple gestations which present particular problems in counselling, sampling and 
management. 
The study question was: 
- What recornmendations could be made in this group of patients? 
Recommendatians tcrwards multiple gestatians 
Compared with am.niocentesis there is a somewhat higher risk of uncertain results and 
a greater risk of mixed sampling leading to cross-contarnination in chorionic villus 
sampling. However, the sirnuItaneous cytogenetic investigation of both STC- and LTC-
villi will reduce the chance of uncertain results. The identification of potential cross-
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contamination in cases of biochemical andj or DNA indications by multiple marker 
DNA analysis will eliminate the chance of misdiagnosis. 
Together with the benefit of an earlier and safer selective reduction we consider 
chorionic villus sampling the method of choke for prenatal diagnosis in multiple 
gestations. This view was shared during the 10th International Conference on Prenatal 
Diagnosis and Therapy (Barcelona, Spain, June 2000) where Wapner stated that 
chorionic villus sampling is the mode of sampling of first choke in !win pregnancies. 
7.1.4 Recurrent andjor specific problems in prenatal cytogenetics 
In prenatal cytogenetic diagnosis recurrent andj or specific cytogenetic problems occur. 
In chapter 6 of this thesis some of these problems are described and suggestions about 
solutions are made. 
Tetraploidy mosaicism in chorionic villi 
A frequent recurrent phenomenon in cytogenetic diagnosis is the presence of a 
tetraploidy mosaicism. We developed a work-up protocol for the management of 
tetraploid ceUs in chorionic villi based on theoretical experiments and distributions of 
tetraploid and diploid ceUs in the various compartrnents. This protocol turned out to be 
a very good tooi for handlingthis phenomenon and alsoresulted in a decrease of foUow-
up investigations from 0.7% to almost 0% (Noomen et al., 2001). 
Non-mosaic discordance between STC-villi and LTC-villi 
TheoreticaIly, non-mosaic abnormaI STC-villi with normaI LTC-villi canresultin a CPM 
type I or a GMDC (tabie 5, chapter 1). GMDC has not yet been reported with certainty 
in severallarge studies in contrast to CPM type I (Hahneman and Vejerslev 1997b; 
Pittalis et aI. 1994; ACC 1994; Van den Berg et.al., 2000b; Ledbetter et aI. 1992). A 
presumed case of GMDC concerning a 45,Xj 46,XY mosaicism turned out to be a case 
of GMAC thanks to foUow-up and confirmatory investigations. We condude that in 
cases of sex-chromosomal discordancies foUow-up investigations are indicated because 
the experiences with those cases are limited (Smith et al., 1999, Van den Berg et al., 
2000a). In aU other cases (autosomaI aneuploidies) one may consider foUow-up 
investigations in case of a "XX" karyotype to rule out maternal ceU contaminationin the 
LTC-villi. 
Trisomy 9 
Aspecific problem in prenatal diagnosis is the presence of a trisomy 9 (mosaicism) in 
chorionic villi and AF-ceUs, since insome cases the abnormality could not be confirmed. 
The latter poses a serious problem for genetic counseUing. Subsequent cytogenetic 
investigations in other compartments are essentiaI for a correct prediction of the 
chromosomaI slale of the fetus. FISH turned out 10 be a rapid and accurate method for 
verification of trisomic ceU lines and may provide additional information for the 
prenatal cytogenetic results. Comparison of the level of mosaicism in uncultured and 
cultured AF-ceUs demonstrated the rapid disappearance of the abnormal ceU-line by 
overgrowth of the normal ceUs in ceU culture. 
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Isochromosome 18p and 18q formation 
Although, the diagnosis of trisomy 18 caused by isochromosomes 18p and 18q poses no 
problem for genetic counselling, DNA analysis was carried out to determine the 
mechanism of formation of the isochromosomes and the parental origin. Gaining more 
insight in the mechanism of formation of the isochromosomes has helped in similar 
cases, especially when the isochromosornes were present in combination with a normal 
cellline. 
7.1.5 Chorionic villus sampling or amniocenlesis? 
Our finaJ aim was to investigate whether a difference in the diagnostic performance of 
cytogenetic investigation in chorionic villi and AF-celJs in favour of the last justifies the 
fact that chorionic villus sampling has not reached the popularity of amruocentesis. 
These diagnostic performances have been the subject of chapter 5. The data are 
summarised in Table 1. Additionally, data on the reporling time of laboratory results, 
the potential signalJing of uniparental disomy (UPD), and on some sampling related 
factors are presented in Table 1 as weIl. 
Together these data reflect the total performance in the years 1993-1999, and give the 
possibility to weigh the pros and cons of chorionic villus sampling and amruocentesis. 
Table 1- Tbe total performance (1993-1999): Cborionic Villi versus Amniotic Fluid 
STC-villi only STC- and LTC-villi 
Factor/Condition 1993 -1996 1997 -1999 
False positive (discrepant) 2/3499 0/1829 
False negative 0/3499 0/1829 
success rate 99.5% 
Chromosome quality 364 ± 32.6 
mean±SD) 
Follow-up sampling rate 
5.6 ±2.8 
Potential UPD signalling + 
Desirability in multiple gestations + 
26/26602 
1; p< 
exc1udedi amniocentesis or chorionic viUus sampling in Dijkzigt 
fromH. Brandenburg and F.J. Los). 
Amniotic Fluid 
1993 - 1999 
0/11.753 
2/11.753 
99.6% 
37J± 38.1 
Statistics 
NS 
NS 
NS 
P = 0.001 
0.001 
".,----
NS 
The shaded squares indicate the level of performance where wrute to dark grey represents good to poorer 
performance. 
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lt has been shown in chapter 5 that the follow-up sampling rate depends on the 
representativity of the cytogenetic results in the prenatal sample for the actual karyotype 
of the fetus. Mosaicisrns apear to play a major part in this rate and again in relation to 
the distribution of normal and abnormal cells among the different compartments 
(chapter 1). Inchorionic villi the follow-up samplingrate can be reduced to a minimum 
when both villi compartments (STC + LTC-villi) are investigated. Since both villi 
compartments were investigated in our laboratory, the follow-up sampling rate 
declined to 1.2% in 2000. 
Regarding the question 'why did chorionic villus sampling did notreach the popularity 
of amniocentesis', it is obvious that there are !wo sides regarding this question: 
- From a laboratory point of view it has become c1ear that most diagnostic pitfalls 
encountered in chorionic villus sampling can now be avoided in the light of the 
knowledge and expertise in our department. 
- The other side is that the parents decide whether they request first- or second 
trimester prenatal diagnosis. The parents are informed about the options of 
prenatal diagnosis and about the advantages and disadvantages of the different 
techniques. 
In our opinion, arnniocentesis is to be preferred over chorionic villus sampling at low 
(cytogenetic) risks « 3%) but chorionic villus sampling should be the firstchoice at high 
(cytogenetic) risks (;, 3%). 
186 
Gelleral discussioll aud tuture prospeets 
7.2 Future prospects 
lt is known that procedure related risks have a great impact not only on the decision to 
choose between chorionlc villi and arnniocentesis but also on the decision whether to 
choose prenatal diagnosis or not. In the last two decades different lines of research have 
been followed to find a screenlng test to identify wamen with an increased risk or even 
to find an alternative test for invasive prenatal diagnosis. 
The fust test which could identify wamen at an increased risk for neural tube defects 
and Down syndrome was the so-called triple test (Wald et al., 1988). lt concerns the 
measurements of AFP ,hCG and unconjugated oestriol in matemal serum in the second 
trimester of pregnancy. Important disadvantages are a detection rate of only 70% and 
external factors which influence the levels of the markers tested (Chuckle et al., 1990; 
Wald et al., 1992; Dar et al., 1995; Neveux et al., 1996), the high percentages of false-
positives and the relatively late and narrow period of gestation during which the tests 
must be performed. The definite diagnasis must be made by arnniocentesis. As aresuit, 
many women become worried unnecessary and in case of an abnormal fetus, 
termination of pregnancy cannot be offered befare 18-19 weeks of gestation. In The 
Netherlands, for a long period the negative aspects prevailed but, recently, the Health 
Council of The Netherlands advised the govemment to implement the triple test on a 
national scale. 
Due to improvements of ultrasound resolution, measurement of the nuchal translucency 
(NT) thickness between 10-14 weeks of gestation is shown to be a useful marker for fetal 
aneuploidy. Severalreports have demonstrated a link between increased thickness of NT 
and chromosomal abnormalities, struclural and cardiac defects and other syndromes 
(Brambati et al., 1995; Pandya et al., 1995; Snijders et al., 1998). For women who are 
initially afraid of invasive prenatal diagnosis because of the procedure related risks, this 
could be a more attractive alternative than triple test screenlng in the second trimester. 
lt is noteworthy, that the combination of measurements of serum markers (free p hCG, 
P APP A) in the fust trimester of pregnancy and ultrasound NT thickness may lead to a 
better risk eslimation than the measurement of NT thickness alone (Nobie et al., 1995; de 
Graaf, 1999). However, the limitations of screenlng tests, false-positive and maybe more 
important, false-negative results should be explained to the wamen involved. However, 
there is a fair risk that this complex information wil! not be weil understood. The same 
is true for the triple test, so the expectations of pregnant wamen embarking on screenlng 
may be quite different from reality. Again, the definitive diagnosis must be made by an 
invasive test. Only, with one major advantage that this can be made by chorionic vil!us 
sampling. 
For severa! decades, fetal cells isolated from matemal blood seemed to be a promising 
alternative to non-invasive prenata! diagnosis. This approach avoids the risks associated 
with invasive techniques and might provide a definitive diagnasis instead of a risk 
eslimation. Various attempts of isolating fetal nucleated cells from matemal blood 
samples have been carried out but is restricted by the low frequency of these cells in 
materna! blood, requiring extensive enrichment and purification procedures (Lo et al., 
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1989; Bianchi et al., 1990; Jansen, 2000). For an overview of isolation approaches to 
recover fetal cells from the maternal circulation and for an overview of cell markers used 
for the enrichment of fetal nucleated blood cells and depletion of maternal cells, see 
Jansen, 2000. However, after many years of investment, this non-invasive diagnostic 
method has not developed into a routine method for prenatal diagnosis. 
Maybe more promising is the discovery of the existence of fetal DNA in maternal plasma 
by Lo et al. in 1997. Fetal DNA has been identified in the plasma of pregnant women at 
concentrations higher than in the cellular fraction, which may have new implications for 
non-invasive prenatal diagnosis (Lo et al., 1997; Poon et al., 2000). Furthermore, the 
detection of fetal DNA in maternal plasma does notrequire prior enrichment of fetal cells 
and is much simpier than detecting the few nucleated cells in maternal blood. This new 
approach has a!ready been used for the prenatal diagnosis of fetal Rhesus D status and 
fetal gender by PCR (Lo et al., 1998; Zongh et al., 2000). lt has also been shown that the 
amount of fetal DNA is elevated in pregnancies with aneuploidies and that the prenatal 
detection of trisomy 21 can be accomplished by FISH analysis (Lo et al., 1999; Poon et al., 
2000; Van Wijk et al., 2000). At this moment, all reports seems to illustrate the potential 
applicability of matemal plasma DNA analysis for the prenatal diagnosis of a wide 
variety of disorders. Although the present results are promising, further investigations 
and large-scale Irials are needed to assess the diagnostic accuracy of this new approach. 
In the meantime, we must be aware of the fact that these new approaches will probably 
never replace the invasive tests completely. Therefore, we must continue with the 
refinement anel development of existing additional techniques, such as FISH, 
comparative genOInic hybridization (CGH) and spectral karyotyping (SKY), and possibly 
the use of DNA microarrays in the future. 
The advent of human telomere probes is a good example of such development (Flint et 
al., 1995; Knight et al., 2000). However, refinement of the FISH protocols are still 
necessary to achieve a higher hybridization efficiency needed for prenatal diagnostic 
applications at metaphase as weil as interphase level. Another molecular cytogenetic 
technique for the identification of chromosomal aberration is SKY -FISH, a technique 
widely used in tumor cytogenetics (Veldman et al., 1997; Nordgren et al., 2001), also 
available for chromosomal aberrations of unknown origin in prenatal cytogenetics. 
Sirnilarly, high resolution CGH is a valuable technique for the detection of chromosomal 
unbalances and has been broadly applied in a variety of malignancies (Pinkel et al., 1998; 
Kirchhoff et al., 2000). However, at the present time, CGH still has some pitfalls and 
technical difficulties which makes the technique not suitable yet for prenatal diagnosis. 
The sensitivity of CGH in detecting gains and losses of DNA sequences is approximately 
3-5 Mb. For the detection of events involving regions less than 3 Mb locus by locus 
techniques are required, called DNA microarray, allowing detection of aberrations atthe 
genomic levelless than 100kb (MacBeath et al., 2000; Shoemaker et al., 2001). However, 
this technique is still in a developmental stage. 
Fortunatly, it has been shown that prenatal diagnosis can be performed with a high 
quality and reliability. 
188 
Geueral discussio1l and future prospeets 
7.3 References 
Associationof Clinical Cytogeneticists (ACqWorking Party on Chorionic Villi in prenatal diagnosis.1994. 
Cytogenetic analysis of chorionic villi for Prenatal Diagnosis: an ACC collaborative study of U.K. data. 
Prenat Diagn 14: 363-379 
Bianchi OW, Flint AF, Pizzimenti 11F, KnoU JH, Latt SA. 1990. Isolation of fetal DNA from nucleated 
erythrocytes in maternal blood. Proe Natl Acad Sd U S A 87: 3279-3283. 
Brambati B,Cislaghi C, Tului 1, Alberti E, Amidani M, Colombo U, Zuliani G.1995.First-1rimesterDown's 
syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic 
villus sampling. Wtrasound Obstet GynecoI 5: 9-14. 
Breed AS, Mantingh A Beekhuis JR, Kloosterman MD, ten Bolscher H, Anders CI. 1990. ll1e predictive 
value of cytogenetic diagnosis af ter CVS: 1500 cases. Prenat Diagn 10: 101-110. 
Cuckle HS, Alberman E, Wald NJ, Royston P, Knight C. 1990. MaternaI smoking habits and Down's 
syndrome. Prenat Diagn 10: 561-567. 
Dar H, Merksamer R, Berdichevsky D, David M. 1996. Maternal serum markers levels in consecutive 
pregnancies: a possible genetic predisposition to abnormallevels. Am J Med Genet 61: 154-157. 
Firth H. 1997. Chorion villus sampling and limb deficiency-cause or coincidence? Prellat Diagn17: 1313-
1330. 
Flint], Wilkie AO, Buckle VJ, Winter RM, Holland A], McDermid HE. 1995. The detectionof subtelomeric 
chromosomal rearrangements in idiopatruc mental retardation. Nat Genet 9: 132-140. 
Froster UG, ]ackson L. 1996. Limb defects and chorionic villus sampling: results trom an international 
registry, 1992-94. Lallcet 347: 489-494. 
Graaf de IM, Pajkrt E, Bilardo CM, Leschot NJ, Cuckle HS, van LithJMM.1999. Early pregnancy screening 
for fetal aneuploidy with serum markers and nuchal translucency. Prenat Diagn 19: 458-462. 
Hahnemann JM, Vejerslev LO. 1997a. Accuracy of cytogenetic findings on chorionic villus sampling 
(CVS)-diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing 
to EUCROMIC 1986-1992. Prenat DiagIl 17: 801-820. 
Hahnemann JM, Vejerslev W. 1997b. European collaborative research on mosaicism in CVS 
(EUCROMIq-fetal and extrafetal celIlineages in 192 gestations with CVS mosaicism involving single 
autosomal trisomy. Am J Med Genet 70: 179-187. 
Health Council of the Netherlands. Prenatal Screening: Down's syndrome, neural tube defects, routine-
ultrasonography. The Hague: Health COlUlcil of the Netherlands, 2001; publication no. 2001/11 
Jansen M. 2000. Isolation of fetal celIs from matemal blood. Thesis, Erasmus University, Rotterdam, The 
Netherlands. 
Kirchhoff, M, Rose H , Maahr J, Gerdes T, Bugge M, Tonunerup N, Tümer Z, Lespinasse J, Jensen PKA, 
Wirth J, Lundsteen C. 2000. High resolution comparative genomic hybridisation analysis reveals 
imbalances in dyschromosomal patients with normal or apparently balanced conventional karyotypes. 
Eur J Hum Gellet 8: 661-668. 
189 
Chapter 7 
Knight 5 J, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S, Regan R, Brenan M, Nicod A, Lawrie NM, Cardy 
DLN, Nguyen H, Hudson TJ, Rietlunan He, Ledbetter DH, Flint J. 2000. An optimized set of human 
telornere danes for studying telomere integrity and architecture. Am J Hum Genet 67: 320-332. 
MacBeath G and Schreiber Slo 2000. Printing proteins as microarrays for high-throughput function 
determination. Science 289(5485): 1760-1763. 
Ledbetter DH, Zachary JM, Sirnpson JL, Golbus MS, Pergament EI Jackson L, Mahoney MJ, Desnick RI, 
SchulmanJ, Copeland KL, al. e.1992. Cytogenetic results from the U,S. Colla borative Shldy on CVS. Prenat 
Diagn 12: 317-345, 
Leschot NI, Schuring-Blom GH, Van Prooijen-Knegt AC, Verjaal M, Hansson KI WolfH, Kanhai HH, Van 
Vugt JM, Christiaens Cc. 1996. The outcome of pregnancies with confined placental cluomosome 
mosaicism in cytob'ophoblast cells. Prenat Diag1l16: 705-712. 
La YM, Patel p, Wainscoat JS, Sampietro M, Gillmer MD, Fleming KA. 1989. Prenatal sex determination 
by DNA amplification from matemal peripheral blood. Lancet 2: 1363-1365. 
Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, WainscoatJS. 1997. Presence of 
fetal DNA in maternal plasma and serum. Lancet 350: 485--487. 
Lo YMD, Hjelm N11, Path FRC, Fidler Cl Sargent IC Murphy MF, Chamberlain PF, Poon PMK, Redman 
CWG, WainscoatJS.1998. Prenatal diagnosis of fetal Rhd status by molecular analysis of matemal plasma. 
N Eng) Med 339: 24: 1734-1738, 
Lo YMD, Lau TK, Zhang), Leung TN, Chang AMZ, Hjelm NM, Elmers RS, Bianehi OW, 1999, Inereased 
feta! DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Cli1l Chem 
45: 1747-1751. 
LosFJ, NoomenP, Vermeij-Keers C,GaillardJL, Brandenburg H,Jahoda MG, Luider TM. 1996. Chorionic 
villus sampling and matemo-fetal transfusions: an lllliDWlOlogical pathogenesis of vascular disruptive 
syndromes? Prenat Diagn 16: 193-198. 
Los FJ, van Opstal 0, van den Berg C, Braat AP, VerhoefS, Wesby-vanSwaay E, van den Ouweland AM, 
Halley DJ . 199B. Uniparental disomy with and without confined placenta! mosaicism: a model for trisomic 
zygote rescue. Prenat Diagn 18: 659-668. 
Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. 1996. Refinements inmanaging matemal 
weight adjustment for interpreting prenatal screening results. Prenat Diagn 16: 1115-1119. 
Noble PL, Abraha HO, Snijders RJM, Sherwood R, Nicolaides KH.1995. Screening for fetal trisomy 21 in 
the fust trimester of pregnancy: matema! serumfree P-hCG and nuchal translucency thickness. Wtr Obstet 
Gyneeol6: 390-395, 
Nordgren A, Famebo F, Johansson B, Forestier E, Larsson C, Soderhall S, Nordenskjold M, BleIUlow E. 
2001. Identification of numerical and struchual chromosome aberrations in 15 high hyperdiploid 
childhood acute lymphoblastic leukemias using spectral karyotyping. Eur J Haematol66: 297-304. 
Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. 1995. Screening for fetal 
trisomies by matemal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation Isee 
comrnents]. Br J Obstet Gynaecol102: 957-962. 
Pinkel 0, Segraves R, Sudar 0, Clark S, Poole I, Kowbel 0, Collins C, Kuo W-L, Chen C, 2hai Y, Dairkee 
SH, Ljung B, Gray JW, Albertson DG. 199B. High resolution analysis of DNA copy numbervariation using 
comparative genomic hybridization to microarrays. Nat Genet 20(2): 207-211. 
190 
Gelleral discussio1t and fllhlre prospeets 
Pittalis MC, Dalpra L, Torricelli F, Rizzo N, Nocera G, Cariati E, Santarini L, Tibiletti MG, Agosti S, 
Bovicelli L, et al. 1994. The predictive value of cytogenetic diagnosis af ter CVS based on 4860 cases with 
both direct and culture methods. Prtmat Diagn 14: 267-278. 
Poon LLM, LeungTN, Lau TK, Lo YMD. 2000. Prenatal detectionoffetal Down'ssyndromefrommatemal 
plasma. Lancet 356: 1819-1820. 
Rhoads GG, Jackson LG, Schlesselman SE, de la Cruz FF, Desnick RJ, Golbus MS, Ledbetter DH, Lubs HA, 
Mahoney MJ, pergament E. 1989. The safety and efficacy of chorionic villus sampling for early prenatal 
diagnosis of cytogenetic abnormalities. N Ellg1 J Med 320: 609-617. 
Shoemaker DD,Schadt EE, Annour CD, et al. 2001. Experimental annotation of the hllman genome using 
microarray teclmology. Nature 409: 922-927. 
Smidt-Jensen S, Permin M, Philip J, Lundsteen C, Zachary JM, Fowler SE, Gruning K. 1992. Randomised 
comparison of amniocentesis and transabdominal and transcervical chorionic vilIus sampling [see 
conunents].LAncet 340: 1237-1244. 
Smith K, Lowther G, Maher E, Hourihan T, Wilkinson T, Wolstenholme J. 1999. The predictive value of 
findings of the common aneuploidies, trisomies 13, 18 and 21, and numerical sex chromosome 
abnormalities at CVS: experience from the ACC U.K. Collaborative Study. Association of Clinical 
Cytogeneticists Prenatal Diagnosis Working Party. Prenat Diagn 19: 817-826. 
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of 
risk of trisomy 21 by matemal age and fetal nuchal-translucency thickness at 10-14 weeks of gestatiorL 
Fetal Medicine Foundation First Trimester Screening Group [see comments]. Lancet 352: 343-346. 
Stranc Le, Evans JA, Hamerton JL. 1997. Chorionic villus sampling and arrmioCt~ntesis for prenatal 
diagnosis. Lancet 349: 7l1-714. 
Tabor A, Philip Jr Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. 1986. Randomised controlled trial 
of genetic amniocentesîs in 4606 low-risk women. Lancet 1: 1287-1293. 
Van den Berg C, Van Opstal D, Brandenburg H, LosFJ. 2000a. A case of45,X/ 46,XY mosaicism with non-
rnosaic discordance betweenshort-term villi (45,X) andcultured villi (46,XY). Am J Med Gellet93: 230-233. 
Van den Berg C, Van Opstal D, Brandenburg H, Wildschut HIJ, den Hollander NS, Pijpers L, Galjaaard 
RJH, Los FJ. 2000b. Accuracy of abnonnal karyotypes af ter the analysis of both short- and long-term 
culture of chorionic villi. Prenat Diagn 2000; 20: 956-69. 
Van Wijk IJ, de Hoon AC, Jurhawan R, Tjoa ML, Griffioen S, Mulders MAM, van Vught JMG, Oudejans 
CBM. 2000. Clin Ozem 46: 729-731. 
Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. 1997. Hidden chromosome abnoffilalities in 
haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15: 406-410. 
Wald N}, Cuckle HS, Densem JW, Kennard A, Smith D. 1992. Matemal serum screening for Down's 
syndrome: the effect of routine ultrasound scan deterrnination of gestational age <lnd adjustrnent for 
maternal weight. Br J Obstet Gynaecol99: 144-149. 
Wald NJ, Cuckle HS, Densem, Nachahal K, Royston P, Chard T, Haddow, Knight GI, PaJomaki GE, 
CanickJA.1988. Matemal serum screening for Down's syndrome inearly pregnancy. Br Med Joumal297: 
883-887. 
Wolstenholme J. 1996. Confined placental rnosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, 
likely origins, and mechanisms for celllineage compartrnentalization. Prenat Diagn 16: 511-524. 
191 

Sum.mary 
Samenvatting 
Curriculum Vitae 
List of pubHcations 
Dankwoord 

Summary 
Summary 
This thesis presents investigations on the quality and reJiability of prenatal 
cytogenetic diagnosis in amniotic fluid cells and chorionic villi. Amniocentesis and 
chorionic villus sampling are the two routinely used techniques for the sampling of 
fetal material for prenatal laboratory investigations. These investigations include 
DNA analysis, biochemical studies, and cytogenetics (karyotyping and fluorescence 
in situ hybridization). 
In chapter 1, a short overall picture is given on the history of prenatal diagnosis. 
Possible explanations and answers are given on raised questions why fust-trimester 
chorionic villus sampling has not reached the popularity of second-trimester 
amniocentesis for cytogenetic investigation. The attention is focussed on laboratory 
related problems; 1) chromosome quality; 2) laboratory failures and 3) discrepancies 
in karyotypes between prenatal samples and fetus. The latter and most serious one is 
discussed in detail. Attention is given to the arising of mosaicism in the early embryo 
and the subsequent distribution of abnormal and normal cells among the various 
embryonic compartments. Work-up protocols for the differentiation between 
pseudomosaicism and mosaicism in AF-cells and for the differentiation between 
generalized mosaicism and confined placental mosaicism in chorionic villi are given 
in this chapter. 
In chapter 2, the results of abnormal karyotypes in semi-direct (short-term culture; 
STC) villi are presented. Among 3499 cytogenetically investigated STC-villi, during 
the years 1993-1996, 219 abnormal karyotypes were encountered. These abnormal 
karyotypes were devided into two groups; certainly abnormal (n=110) and 
uncertainly abnorrnal (n=109). The latter required further investigation. The certainty 
rates and predictive values of abnormal cytogenetic results of STC-villi (certainly 
abnormal) among the various indications showed that the cytogenetic performance is 
only acceptable when the cytogenetic risk is substantially increased (<:3%). This was 
the case in women with a maternal age of 40 years or more, carriers of structural 
rearrangements and women displaying fetal abnormalities on ultrasound. Because of 
the high rate of prenatal follow-up investigations after the finding of uncertain 
results in STC-villi, recommendations towards the simultaneous analysis of STC-villi 
and cultured (long-term culture; LTC) villi were made. Furthermore, chorionic villus 
sampling for cytogenetic investigation was only advised to women with singleton 
pregnancies having cytogenetic risks equal to or exceeding that of a 40 year old 
pregnant woman, and to women with multiple pregnancies at any risk. 
In chapter 3, cytogenetic results are reported in detail of 1838 consecutive chorionic 
villus samples, during the years 1997-1999. We investigated whether the 
recommendations made towards the desirability of the analysis of both STC- and 
LTC-villi really resulted in; 1) improvement of chromosome quaJity by the 
investigation of LTC-villi; 2) a decrease in the rate of uncertain cytogenetic results 
with a concomitant decrease in the rate of follow-up investigations. The routine 
analysis of 16 cells was maintained but was devided among STC- and LTC-villi and 
weil adjusted in various circumstances. Cytogenetic investigations in both villi 
compartments could be made in almost 85%. In just over 15% of the cases, LTC-villi 
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(91.4%) and abnormal karyotypes were seen in 158 (8.6%) cases divided into 6 
categories. Finally only 34 of these cases (21.5%) turned out to be uncertain. 
The improvement of karyotype quality was evidently shown in this chapter. The 
investigation of both villi compartments showed a high degree oflaboratory success and 
reduced follow-up amruocenteses with one-third in comparison with the analysis of 
STC-villi alone. We believe and condude that the desired level of quality and accuracy 
of prenatal cytogenetics in chorionic villi can only be achieved when both STC- and 
LTC-villi are available. 
In chapter 4, amniocentesis and chorionic villus sampling are compared in multiple 
pregnancies. The laboratory aspects and the consequences of discordant laboratory 
findings are evaluated in 500 women with multiple gestations (482 twins and 18 
triplets). For this study the patients were divided into four groups; twin pregnancies 
with 2 chorionic villus samples; twin pregnancies with two amniocenteses; twin 
pregnancies with only one sample or two different samples and the last group 
comprised the triplet pregnancies. One uncertainly concordant result and six uncertainly 
discordant results were achieved in seven pregnancies after chorionic villus sampling, 
and one uncertainly concordant result after amniocentesis. Follow-up investigations 
were needed in these cases to come to certain results. Finally normal results were seen 
in 442 pregnancies (88.4 %) and abnormal results in 58 pregnancies (11.6%). 
Comparing amruocentesis and chorionic villus sampling in multiple gestations allowed 
the following conclusions; 1) there is a greater risk of uncertain results in chorionic villus 
sampling, which can be minirnized by the simultaneous investigation ofSTC- and LTC-
villi; 2) there is a substantial risk of cross contarnination in chorionic villus sampling 
which can cause problems especially in prenatal biochemical investigations; 3) there is 
a better performance of selective reduction after chorionic villus sampling than after 
arrmiocentesis. 
In chapter 5, the cliagnostic performances of cytogenetic investigation in AF cells and 
chorionic villi are compared in order to answer the question when to chose or 
recommend amniocentesis or chorionic villus sampling. Over a period of seven years 
(1993-1999) 11.883 AF samples and 5328 chorionic villus samples were investigated in 
our departrnent. Laboratory failure rate (proportion of appropriate samples without 
results), karyotype quality (G-band score, rate of follow-up samples, rate of wrong 
diagnoses) and karyotype representativity (rate of follow-up samples, rate of wrong 
diagnoses) were measured. The results of this study pointed out that the laboratory 
failure rate was the same after amniocentesis (0.40%) and chorionic villus sampling 
(0.50%). The G-band scores were equal in AF-cells and LTC-villi but significantly lower 
in STC-villi. The rates of follow-up sampling because of quality reasons were the same. 
Those because of representativity reasons differed significantly in the rank order AF-
cells (0.10%), (STC + LTC-) villi (1.31 %) and STC-villi (1.99%). 
This difference has a biological background; a mosaicism in the blastomeres of the early 
embryo, may lead to unequal distributions among the embryonic compartrnents of 
trophoblast, extra-embryonic mesoderm, and fetus proper. AF-cells are derived from the 
compartment of interest, but chorionic villi, STC- as weil as LTC-villi are derived from 
other compartrnents than the compartrnent of interest. However, the ratios of allfollow-
up samples and uncertain or abnormal results in STC-, and (STC+LTC-) villi at 
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cytogenetic risks ;,; 3 % were equa! to that of AF-cells at risks < 3 %. 
This indicates that, from a laboratory point of view, amniocentesis is to be preferred 
over chorionic villus sampling at low cytogenetic risks «3%), especially when onlySTC-
villi are investigated. At cytogenetic risks ;,;3%, chorionic villus sampling is to be 
preferred. 
In chapter 6, several recurrent andj or specific problems are presented. 
In chapter 6.1, a cytogenetic survey and follow-up studies are presented of eight trisomy 
9 cases (full, mosaic, pseudomosaic and CPM). Essential steps for the differentiation 
between pseudomosaicism and true mosaicism or CPM and generalized mosaicism are 
shown. FISH demonstrated that a large number of interphase nuclei ean be screened 
quickly for the presence of a trisornic cell line in a subsequent tissue sample. 
Recommendations for the management in cases with trisomy 9 are made. 
In chapter 6.2, the prevalenee and distribution of tetraploid metaphases in chorionic villi 
are eva!uated. A protocol for the management of tetraploid metaphases in chorionic villi 
was developed which resulted in a strongly reduced number of prenatal follow-up 
investigations. 
In chapter 6.3, a case of trisomy 18 caused by isochromosome 18p and 18q formation is 
presented. The diagnosis was made by standard cytogenetic techniques in AF cells and 
confirmed by FISH. The most likely hypothesis regarding the formation of these 
isochromosomesl appeared to be a postzygotic centromere misdivision followed hy a 
non-disjunctiona! error since no recombination was observed at any of the investigated 
loci. 
In chapter 6.4, a case of 45,Xj46)CY mosaicism is documented. A 45,X karyotype was 
found in STC-villi and a 46)CY karyotype in LTC-villi, with a 45,Xj46,XY karyotype in 
subsequent AF-cells. Extensive follow-up investigations were carried outto gaininsight 
into this cytogenetic inconsistency. This resulted in two theoretical modes of origin 
based on the embryonic models presenting combinations of different karyotypes in 
varlous feta! compartrnents. 
In chapter 7, the conclusions and implications of the studies in the previous chapters are 
discussed in genera!. Our results form a detailed documentation of the accuracy and 
reliability of cytogenetic investigation in STC-, (STC + LTC-) villi and AF-cells. Fina!ly, 
this well-ordered total performance showed us that from a laboratory point of view 
amniocentesis is to be preferred over chorionic villus sampling atlow (cytogenetic) risks 
« 3%) and chorionic villus sampling should be the prenatal test of choice at high 
(cytogenetic) risks (;,; 3%). 
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Dit proefschrift beschrijft onderzoek naar de kwaliteit en de betrouwbaarheid van 
cytogenetische diagnostiek in vruchtwater en chorionvlokken. 
De vruchtwaterpunctie en de vlokkentest zijn de twee routinematig gebruikte 
technieken voor het verkrijgen van foetaal materiaal ten behoeve van prenataal 
laboratoriumonderzoek. Prenataal onderzoek omvat DNA-analyse, biochemische 
studies en cytogenetisch onderzoek (karyotypering en fluorescentie in situ hybridisatie). 
Hoofdstuk 1 start met een korte beschrijving van de geschiedenis van de prenatale 
diagnostiek. Mogelijke verklaringen en antwoorden worden gegeven op de vraag 
waarom de vlokkentest in het eerste trimester van de zwangerschap nooit de 
populariteit van de vruchtwaterpunctie in het tweede trimester heeft gehaald. 
Aansluitend richt de aandacht zich op laboratorium gerelateerde problemen als: 1) 
chromosoom kwaliteit, 2) mislukken van het onderzoek; 3) discrepanties tussen het 
karyotype in het prenataal onderzochte materiaal en de foetus. Dit laatste blijkt het 
grootste probleem te zijn en hangt samen met het ontstaan van mozaïeken in een vroeg 
stadium van het embryo en de daarop volgende distributie van normale- en afwijkende 
cellen over de verschillende embryonale compartimenten. 
Het hoofdstuk sluit afmet een beschrijving van twee uitgebreide protocollen. Ten eerste 
voor de differentiatie tussen pseudomozaïeken en een werkelijk mozaïek in vruchtwater 
cellen en ten tweede voor de differentiatie tussen gegeneraliseerde mozaïeken en 
mozaïeken beperkt tot de placenta in cellen van de chorionvlokken. 
Hoofdstuk 2 richt zich op de resultaten van afwijkende karyotypes in semi-directe 
vlokken (STC-villi). In een periode van 6 jaar (1993-1999) zijn 3499 STC-villi onderzocht 
en werden er 219 afwijkende karyotypes gevonden welke in twee groepen werden 
onderverdeeld; zeker afwijkend (n=110) en onzeker afwijkend (n=109). Voor de laatste 
groep was vervolgonderzoek noodzakelijk. De voorspellende waarde van de zekere 
uitslagen verdeeld over de verschillende indicaties scoorde het best bij de hoge risico's 
(vrouwen van 40 jaar en ouder, dragers van structurele afwijkingen en 
zwangerschappen met echo afwijkingen). 
Naar aanleiding van het hoge aantal vervolgonderzoeken na onzekere uitslagen 
gevonden in STC-vilIi, verdiende het aanbeveling om zowel STC-villi als gekweekte 
vlokken (LTC-vilIi) te onderzoeken. Tevens kregen vrouwen met een hoog risico, naar 
aanleiding van deze studie, desgevraagd het advies om een vlokken test te ondergaan 
in plaats van een vruchtwaterpunctie. 
In hoofdstuk 3 wordt een gedetailleerde studie naar de cytogenetische resultaten van 
1838 vlokkentetsen (1997 tot en met 1999) gepresenteerd. Deze studie had tot doel te 
onderzoeken of de in 1996 gedane aanbevelingen om zowel STC-villi als LTC-vilIi te 
onderzoeken werkelijk een betere chromosoomkwaliteit opleverde en resulteerde in een 
afname van het aantal onzekere resultaten. 
In deze studie was er in 85% van de vlokkentesten voldoende materiaal om beide 
compartimenten (STC- + LTC-villi) te onderzoeken. Van de resterende 15% was er niet 
genoeg materiaal beschikbaar en kon alleen het compartiment van de STC-vilIi 
onderzocht worden. In 158 patiënten werden afwijkende karyotypes gevonden (8.6%) 
welke in zes categorieën werden onderverdeeld. Uiteindelijk bleken slechts 34 uitslagen 
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(21.5%) werkelijk onzeker te zijn. In dit hoofdstuk zijn ook voorbeelden te zien waar de 
verbetering van de kwaliteit van chromosomen in LTC-villi duidelijk blijkt. Samen met 
het hoge percentage zekere uitslagen en de sterke afname van het aantal 
vervolgonderzoeken kan gesteld worden dat een hoge kwaliteit en betrouwbaarheid 
alleen bereikt kan worden als zowel de STC- en de LTC-villi worden onderzocht. 
Hoofdstuk 4 betreft een studie waarbij de vruchtwaterpunctie en de vlokkentest met 
elkaar vergeleken worden in geval van meerling-zwangerschappen. Een evaluatie van 
laboratoriumaspecten en de consequenties van discordante uitslagen van 500 meerling-
zwangerschappen is daarbij opgenomen. 
Er werd een onderverdeling gemaakt in vier groepen: 1) tweelingen met twee 
vruchtwaterpuncties; 2) tweelingen met twee vlokkentesten; 3) tweelingen met twee 
verschillende afnames of slechts één afname; 4) drielingen. In 7 zwangerschappen 
werden na een vlokkentest onzekere uitslagen gevonden en in 1 na een 
vruchtwaterpunctie. In alle 8 zwangerschappen werd vervolgonderzoek verricht. 
Vruchtwaterpunctie en vlokkentest met elkaar vergelijkend in geval van meerling-
zwangerschappen gaf de volgende conclusies. Er is een groter risico op 
vervolgonderzoek na een vlokkentest. Dit percentage is echter tot een minimum terug 
te brengen wanneer zowel STC- als LTC-villi wordt onderzocht. Er is een zeker risico 
opcross-contarninatie bij een vlokkentest wat een probleem bij biochemische bepalingen 
kan vormen. Er is een geringere kans op het verlies van de gezonde foetus na een 
selectieve reductie uitgevoerd na de vlokkentest dan na de vruchtwaterpunctie. 
In hoofdstuk 5 wordt de diagnostische kwaliteit van cytogenetisch onderzoek na een 
vruchtwaterpunctie vergeleken met die na de vlokkentest met als doel een antwoord te 
kunnen geven op de vraag of en wanneer de vruchtwaterpunctie dan wel de vlokkentest 
de voorkeur geniet. Gedurende een periode van zeven jaar (1993-1999) zijn er 11.883 
vIuchtwatermonsteIs en 5328 vlokkenmonsters onderzocht. 
Het percentage van mislukte onderzoeken, de kwaliteit en de representativiteit van de 
karyotypen werden daarbij gemeten. 
Het aantal mislukte onderzoeken bij beide bleek erg laag (0.5%). De kwaliteit van de 
chromosomen van vruchtwatercellen en LTC-villi was gelijk, terwijl de kwaliteit in de 
STC-villi beduidend minder was. 
Het aantal vervolgonderzoeken om kwaliteitsredenen was ook gelijk. Het aantal 
vervolgonderzoeken als gevolg van representativiteit echter, was bij STC-villi het hoogst 
en bij vruchtwater het laagst. Hieraan ligt een biologische oorzaak ten grondslag. Een 
mozaïek in de blastomeren van een jong embryo kan leiden tot een ongelijke verdeling 
van afwijkende en normale cellen tussen de verschillende embryonale compartimenten; 
de trophoblast cellen (STC-villi), cellen van het extra embryonale mesoderm (LTC-villi) 
en cellen van de toekomstige foetus (vruchtwatercellen). 
Deze studie liet wel zien dat de verhouding van het totaal aantal vervolgonderzoeken, 
in relatie tot onzekere en zeker- afwijkende uitslagen na de vlokkentest bij hoge risico's 
(<:3%) gelijk was aan die na de vruchtwaterpunctie bij lage risico's « 3%). Vanuit 
laboratorium oogpunt gaat de voorkeur uit naar een vruchtwaterpunctie waar het lage 
risico's betreft en naar de vlokkentest bij hoge risicogroepen (2: 3%). 
Tijdens de eerder beschreven studies deden zich regelmatig terugkerende specifieke 
problemen voor welke in hoofdstuk 6 onder de loep zijn genomen. 
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In hoofdstuk 6.1 wordt een overzicht gegeven van acht casussen met of een volledige 
trisomie 9, een mozaïek trisomie 9, een pseudomozaïek of een mozaïek beperkt tot de 
placenta. Centraal hierbij staan de te nemen essentiële stappen om onderscheid te 
kUIUlen maken tussen de verschillende mozaïeken en het gebruik van FISH. 
Hoofdstuk 6.2 betreft een evaluatie met betrekking tot het voorkomen van tetraploide 
metafases in chorionvlokken. Aansluitend wordt een werkprotocol geïntroduceerd om 
ingeval van tetraploidie mozaïeken het aantal vervolgonderzoeken terug te dringen met 
behoud van diagnostische accuraatheid. 
Hetvoorkomen van isochromosomen en een hypothese over het ontstaans-mechanisme 
van isochromosoom l8p en l8q wordt in hoofdstuk 6.3 besproken. 
In hoofdstuk 6.4 wordt een casus besproken met een mozaïek 45,Xj46,XY. Na de 
vlokkentest werd een 45,X karyotype in STC-villi een 46,XY karyotype in LTC-villi. 
Vervolgonderzoek in vruchtwatercellen liet een mozaiek 45,Xj46,XY zien. Ook hier 
werd door middel van uitgebreid follow up onderzoek een verklaring in het ontstaans-
mechanisme neergelegd. 
Tot slot worden in hoofdstuk 7 de conclusies en implicaties van alle hoofdstukken 
bediscussieerd. Alle resultaten vormen een zeer gedetailleerde documentatie over de 
accuraatheid en betrouwbaarheid van prenataal cytogenetisch onderzoek middels 
vruchtwaterpunctie en vlokkentest. 
Uit de in dit proefschrift beschreven resultaten kan worden afgeleid dat, vanuit 
laboratorium oogpunt gezien, een vruchtvvaterpunctie wordt verkozen boven een 
vlokkentest als het gaat om de lage risico's «3%) en dat bij de hoge risico's (<:3%) een 
vlokkentest geadviseerd en verkozen wordt boven een vruchtwaterpunctie. 
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Dankwoord 
Het schrijven van de laatste bladzijden van mijn boekje, het dankwoord, geeft na de 
geleverde inspanningen een voldaan gevoel. Wat dat betreft lijkt een promotie-
onderzoek op een rugzakvakantie in de bergen. Je hebt mooie dagen en je hebt zware 
dagen, maar altijd is er weer dat voldane gevoel als je 's-avonds je kamp opslaat. 
Datzelfde gevoel kreeg ik ook als er weer een artikel werd geaccepteerd. Echter, waar 
bij het wandelen de druk van de rugzak steeds meer afneemt, lijkt bij het schrijven van 
het proefschrift de druk eerder toe te nemen. Maar nu bij het afronden ervan, is de 
rugzak leeg en ligt de hele tocht in dit proefschrift vastgelegd. De druk is eraf! 
De tocht van het promoveren was echter niet mogelijk geweest zonder de hulp van drie 
gidsen. Als eerste gaat mijn oprechte dank naar mijn allereerste gids professor Sachs. 
Mevrouw Sachs, u bent degene geweest die mij in contact heeft gebracht met de natuur 
van de prenatale cytogenetica, en mij het vak leerde. Na een survivaltocht door het 
gebied van de prenatale cytogenetica, waarbij u mij als goede gids van advies voorzag, 
kon ik met een goed gevulde rugzak aan de tocht van promoveren beginnen. 
Mijn tweede gids en co-promotor Frans Los ben ik ook veel dank verschuldigd. Frans, 
jij bent degene geweest die mijn ambitie om te promoveren gestalte heeft gegeven. Je 
hebt mij begeleid in het vinden van de juiste route en hebt mij tijdens mijn tocht behoed 
voor de valkuilen. Soms verschillenden we van mening, maar net als op een 
wandelkaart vormde de variant dan de oplossing. Je steun en vertrouwen in mij heeft 
er mede voor gezorgd dat ik me beter heb kunnen ontplooien. Het resultaat daarvan ligt 
nu vast in dit proefschrift en we gaan vast en zeker op zoek naar nieuwe uitdagingen. 
Om sommige landen en gebieden te mogen bezoeken heb je een visum en soms ook nog 
een permit nodig. Mijn visum en permit voor de tocht van promoveren heb ik te danken 
aan mijn derde gids en promotor professor Galjaard. Professor Galjam'd, ik ben u veel 
dank verschuldigd, voor het vertrouwen dat u al die jaren in mij heeft gehad en dat u 
mij de gelegenheid hebt gegeven om te kunnen promoveren. Het feit dat de deur van 
uw kmner altijd voor mij openstond èn ik geen belemmering voelde om bij u aan te 
kloppen heb ik altijd als zeer prettig ervaren en zal ik zeker missen. 
Wanneer je een grote verre reis gaat maken dan komt daar veel voor kljken. Als je 
bijvoorbeeld een trekking gaat doen moet er behalve visum, permit en gidsen nog veel 
meer geregeld worden zoals; hulpgids(en), dragers, kok en keukenhulpen. Zo komt er 
bij het werken aan een proefschrift ook veel kljken. Dus, naast de eerder genoemde 
gidsen gaat mijn dank ook uit naar al degene die meehielpen mijn reis te voltooien en 
mijn reisverslag of een deel daarvan met kritische blik hebben gelezen en van 
commentaar hebben voorzien. Ik denk daarbij natuurlijk aan de leden van de kleine 
commissie die ik erkentelijk ben voor het snelle beoordelen van mijn boekje. 
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Daar ik al heel wat jaren op de prenatale diagnostiek werk heb ik met heel veel mensen 
samengewerkt. Zou ik deze met naam en toename gaan noemen dan zou ik zeker 
mensen vergeten of te kort doen. 
De medewerkers van de 24ste, met name die van postnataal, biochemie en de 
medewerkers van de sector prenatale diagnostiek van Dijkzigt en Dordt wil ik bedanken 
voor hun prettige samenwerking. 
Het DNA lab wil ik danken voor hun gastvrijheid en de inspanningen die ze geleverd 
hebben om mij wegwijs te maken in enkele DNA technieken. Datgene wat ik bij jullie 
geleerd heb is ook in dit boekje terug te vinden. 
Natuurlijk gaat mijn dank ook uit naar al die medewerkers/ collega' s die er steeds weer 
voor zorgen dat het lab optimaal kan functioneren. Dank voor al het steriele glaswerk, 
de foto' s , bestellingen en niet te vergeten het secretariële werk. 
Bij het schrijven van dit dankwoord heb ik er voor gekozen om eigenlijk zo min mogelijk 
namen te noemen om te voorkomen dat ik iemand afvergeet of te kort doe. Toch valt 
dat niet mee wanneer ik uiteindelijk bij de belangrijkste crew van mijn tocht beland en 
dat zijn de harde werkers van het prenatale lab. Tegen al mijn collega's van het 
prenatale diagnostiek lab durf ik met enige trots het volgende te zeggen: "Jullie inzet en 
betrokkenheid vormen de kern en de kracht van de afdeling". Hetfeit dat hier een team 
werkt heeft mij in de gelegenheid gesteld om mijn aandacht te verdelen tussen mijn 
dagelijkse werkzaamheden en het schrijven van artikelen en het afronden van dit 
proefschrift. Mijn dank is niet alleen voor jullie keiharde werken en jullie hulp maar ook 
voor jullie begrip, niet alleen voor mij maar ook voor elkaar. 
Voor mijn twee paranimfen, Armando en Diane, wil ik net als mijn drie gidsen een 
uitzondering maken in de vorm van een persoonlijke noot. 
Armando, ik ben blij dat je mijn paranimf wil zijn (en blijven). Jouw inzet en 
betrokkenheid voor het lab is niet alleen voor mij maar voor het hele lab van 
onschatbare waarde geweest. Je liefde voor computers heeft het uiteindelijk gewonnen 
en ik wens je dan ook veel succes bij je nieuwe uitdaging. 
Diane, het feit dat jij vanaf het moment dat ik het je vertelde, heel enthousiast en positief 
met mijn promotie plannen bent omgegaan heeft mij meer dan goed gedaan. Ik ben blij 
dat we goede collega' s zijn en datik op mijn beurt veel van je kan Ieren. Ik hoop dan ook 
dat we nog lang en met heel veel plezier en wederzijds respect collega's zullen blijven. 
Het leven buiten het lab speelt natuurlijk ook een grote rol en vandaar dat ik de laatste 
alinea's aan fanrilie en vrienden wil wijden. Lieve mensen, de aandacht en interesse in 
mijn voortgang van mijn proefschrift die ik van jullie kreeg hebben mij veel goed 
gedaan. Tijdens alle etentjes, borrels, weekendjes Ardennen, zeil- en kanotochtjes, 
weekjes Verdon, en andere uitstapjes kreeg ik altijd jullie aandacht. Dit heeft mij vaak 
weer een stukje extra energie gegeven op die momenten waar ik het harder nodig had 
dan menigeen besefte. Ik ben jullie daar veel dank voor verschuldigd. Hopelijk gaan we 
weer snel wat ondernemen! 
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Tijdens de tocht van het promoveren heb ik natuurlijk veel aan het thuisfront gedacht. 
Immers, dank zij hen kreeg ik het vermogen en de vrijheid om zo'n belangrijke tocht als 
deze te ondernemen. 
Lieve pa en ma, ik weet dat jullie trots op mij zijn maar misschien ben ik nog wel trotser 
op jullie, want voor een heel groot deel ben ik dankzij jullie diegene die ik nu ben. Het 
doorzettingsvermogen, zeker in moeilijke tijden, is een goede voorbeeldfunctie geweest 
waar ik veel aan heb gehad en nog steeds heb. 
Robert, jij bent de laatste maar wel de belangrijkste die ik wil bedanken. Soms was het 
moeilijk om alle bagage in mijn rugzak mee te nemen en de juiste balans te vinden op 
het soms moeilijk begaanbare pad. Gelukkig was jij er dan altijd die mij in alle rust 
bijstond. Ik besef dat ik je veel dank ben verschuldigd en ik zou niet weten hoe het 
zonder jou en je 'mooi' had gemoeten. 
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Stellingen 
behorend bij het proefschrift 
Quality and Reliability of Prenatal Cytogenetics 
1. Cytogenetische discrepanties tussen chorion vlokken en foetus zijn in principe te 
verklaren door de distributie van cellen over de verschillende embryonale 
compartimenten. 
Dit proefschlift 
2. Een betrouwbare cytogenetische diagnose in chorion vlokken kan alleen worden 
gesteld wanneer zowelcytotrophoblast-cellen als cellen uit de mesenchymale kern 
zijn onderzocht. 
Dit proefsc/llift 
3. Bij monochoriale bianmiotische tweelingen is het van belang om in geval van een 
vlokkentest beide foetus en beide compartimenten van de vlokken te 
onderzoeken. 
Dit proefschrift 
4. Bij meerlingzwangerschappen verdient de vlokkentest de voorkeur boven de 
vruchtwaterpunctie. 
Dit proefschrift 
5. De afname van het aantal vlokkentesten ten opzichte van het aantal 
vruchtwaterpuncties is eerder te verklaren door een selectief gebruik dan door 
beperkingen van de vlokkentest. 
Dit proefschrift 
6. Het inbrengen van mitochondriaal DNA van een jonge donorvrouw in eicellen 
van onvruchtbare vrouwen lijkt technisch veelbelovend ware het niet dat deze 
ooplasma transfer ook erfelijke ziektes kan introduceren. 
7. Als serurnscreening ook gebruikt zou kunnen worden om de juistheid van een 
politiek besluit te bepalen, zou deze test nooit door de Kamer worden 
aangenomen. 
8. Het ontrafelen van het menselijk genoom is een voorbeeld van het vinden van 
antwoorden op nog onbekende vragen. 
9. Het begrip wetenschap suggereert dat kennis op een plank ligt. 
10. Naarmate de belijders van een geloof sterker georganiseerd raken, neemt de mate 
van tolerantie af. 
11. Als je kennis wilt vermenigvuldigen, moet je bereid zijn haar te delen. 
Rotterdam, 9 januari 2002 
Cardi van den Berg 
